{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:16:23Z","timestamp":1795148183271,"version":"4.10.3"},"reference-count":1108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    T cells are crucial for immune functions to maintain health and prevent disease. T cell development occurs in a stepwise process in the thymus and mainly generates CD4\n                    <jats:sup>+<\/jats:sup>\n                    and CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell subsets. Upon antigen stimulation, na\u00efve T cells differentiate into CD4\n                    <jats:sup>+<\/jats:sup>\n                    helper and CD8\n                    <jats:sup>+<\/jats:sup>\n                    cytotoxic effector and memory cells, mediating direct killing, diverse immune regulatory function, and long-term protection. In response to acute and chronic infections and tumors, T cells adopt distinct differentiation trajectories and develop into a range of heterogeneous populations with various phenotype, differentiation potential, and functionality under precise and elaborate regulations of transcriptional and epigenetic programs. Abnormal T-cell immunity can initiate and promote the pathogenesis of autoimmune diseases. In this review, we summarize the current understanding of T cell development, CD4\n                    <jats:sup>+<\/jats:sup>\n                    and CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell classification, and differentiation in physiological settings. We further elaborate the heterogeneity, differentiation, functionality, and regulation network of CD4\n                    <jats:sup>+<\/jats:sup>\n                    and CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells in infectious disease, chronic infection and tumor, and autoimmune disease, highlighting the exhausted CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell differentiation trajectory, CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cell helper function, T cell contributions to immunotherapy and autoimmune pathogenesis. We also discuss the development and function of \u03b3\u03b4 T cells in tissue surveillance, infection, and tumor immunity. Finally, we summarized current T-cell-based immunotherapies in both cancer and autoimmune diseases, with an emphasis on their clinical applications. A better understanding of T cell immunity provides insight into developing novel prophylactic and therapeutic strategies in human diseases.\n                  <\/jats:p>","DOI":"10.1038\/s41392-023-01471-y","type":"journal-article","created":{"date-parts":[[2023,6,18]],"date-time":"2023-06-18T20:02:08Z","timestamp":1687118528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1068,"title":["T cells in health and disease"],"prefix":"10.1038","volume":"8","author":[{"given":"Lina","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjun","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7786-4304","authenticated-orcid":false,"given":"Baojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"key":"1471_CR1","doi-asserted-by":"publisher","first-page":"a028621","DOI":"10.1101\/cshperspect.a028621","volume":"10","author":"H Hosokawa","year":"2018","unstructured":"Hosokawa, H. & Rothenberg, E. V. Cytokines, transcription factors, and the initiation of T-cell development. Cold Spring Harb. Perspect. Biol. 10, a028621 (2018).","journal-title":"Cold Spring Harb. Perspect. Biol"},{"key":"1471_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nri3702","volume":"14","author":"MA Yui","year":"2014","unstructured":"Yui, M. A. & Rothenberg, E. V. Developmental gene networks: a triathlon on the course to T cell identity. Nat. Rev. Immunol. 14, 529\u2013545 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41577-020-00426-6","volume":"21","author":"H Hosokawa","year":"2021","unstructured":"Hosokawa, H. & Rothenberg, E. V. How transcription factors drive choice of the T cell fate. Nat. Rev. Immunol. 21, 162\u2013176 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri2232","volume":"8","author":"EV Rothenberg","year":"2008","unstructured":"Rothenberg, E. V., Moore, J. E. & Yui, M. A. Launching the T-cell-lineage developmental programme. Nat. Rev. Immunol. 8, 9\u201321 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1600-065X.2010.00956.x","volume":"238","author":"Q Yang","year":"2010","unstructured":"Yang, Q., Jeremiah Bell, J. & Bhandoola, A. T-cell lineage determination. Immunol. Rev. 238, 12\u201322 (2010).","journal-title":"Immunol. Rev."},{"key":"1471_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/imr.12398","volume":"271","author":"N Kurd","year":"2016","unstructured":"Kurd, N. & Robey, E. A. T-cell selection in the thymus: a spatial and temporal perspective. Immunol. Rev. 271, 114\u2013126 (2016).","journal-title":"Immunol. Rev."},{"key":"1471_CR7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.it.2021.06.005","volume":"42","author":"A Dutta","year":"2021","unstructured":"Dutta, A., Zhao, B. & Love, P. E. New insights into TCR beta-selection. Trends Immunol. 42, 735\u2013750 (2021).","journal-title":"Trends Immunol."},{"key":"1471_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nri1781","volume":"6","author":"Y Takahama","year":"2006","unstructured":"Takahama, Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat. Rev. Immunol. 6, 127\u2013135 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nri3667","volume":"14","author":"L Klein","year":"2014","unstructured":"Klein, L., Kyewski, B., Allen, P. M. & Hogquist, K. A. Positive and negative selection of the T cell repertoire: what thymocytes see (and don\u2019t see). Nat. Rev. Immunol. 14, 377\u2013391 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR10","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.284.5415.770","volume":"284","author":"S Artavanis-Tsakonas","year":"1999","unstructured":"Artavanis-Tsakonas, S., Rand, M. D. & Lake, R. J. Notch signaling: cell fate control and signal integration in development. Science 284, 770\u2013776 (1999).","journal-title":"Science"},{"key":"1471_CR11","doi-asserted-by":"publisher","first-page":"6649","DOI":"10.4049\/jimmunol.1003703","volume":"186","author":"EV Rothenberg","year":"2011","unstructured":"Rothenberg, E. V. T cell lineage commitment: identity and renunciation. J. Immunol. 186, 6649\u20136655 (2011).","journal-title":"J. Immunol."},{"key":"1471_CR12","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1084\/jem.194.7.1003","volume":"194","author":"A Wilson","year":"2001","unstructured":"Wilson, A., MacDonald, H. R. & Radtke, F. Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J. Exp. Med. 194, 1003\u20131012 (2001).","journal-title":"J. Exp. Med."},{"key":"1471_CR13","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/intimm\/dxf030","volume":"14","author":"H Han","year":"2002","unstructured":"Han, H. et al. Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int. Immunol. 14, 637\u2013645 (2002).","journal-title":"Int. Immunol."},{"key":"1471_CR14","doi-asserted-by":"publisher","first-page":"20060","DOI":"10.1073\/pnas.1110230108","volume":"108","author":"K Germar","year":"2011","unstructured":"Germar, K. et al. T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling. Proc. Natl Acad. Sci. USA 108, 20060\u201320065 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR15","doi-asserted-by":"publisher","first-page":"eaaw7313","DOI":"10.1126\/sciadv.aaw7313","volume":"6","author":"L Garcia-Perez","year":"2020","unstructured":"Garcia-Perez, L. et al. Functional definition of a transcription factor hierarchy regulating T cell lineage commitment. Sci. Adv. 6, eaaw7313 (2020).","journal-title":"Sci. Adv."},{"key":"1471_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nature10279","volume":"476","author":"BN Weber","year":"2011","unstructured":"Weber, B. N. et al. A critical role for TCF-1 in T-lineage specification and differentiation. Nature 476, 63\u201368 (2011).","journal-title":"Nature"},{"key":"1471_CR17","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1182\/blood-2012-08-447839","volume":"122","author":"L Li","year":"2013","unstructured":"Li, L. et al. A far downstream enhancer for murine Bcl11b controls its T-cell specific expression. Blood 122, 902\u2013911 (2013).","journal-title":"Blood"},{"key":"1471_CR18","doi-asserted-by":"publisher","first-page":"e37851","DOI":"10.7554\/eLife.37851","volume":"7","author":"KK Ng","year":"2018","unstructured":"Ng, K. K. et al. A stochastic epigenetic switch controls the dynamics of T-cell lineage commitment. Elife. 7, e37851 (2018).","journal-title":"Elife"},{"key":"1471_CR19","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/ni.3514","volume":"17","author":"HY Kueh","year":"2016","unstructured":"Kueh, H. Y. et al. Asynchronous combinatorial action of four regulatory factors activates Bcl11b for T cell commitment. Nat. Immunol. 17, 956\u2013965 (2016).","journal-title":"Nat. Immunol."},{"key":"1471_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.1188063","volume":"329","author":"P Li","year":"2010","unstructured":"Li, P. et al. Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion. Science 329, 85\u201389 (2010).","journal-title":"Science"},{"key":"1471_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.1188989","volume":"329","author":"L Li","year":"2010","unstructured":"Li, L., Leid, M. & Rothenberg, E. V. An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. Science 329, 89\u201393 (2010).","journal-title":"Science"},{"key":"1471_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1126\/science.1188995","volume":"329","author":"T Ikawa","year":"2010","unstructured":"Ikawa, T. et al. An essential developmental checkpoint for production of the T cell lineage. Science 329, 93\u201396 (2010).","journal-title":"Science"},{"key":"1471_CR23","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/s41590-018-0238-4","volume":"19","author":"H Hosokawa","year":"2018","unstructured":"Hosokawa, H. et al. Bcl11b sets pro-T cell fate by site-specific cofactor recruitment and by repressing Id2 and Zbtb16. Nat. Immunol. 19, 1427\u20131440 (2018).","journal-title":"Nat. Immunol."},{"key":"1471_CR24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41590-020-00833-w","volume":"22","author":"ACF Ferreira","year":"2021","unstructured":"Ferreira, A. C. F. et al. RORalpha is a critical checkpoint for T cell and ILC2 commitment in the embryonic thymus. Nat. Immunol. 22, 166\u2013178 (2021).","journal-title":"Nat. Immunol."},{"key":"1471_CR25","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.immuni.2017.04.022","volume":"46","author":"M Miyazaki","year":"2017","unstructured":"Miyazaki, M. et al. The E-Id protein axis specifies adaptive lymphoid cell identity and suppresses thymic innate lymphoid cell development. Immunity 46, 818\u2013834 e814 (2017).","journal-title":"Immunity"},{"key":"1471_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.immuni.2015.12.007","volume":"44","author":"RB Delconte","year":"2016","unstructured":"Delconte, R. B. et al. The helix-loop-helix protein ID2 governs NK cell fate by tuning their sensitivity to interleukin-15. Immunity 44, 103\u2013115 (2016).","journal-title":"Immunity"},{"key":"1471_CR27","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1084\/jem.20061959","volume":"204","author":"MD Boos","year":"2007","unstructured":"Boos, M. D., Yokota, Y., Eberl, G. & Kee, B. L. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J. Exp. Med. 204, 1119\u20131130 (2007).","journal-title":"J. Exp. Med."},{"key":"1471_CR28","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1084\/jem.20140145","volume":"211","author":"C Seillet","year":"2014","unstructured":"Seillet, C. et al. Nfil3 is required for the development of all innate lymphoid cell subsets. J. Exp. Med. 211, 1733\u20131740 (2014).","journal-title":"J. Exp. Med."},{"key":"1471_CR29","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.1073\/pnas.1423244112","volume":"112","author":"MG Constantinides","year":"2015","unstructured":"Constantinides, M. G. et al. PLZF expression maps the early stages of ILC1 lineage development. Proc. Natl Acad. Sci. USA 112, 5123\u20135128 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.immuni.2008.07.011","volume":"29","author":"AK Savage","year":"2008","unstructured":"Savage, A. K. et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29, 391\u2013403 (2008).","journal-title":"Immunity"},{"key":"1471_CR31","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ni.1887","volume":"11","author":"AC Carpenter","year":"2010","unstructured":"Carpenter, A. C. & Bosselut, R. Decision checkpoints in the thymus. Nat. Immunol. 11, 666\u2013673 (2010).","journal-title":"Nat. Immunol."},{"key":"1471_CR32","doi-asserted-by":"publisher","first-page":"28646","DOI":"10.18632\/oncotarget.5796","volume":"6","author":"H Sahni","year":"2015","unstructured":"Sahni, H. et al. A genome wide transcriptional model of the complex response to pre-TCR signalling during thymocyte differentiation. Oncotarget 6, 28646\u201328660 (2015).","journal-title":"Oncotarget"},{"key":"1471_CR33","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.4049\/jimmunol.1003567","volume":"186","author":"N Harker","year":"2011","unstructured":"Harker, N. et al. Pre-TCR signaling and CD8 gene bivalent chromatin resolution during thymocyte development. J. Immunol. 186, 6368\u20136377 (2011).","journal-title":"J. Immunol."},{"key":"1471_CR34","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/375795a0","volume":"375","author":"HJ Fehling","year":"1995","unstructured":"Fehling, H. J., Krotkova, A., Saint-Ruf, C. & von Boehmer, H. Crucial role of the pre-T-cell receptor alpha gene in development of alpha beta but not gamma delta T cells. Nature 375, 795\u2013798 (1995).","journal-title":"Nature"},{"key":"1471_CR35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1074-7613(00)80381-7","volume":"7","author":"I Aifantis","year":"1997","unstructured":"Aifantis, I., Buer, J., von Boehmer, H. & Azogui, O. Essential role of the pre-T cell receptor in allelic exclusion of the T cell receptor beta locus. Immunity 7, 601\u2013607 (1997).","journal-title":"Immunity"},{"key":"1471_CR36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/360225a0","volume":"360","author":"P Mombaerts","year":"1992","unstructured":"Mombaerts, P. et al. Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature 360, 225\u2013231 (1992).","journal-title":"Nature"},{"key":"1471_CR37","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1101\/gad.10.8.948","volume":"10","author":"ES Hoffman","year":"1996","unstructured":"Hoffman, E. S. et al. Productive T-cell receptor beta-chain gene rearrangement: coincident regulation of cell cycle and clonality during development in vivo. Genes Dev. 10, 948\u2013962 (1996).","journal-title":"Genes Dev."},{"key":"1471_CR38","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1084\/jem.172.6.1583","volume":"172","author":"HT Petrie","year":"1990","unstructured":"Petrie, H. T., Hugo, P., Scollay, R. & Shortman, K. Lineage relationships and developmental kinetics of immature thymocytes: CD3, CD4, and CD8 acquisition in vivo and in vitro. J. Exp. Med. 172, 1583\u20131588 (1990).","journal-title":"J. Exp. Med"},{"key":"1471_CR39","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S1074-7613(02)00474-0","volume":"17","author":"TM Schmitt","year":"2002","unstructured":"Schmitt, T. M. & Zuniga-Pflucker, J. C. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17, 749\u2013756 (2002).","journal-title":"Immunity"},{"key":"1471_CR40","doi-asserted-by":"publisher","first-page":"5230","DOI":"10.4049\/jimmunol.172.9.5230","volume":"172","author":"M Ciofani","year":"2004","unstructured":"Ciofani, M. et al. Obligatory role for cooperative signaling by pre-TCR and Notch during thymocyte differentiation. J. Immunol. 172, 5230\u20135239 (2004).","journal-title":"J. Immunol."},{"key":"1471_CR41","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1146\/annurev.immunol.23.021704.115747","volume":"23","author":"I Maillard","year":"2005","unstructured":"Maillard, I., Fang, T. & Pear, W. S. Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu Rev. Immunol. 23, 945\u2013974 (2005).","journal-title":"Annu Rev. Immunol."},{"key":"1471_CR42","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/ni1234","volume":"6","author":"M Ciofani","year":"2005","unstructured":"Ciofani, M. & Zuniga-Pflucker, J. C. Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. Nat. Immunol. 6, 881\u2013888 (2005).","journal-title":"Nat. Immunol."},{"key":"1471_CR43","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S1074-7613(02)00330-8","volume":"16","author":"A Wolfer","year":"2002","unstructured":"Wolfer, A. et al. Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta lineage thymocytes. Immunity 16, 869\u2013879 (2002).","journal-title":"Immunity"},{"key":"1471_CR44","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.4049\/jimmunol.1801650","volume":"202","author":"A Rodriguez-Caparros","year":"2019","unstructured":"Rodriguez-Caparros, A. et al. Notch signaling controls transcription via the recruitment of RUNX1 and MYB to enhancers during T cell development. J. Immunol. 202, 2460\u20132472 (2019).","journal-title":"J. Immunol."},{"key":"1471_CR45","doi-asserted-by":"publisher","first-page":"e69975","DOI":"10.7554\/eLife.69975","volume":"10","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. Notch-induced endoplasmic reticulum-associated degradation governs mouse thymocyte beta-selection. Elife. 10, e69975 (2021).","journal-title":"Elife"},{"key":"1471_CR46","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41590-019-0469-z","volume":"20","author":"B Zhao","year":"2019","unstructured":"Zhao, B. et al. Notch and the pre-TCR coordinate thymocyte proliferation by induction of the SCF subunits Fbxl1 and Fbxl12. Nat. Immunol. 20, 1381\u20131392 (2019).","journal-title":"Nat. Immunol."},{"key":"1471_CR47","doi-asserted-by":"publisher","first-page":"e201908108","DOI":"10.1083\/jcb.201908108","volume":"220","author":"AH Allam","year":"2021","unstructured":"Allam, A. H., Charnley, M., Pham, K. & Russell, S. M. Developing T cells form an immunological synapse for passage through the beta-selection checkpoint. J. Cell Biol. 220, e201908108 (2021).","journal-title":"J. Cell Biol"},{"key":"1471_CR48","doi-asserted-by":"publisher","first-page":"e75508","DOI":"10.7554\/eLife.75508","volume":"11","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Zinc finger protein Zfp335 controls early T-cell development and survival through beta-selection-dependent and -independent mechanisms. Elife. 11, e75508 (2022).","journal-title":"Elife"},{"key":"1471_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33610-4","volume":"13","author":"JJ Ratiu","year":"2022","unstructured":"Ratiu, J. J. et al. Loss of Zfp335 triggers cGAS\/STING-dependent apoptosis of post-beta selection thymocytes. Nat. Commun. 13, 5901 (2022).","journal-title":"Nat. Commun."},{"key":"1471_CR50","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/335229a0","volume":"335","author":"HS Teh","year":"1988","unstructured":"Teh, H. S. et al. Thymic major histocompatibility complex antigens and the alpha beta T-cell receptor determine the CD4\/CD8 phenotype of T cells. Nature 335, 229\u2013233 (1988).","journal-title":"Nature"},{"key":"1471_CR51","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1146\/annurev-immunol-042617-053411","volume":"36","author":"I Taniuchi","year":"2018","unstructured":"Taniuchi, I. CD4 helper and CD8 cytotoxic T cell differentiation. Annu. Rev. Immunol. 36, 579\u2013601 (2018).","journal-title":"Annu. Rev. Immunol."},{"key":"1471_CR52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1074-7613(00)00008-X","volume":"13","author":"E Brugnera","year":"2000","unstructured":"Brugnera, E. et al. Coreceptor reversal in the thymus: signaled CD4\u2009+\u20098+ thymocytes initially terminate CD8 transcription even when differentiating into CD8\u2009+\u2009T cells. Immunity 13, 59\u201371 (2000).","journal-title":"Immunity"},{"key":"1471_CR53","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0952-7915(02)00323-0","volume":"14","author":"A Singer","year":"2002","unstructured":"Singer, A. New perspectives on a developmental dilemma: the kinetic signaling model and the importance of signal duration for the CD4\/CD8 lineage decision. Curr. Opin. Immunol. 14, 207\u2013215 (2002).","journal-title":"Curr. Opin. Immunol."},{"key":"1471_CR54","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0065-2776(04)83003-7","volume":"83","author":"A Singer","year":"2004","unstructured":"Singer, A. & Bosselut, R. CD4\/CD8 coreceptors in thymocyte development, selection, and lineage commitment: analysis of the CD4\/CD8 lineage decision. Adv. Immunol. 83, 91\u2013131 (2004).","journal-title":"Adv. Immunol."},{"key":"1471_CR55","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1084\/jem.20021765","volume":"197","author":"Q Yu","year":"2003","unstructured":"Yu, Q. et al. In vitro evidence that cytokine receptor signals are required for differentiation of double positive thymocytes into functionally mature CD8\u2009+\u2009T cells. J. Exp. Med. 197, 475\u2013487 (2003).","journal-title":"J. Exp. Med."},{"key":"1471_CR56","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nri2416","volume":"8","author":"A Singer","year":"2008","unstructured":"Singer, A., Adoro, S. & Park, J. H. Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice. Nat. Rev. Immunol. 8, 788\u2013801 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR57","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.4049\/jimmunol.1801464","volume":"202","author":"N Zeidan","year":"2019","unstructured":"Zeidan, N., Damen, H., Roy, D. C. & Dave, V. P. Critical Role for TCR signal strength and MHC specificity in ThPOK-induced CD4 helper lineage choice. J. Immunol. 202, 3211\u20133225 (2019).","journal-title":"J. Immunol."},{"key":"1471_CR58","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nature03338","volume":"433","author":"X He","year":"2005","unstructured":"He, X. et al. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment. Nature 433, 826\u2013833 (2005).","journal-title":"Nature"},{"key":"1471_CR59","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni1183","volume":"6","author":"G Sun","year":"2005","unstructured":"Sun, G. et al. The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection. Nat. Immunol. 6, 373\u2013381 (2005).","journal-title":"Nat. Immunol."},{"key":"1471_CR60","doi-asserted-by":"publisher","first-page":"8187","DOI":"10.1073\/pnas.95.14.8187","volume":"95","author":"VP Dave","year":"1998","unstructured":"Dave, V. P. et al. HD mice: a novel mouse mutant with a specific defect in the generation of CD4(+) T cells. Proc. Natl Acad. Sci. USA 95, 8187\u20138192 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR61","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/ni.1652","volume":"9","author":"T Egawa","year":"2008","unstructured":"Egawa, T. & Littman, D. R. ThPOK acts late in specification of the helper T cell lineage and suppresses Runx-mediated commitment to the cytotoxic T cell lineage. Nat. Immunol. 9, 1131\u20131139 (2008).","journal-title":"Nat. Immunol."},{"key":"1471_CR62","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1126\/science.1151844","volume":"319","author":"R Setoguchi","year":"2008","unstructured":"Setoguchi, R. et al. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science 319, 822\u2013825 (2008).","journal-title":"Science"},{"key":"1471_CR63","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/ni.1647","volume":"9","author":"L Wang","year":"2008","unstructured":"Wang, L. et al. Distinct functions for the transcription factors GATA-3 and ThPOK during intrathymic differentiation of CD4(\u2009+\u2009) T cells. Nat. Immunol. 9, 1122\u20131130 (2008).","journal-title":"Nat. Immunol."},{"key":"1471_CR64","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/ni.2917","volume":"15","author":"MA Luckey","year":"2014","unstructured":"Luckey, M. A. et al. The transcription factor ThPOK suppresses Runx3 and imposes CD4(+) lineage fate by inducing the SOCS suppressors of cytokine signaling. Nat. Immunol. 15, 638\u2013645 (2014).","journal-title":"Nat. Immunol."},{"key":"1471_CR65","doi-asserted-by":"publisher","first-page":"eabn5917","DOI":"10.1126\/sciimmunol.abn5917","volume":"7","author":"Y Gao","year":"2022","unstructured":"Gao, Y. et al. NuRD complex recruitment to Thpok mediates CD4(\u2009+\u2009) T cell lineage differentiation. Sci. Immunol. 7, eabn5917 (2022).","journal-title":"Sci. Immunol."},{"key":"1471_CR66","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0092-8674(02)01111-X","volume":"111","author":"I Taniuchi","year":"2002","unstructured":"Taniuchi, I. et al. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111, 621\u2013633 (2002).","journal-title":"Cell"},{"key":"1471_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00768-1","volume":"8","author":"S Kojo","year":"2017","unstructured":"Kojo, S. et al. Priming of lineage-specifying genes by Bcl11b is required for lineage choice in post-selection thymocytes. Nat. Commun. 8, 702 (2017).","journal-title":"Nat. Commun."},{"key":"1471_CR68","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1002\/eji.200940258","volume":"40","author":"P Kastner","year":"2010","unstructured":"Kastner, P. et al. Bcl11b represses a mature T-cell gene expression program in immature CD4(+)CD8(+) thymocytes. Eur. J. Immunol. 40, 2143\u20132154 (2010).","journal-title":"Eur. J. Immunol."},{"key":"1471_CR69","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1074-7613(03)00176-6","volume":"19","author":"G Hernandez-Hoyos","year":"2003","unstructured":"Hernandez-Hoyos, G. et al. GATA-3 expression is controlled by TCR signals and regulates CD4\/CD8 differentiation. Immunity 19, 83\u201394 (2003).","journal-title":"Immunity"},{"key":"1471_CR70","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S1074-7613(03)00328-5","volume":"19","author":"SY Pai","year":"2003","unstructured":"Pai, S. Y. et al. Critical roles for transcription factor GATA-3 in thymocyte development. Immunity 19, 863\u2013875 (2003).","journal-title":"Immunity"},{"key":"1471_CR71","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/ni.1840","volume":"11","author":"JH Park","year":"2010","unstructured":"Park, J. H. et al. Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells. Nat. Immunol. 11, 257\u2013264 (2010).","journal-title":"Nat. Immunol."},{"key":"1471_CR72","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1146\/annurev.immunol.16.1.523","volume":"16","author":"MM Davis","year":"1998","unstructured":"Davis, M. M. et al. Ligand recognition by alpha beta T cell receptors. Annu. Rev. Immunol. 16, 523\u2013544 (1998).","journal-title":"Annu. Rev. Immunol."},{"key":"1471_CR73","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","volume":"28","author":"J Zhu","year":"2010","unstructured":"Zhu, J., Yamane, H. & Paul, W. E. Differentiation of effector CD4 T cell populations (*). Annu. Rev. Immunol. 28, 445\u2013489 (2010).","journal-title":"Annu. Rev. Immunol"},{"key":"1471_CR74","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1146\/annurev-immunol-103019-085803","volume":"38","author":"M Ruterbusch","year":"2020","unstructured":"Ruterbusch, M., Pruner, K. B., Shehata, L. & Pepper, M. In vivo CD4(+) T cell differentiation and function: revisiting the Th1\/Th2 paradigm. Annu. Rev. Immunol. 38, 705\u2013725 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"1471_CR75","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3389\/fimmu.2014.00630","volume":"5","author":"J Geginat","year":"2014","unstructured":"Geginat, J. et al. Plasticity of human CD4 T cell subsets. Front. Immunol. 5, 630 (2014).","journal-title":"Front. Immunol."},{"key":"1471_CR76","doi-asserted-by":"publisher","first-page":"925135","DOI":"10.1155\/2012\/925135","volume":"2012","author":"RV Luckheeram","year":"2012","unstructured":"Luckheeram, R. V., Zhou, R., Verma, A. D. & Xia, B. CD4(+)T cells: differentiation and functions. Clin. Dev. Immunol. 2012, 925135 (2012).","journal-title":"Clin. Dev. Immunol."},{"key":"1471_CR77","doi-asserted-by":"publisher","first-page":"867189","DOI":"10.3389\/fimmu.2022.867189","volume":"13","author":"M Cenerenti","year":"2022","unstructured":"Cenerenti, M., Saillard, M., Romero, P. & Jandus, C. The era of cytotoxic CD4 T cells. Front. Immunol. 13, 867189 (2022).","journal-title":"Front. Immunol."},{"key":"1471_CR78","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cytogfr.2022.08.001","volume":"69","author":"HT Meitei","year":"2022","unstructured":"Meitei, H. T. & Lal, G. T cell receptor signaling in the differentiation and plasticity of CD4(+) T cells. Cytokine Growth Factor Rev. 69, 14\u201327 (2022).","journal-title":"Cytokine Growth Factor Rev"},{"key":"1471_CR79","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fonc.2013.00063","volume":"3","author":"MJ Dobrzanski","year":"2013","unstructured":"Dobrzanski, M. J. Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy. Front. Oncol. 3, 63 (2013).","journal-title":"Front. Oncol."},{"key":"1471_CR80","doi-asserted-by":"publisher","first-page":"a030338","DOI":"10.1101\/cshperspect.a030338","volume":"10","author":"J Zhu","year":"2018","unstructured":"Zhu, J. T helper cell differentiation, heterogeneity, and plasticity. Cold Spring Harb. Perspect. Biol. 10, a030338 (2018).","journal-title":"Cold Spring Harb. Perspect. Biol"},{"key":"1471_CR81","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41423-019-0220-6","volume":"16","author":"J Saravia","year":"2019","unstructured":"Saravia, J., Chapman, N. M. & Chi, H. Helper T cell differentiation. Cell Mol. Immunol. 16, 634\u2013643 (2019).","journal-title":"Cell Mol. Immunol."},{"key":"1471_CR82","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/ni794","volume":"3","author":"M Afkarian","year":"2002","unstructured":"Afkarian, M. et al. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4\u2009+\u2009T cells. Nat. Immunol. 3, 549\u2013557 (2002).","journal-title":"Nat. Immunol."},{"key":"1471_CR83","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1002\/eji.200526101","volume":"35","author":"E Ylikoski","year":"2005","unstructured":"Ylikoski, E. et al. IL-12 up-regulates T-bet independently of IFN-gamma in human CD4\u2009+\u2009T cells. Eur. J. Immunol. 35, 3297\u20133306 (2005).","journal-title":"Eur. J. Immunol."},{"key":"1471_CR84","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nri.2017.118","volume":"18","author":"JA Walker","year":"2018","unstructured":"Walker, J. A. & McKenzie, A. N. J. T(H)2 cell development and function. Nat. Rev. Immunol. 18, 121\u2013133 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR85","doi-asserted-by":"publisher","first-page":"11822","DOI":"10.3390\/ijms222111822","volume":"22","author":"J Jeong","year":"2021","unstructured":"Jeong, J. & Lee, H. K. The role of CD4(+) T cells and microbiota in the pathogenesis of asthma. Int. J. Mol. Sci. 22, 11822 (2021).","journal-title":"Int. J. Mol. Sci"},{"key":"1471_CR86","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/1521-4141(200205)32:5<1428::AID-IMMU1428>3.0.CO;2-0","volume":"32","author":"N Noben-Trauth","year":"2002","unstructured":"Noben-Trauth, N., Hu-Li, J. & Paul, W. E. IL-4 secreted from individual naive CD4\u2009+\u2009T cells acts in an autocrine manner to induce Th2 differentiation. Eur. J. Immunol. 32, 1428\u20131433 (2002).","journal-title":"Eur. J. Immunol."},{"key":"1471_CR87","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/imr.12935","volume":"300","author":"CA Spinner","year":"2021","unstructured":"Spinner, C. A. & Lazarevic, V. Transcriptional regulation of adaptive and innate lymphoid lineage specification. Immunol. Rev. 300, 65\u201381 (2021).","journal-title":"Immunol. Rev."},{"key":"1471_CR88","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/ni.1656","volume":"9","author":"W Liao","year":"2008","unstructured":"Liao, W. et al. Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression. Nat. Immunol. 9, 1288\u20131296 (2008).","journal-title":"Nat. Immunol."},{"key":"1471_CR89","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/ni.1762","volume":"10","author":"Q Yu","year":"2009","unstructured":"Yu, Q. et al. T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-gamma. Nat. Immunol. 10, 992\u2013999 (2009).","journal-title":"Nat. Immunol."},{"key":"1471_CR90","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/ni.1659","volume":"9","author":"M Veldhoen","year":"2008","unstructured":"Veldhoen, M. et al. Transforming growth factor-beta \u2018reprograms\u2019 the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9, 1341\u20131346 (2008).","journal-title":"Nat. Immunol."},{"key":"1471_CR91","doi-asserted-by":"publisher","first-page":"71001","DOI":"10.18632\/oncotarget.11681","volume":"7","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. TH9 cell differentiation, transcriptional control and function in inflammation, autoimmune diseases and cancer. Oncotarget 7, 71001\u201371012 (2016).","journal-title":"Oncotarget"},{"key":"1471_CR92","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41577-020-0396-0","volume":"21","author":"P Angkasekwinai","year":"2021","unstructured":"Angkasekwinai, P. & Dong, C. IL-9-producing T cells: potential players in allergy and cancer. Nat. Rev. Immunol. 21, 37\u201348 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR93","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3389\/fimmu.2018.01139","volume":"9","author":"SP Vyas","year":"2018","unstructured":"Vyas, S. P. & Goswami, R. A decade of Th9 cells: role of Th9 cells in inflammatory bowel disease. Front. Immunol. 9, 1139 (2018).","journal-title":"Front. Immunol."},{"key":"1471_CR94","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.autrev.2016.02.020","volume":"15","author":"WG Rojas-Zuleta","year":"2016","unstructured":"Rojas-Zuleta, W. G. & Vasquez, G. Th9 lymphocytes: a recent history from IL-9 to its potential role in rheumatic diseases. Autoimmun. Rev. 15, 649\u2013655 (2016).","journal-title":"Autoimmun. Rev."},{"key":"1471_CR95","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.immuni.2010.07.014","volume":"33","author":"V Staudt","year":"2010","unstructured":"Staudt, V. et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33, 192\u2013202 (2010).","journal-title":"Immunity"},{"key":"1471_CR96","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/ni.1867","volume":"11","author":"HC Chang","year":"2010","unstructured":"Chang, H. C. et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11, 527\u2013534 (2010).","journal-title":"Nat. Immunol."},{"key":"1471_CR97","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/ni.1677","volume":"9","author":"V Dardalhon","year":"2008","unstructured":"Dardalhon, V. et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9\u2009+\u2009IL-10+ Foxp3(-) effector T cells. Nat. Immunol. 9, 1347\u20131355 (2008).","journal-title":"Nat. Immunol."},{"key":"1471_CR98","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.intimp.2017.08.031","volume":"52","author":"FP You","year":"2017","unstructured":"You, F. P. et al. Th9 cells promote antitumor immunity via IL-9 and IL-21 and demonstrate atypical cytokine expression in breast cancer. Int. Immunopharmacol. 52, 163\u2013167 (2017).","journal-title":"Int. Immunopharmacol."},{"key":"1471_CR99","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00281-016-0601-1","volume":"39","author":"S Koch","year":"2017","unstructured":"Koch, S., Sopel, N. & Finotto, S. Th9 and other IL-9-producing cells in allergic asthma. Semin. Immunopathol. 39, 55\u201368 (2017).","journal-title":"Semin. Immunopathol."},{"key":"1471_CR100","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3389\/fimmu.2020.01026","volume":"11","author":"T Chen","year":"2020","unstructured":"Chen, T. et al. Th9 cell differentiation and its dual effects in tumor development. Front. Immunol. 11, 1026 (2020).","journal-title":"Front. Immunol."},{"key":"1471_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01070-w","volume":"8","author":"E Humblin","year":"2017","unstructured":"Humblin, E. et al. IRF8-dependent molecular complexes control the Th9 transcriptional program. Nat. Commun. 8, 2085 (2017).","journal-title":"Nat. Commun."},{"key":"1471_CR102","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V. K. IL-17 and Th17 cells. Annu. Rev. Immunol. 27, 485\u2013517 (2009).","journal-title":"Annu. Rev. Immunol."},{"key":"1471_CR103","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/COH.0b013e328335c2f6","volume":"5","author":"L Guglani","year":"2010","unstructured":"Guglani, L. & Khader, S. A. Th17 cytokines in mucosal immunity and inflammation. Curr. Opin. HIV AIDS 5, 120\u2013127 (2010).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"1471_CR104","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11684-015-0388-9","volume":"9","author":"L Han","year":"2015","unstructured":"Han, L. et al. Th17 cells in autoimmune diseases. Front. Med. 9, 10\u201319 (2015).","journal-title":"Front. Med."},{"key":"1471_CR105","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov, I. I. et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17\u2009+\u2009T helper cells. Cell 126, 1121\u20131133 (2006).","journal-title":"Cell"},{"key":"1471_CR106","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature04754","volume":"441","author":"PR Mangan","year":"2006","unstructured":"Mangan, P. R. et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441, 231\u2013234 (2006).","journal-title":"Nature"},{"key":"1471_CR107","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature05970","volume":"448","author":"T Korn","year":"2007","unstructured":"Korn, T. et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448, 484\u2013487 (2007).","journal-title":"Nature"},{"key":"1471_CR108","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/ni1488","volume":"8","author":"L Zhou","year":"2007","unstructured":"Zhou, L. et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8, 967\u2013974 (2007).","journal-title":"Nat. Immunol."},{"key":"1471_CR109","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature05969","volume":"448","author":"R Nurieva","year":"2007","unstructured":"Nurieva, R. et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448, 480\u2013483 (2007).","journal-title":"Nature"},{"key":"1471_CR110","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235\u2013238 (2006).","journal-title":"Nature"},{"key":"1471_CR111","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","volume":"14","author":"SL Gaffen","year":"2014","unstructured":"Gaffen, S. L., Jain, R., Garg, A. V. & Cua, D. J. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14, 585\u2013600 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR112","doi-asserted-by":"publisher","first-page":"29039","DOI":"10.1074\/jbc.C110.155820","volume":"285","author":"GJ Martinez","year":"2010","unstructured":"Martinez, G. J. et al. Smad2 positively regulates the generation of Th17 cells. J. Biol. Chem. 285, 29039\u201329043 (2010).","journal-title":"J. Biol. Chem."},{"key":"1471_CR113","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrd4296","volume":"13","author":"R Spolski","year":"2014","unstructured":"Spolski, R. & Leonard, W. J. Interleukin-21: a double-edged sword with therapeutic potential. Nat. Rev. Drug Disco. 13, 379\u2013395 (2014).","journal-title":"Nat. Rev. Drug Disco."},{"key":"1471_CR114","doi-asserted-by":"publisher","first-page":"8137","DOI":"10.1073\/pnas.0600666103","volume":"103","author":"Z Chen","year":"2006","unstructured":"Chen, Z. et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl Acad. Sci. USA 103, 8137\u20138142 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR115","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature09447","volume":"467","author":"K Ghoreschi","year":"2010","unstructured":"Ghoreschi, K. et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 467, 967\u2013971 (2010).","journal-title":"Nature"},{"key":"1471_CR116","doi-asserted-by":"publisher","first-page":"102","DOI":"10.15252\/embj.201694615","volume":"36","author":"IA Mufazalov","year":"2017","unstructured":"Mufazalov, I. A. et al. IL-1 signaling is critical for expansion but not generation of autoreactive GM-CSF+ Th17 cells. EMBO J. 36, 102\u2013115 (2017).","journal-title":"EMBO J."},{"key":"1471_CR117","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jaci.2012.05.003","volume":"129","author":"M Akdis","year":"2012","unstructured":"Akdis, M. et al. TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. J. Allergy Clin. Immunol. 129, 1438\u20131449 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1471_CR118","doi-asserted-by":"publisher","first-page":"806529","DOI":"10.3389\/fimmu.2021.806529","volume":"12","author":"J Campe","year":"2021","unstructured":"Campe, J. & Ullrich, E. T helper cell lineage-defining transcription factors: potent targets for specific GVHD therapy? Front. Immunol. 12, 806529 (2021).","journal-title":"Front. Immunol."},{"key":"1471_CR119","doi-asserted-by":"publisher","first-page":"49238","DOI":"10.1074\/jbc.M205895200","volume":"277","author":"CM Hu","year":"2002","unstructured":"Hu, C. M., Jang, S. Y., Fanzo, J. C. & Pernis, A. B. Modulation of T cell cytokine production by interferon regulatory factor-4. J. Biol. Chem. 277, 49238\u201349246 (2002).","journal-title":"J. Biol. Chem."},{"key":"1471_CR120","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nature08114","volume":"460","author":"BU Schraml","year":"2009","unstructured":"Schraml, B. U. et al. The AP-1 transcription factor Batf controls T(H)17 differentiation. Nature 460, 405\u2013409 (2009).","journal-title":"Nature"},{"key":"1471_CR121","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","volume":"146","author":"EV Dang","year":"2011","unstructured":"Dang, E. V. et al. Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1. Cell 146, 772\u2013784 (2011).","journal-title":"Cell"},{"key":"1471_CR122","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/ni.1663","volume":"9","author":"F Zhang","year":"2008","unstructured":"Zhang, F., Meng, G. & Strober, W. Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat. Immunol. 9, 1297\u20131306 (2008).","journal-title":"Nat. Immunol."},{"key":"1471_CR123","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/ni.1690","volume":"10","author":"AT Bauquet","year":"2009","unstructured":"Bauquet, A. T. et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat. Immunol. 10, 167\u2013175 (2009).","journal-title":"Nat. Immunol."},{"key":"1471_CR124","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/nature08922","volume":"464","author":"K Okamoto","year":"2010","unstructured":"Okamoto, K. et al. IkappaBzeta regulates T(H)17 development by cooperating with ROR nuclear receptors. Nature 464, 1381\u20131385 (2010).","journal-title":"Nature"},{"key":"1471_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12680-x","volume":"10","author":"H Yahia-Cherbal","year":"2019","unstructured":"Yahia-Cherbal, H. et al. NFAT primes the human RORC locus for RORgammat expression in CD4(+) T cells. Nat. Commun. 10, 4698 (2019).","journal-title":"Nat. Commun."},{"key":"1471_CR126","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1084\/jem.20110462","volume":"208","author":"Q Ruan","year":"2011","unstructured":"Ruan, Q. et al. The Th17 immune response is controlled by the Rel-ROR\u03b3-ROR\u03b3 T transcriptional axis. J. Exp. Med. 208, 2321\u20132333 (2011).","journal-title":"J. Exp. Med."},{"key":"1471_CR127","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","volume":"28","author":"XO Yang","year":"2008","unstructured":"Yang, X. O. et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28, 29\u201339 (2008).","journal-title":"Immunity"},{"key":"1471_CR128","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","volume":"29","author":"S Crotty","year":"2011","unstructured":"Crotty, S. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29, 621\u2013663 (2011).","journal-title":"Annu. Rev. Immunol."},{"key":"1471_CR129","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1084\/jem.192.11.1553","volume":"192","author":"P Schaerli","year":"2000","unstructured":"Schaerli, P. et al. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192, 1553\u20131562 (2000).","journal-title":"J. Exp. Med."},{"key":"1471_CR130","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","volume":"34","author":"CG Vinuesa","year":"2016","unstructured":"Vinuesa, C. G., Linterman, M. A., Yu, D. & MacLennan, I. C. Follicular helper T cells. Annu. Rev. Immunol. 34, 335\u2013368 (2016).","journal-title":"Annu. Rev. Immunol."},{"key":"1471_CR131","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","volume":"50","author":"S Crotty","year":"2019","unstructured":"Crotty, S. T follicular helper cell biology: a decade of discovery and diseases. Immunity 50, 1132\u20131148 (2019).","journal-title":"Immunity"},{"key":"1471_CR132","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/s41590-022-01253-8","volume":"23","author":"D Yu","year":"2022","unstructured":"Yu, D. et al. Targeting TFH cells in human diseases and vaccination: rationale and practice. Nat. Immunol. 23, 1157\u20131168 (2022).","journal-title":"Nat. Immunol."},{"key":"1471_CR133","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1126\/science.1176676","volume":"325","author":"RI Nurieva","year":"2009","unstructured":"Nurieva, R. I. et al. Bcl6 mediates the development of T follicular helper cells. Science 325, 1001\u20131005 (2009).","journal-title":"Science"},{"key":"1471_CR134","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1084\/jem.20141380","volume":"212","author":"K Hatzi","year":"2015","unstructured":"Hatzi, K. et al. BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms. J. Exp. Med. 212, 539\u2013553 (2015).","journal-title":"J. Exp. Med."},{"key":"1471_CR135","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.celrep.2016.01.038","volume":"14","author":"X Liu","year":"2016","unstructured":"Liu, X. et al. Genome-wide analysis identifies Bcl6-controlled regulatory networks during T follicular helper cell differentiation. Cell Rep. 14, 1735\u20131747 (2016).","journal-title":"Cell Rep."},{"key":"1471_CR136","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41590-020-0706-5","volume":"21","author":"J Choi","year":"2020","unstructured":"Choi, J. et al. Bcl-6 is the nexus transcription factor of T follicular helper cells via repressor-of-repressor circuits. Nat. Immunol. 21, 777\u2013789 (2020).","journal-title":"Nat. Immunol."},{"key":"1471_CR137","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.4049\/jimmunol.170.5.2435","volume":"170","author":"S Kusam","year":"2003","unstructured":"Kusam, S., Toney, L. M., Sato, H. & Dent, A. L. Inhibition of Th2 differentiation and GATA-3 expression by BCL-6. J. Immunol. 170, 2435\u20132441 (2003).","journal-title":"J. Immunol."},{"key":"1471_CR138","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.immuni.2009.07.002","volume":"31","author":"D Yu","year":"2009","unstructured":"Yu, D. et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 31, 457\u2013468 (2009).","journal-title":"Immunity"},{"key":"1471_CR139","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1126\/science.1175870","volume":"325","author":"RJ Johnston","year":"2009","unstructured":"Johnston, R. J. et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325, 1006\u20131010 (2009).","journal-title":"Science"},{"key":"1471_CR140","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni.3229","volume":"16","author":"L Xu","year":"2015","unstructured":"Xu, L. et al. The transcription factor TCF-1 initiates the differentiation of T(FH) cells during acute viral infection. Nat. Immunol. 16, 991\u2013999 (2015).","journal-title":"Nat. Immunol."},{"key":"1471_CR141","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/ni.3226","volume":"16","author":"YS Choi","year":"2015","unstructured":"Choi, Y. S. et al. LEF-1 and TCF-1 orchestrate T(FH) differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6. Nat. Immunol. 16, 980\u2013990 (2015).","journal-title":"Nat. Immunol."},{"key":"1471_CR142","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nature12910","volume":"507","author":"X Liu","year":"2014","unstructured":"Liu, X. et al. Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development. Nature 507, 513\u2013518 (2014).","journal-title":"Nature"},{"key":"1471_CR143","doi-asserted-by":"publisher","first-page":"e20211406","DOI":"10.1084\/jem.20211406","volume":"219","author":"R Rauschmeier","year":"2022","unstructured":"Rauschmeier, R. et al. Bhlhe40 function in activated B and TFH cells restrains the GC reaction and prevents lymphomagenesis. J Exp Med. 219, e20211406 (2022).","journal-title":"J Exp Med"},{"key":"1471_CR144","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.immuni.2019.10.006","volume":"51","author":"W Xu","year":"2019","unstructured":"Xu, W. et al. The transcription factor Tox2 drives T follicular helper cell development via regulating chromatin accessibility. Immunity 51, 826\u2013839.e825 (2019).","journal-title":"Immunity"},{"key":"1471_CR145","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1016\/j.immuni.2021.09.018","volume":"54","author":"S Wan","year":"2021","unstructured":"Wan, S. et al. Costimulation molecules differentially regulate the ERK-Zfp831 axis to shape T follicular helper cell differentiation. Immunity 54, 2740\u20132755 e2746 (2021).","journal-title":"Immunity"},{"key":"1471_CR146","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1084\/jem.20141432","volume":"212","author":"JP Weber","year":"2015","unstructured":"Weber, J. P. et al. ICOS maintains the T follicular helper cell phenotype by down-regulating Kr\u00fcppel-like factor 2. J. Exp. Med. 212, 217\u2013233 (2015).","journal-title":"J. Exp. Med."},{"key":"1471_CR147","doi-asserted-by":"publisher","first-page":"e17739","DOI":"10.1371\/journal.pone.0017739","volume":"6","author":"D Eto","year":"2011","unstructured":"Eto, D. et al. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS ONE 6, e17739 (2011).","journal-title":"PLoS ONE"},{"key":"1471_CR148","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/intimm\/dxp112","volume":"22","author":"R Spolski","year":"2010","unstructured":"Spolski, R. & Leonard, W. J. IL-21 and T follicular helper cells. Int. Immunol. 22, 7\u201312 (2010).","journal-title":"Int. Immunol."},{"key":"1471_CR149","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.immuni.2012.02.012","volume":"36","author":"A Ballesteros-Tato","year":"2012","unstructured":"Ballesteros-Tato, A. et al. Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation. Immunity 36, 847\u2013856 (2012).","journal-title":"Immunity"},{"key":"1471_CR150","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1084\/jem.20111174","volume":"209","author":"RJ Johnston","year":"2012","unstructured":"Johnston, R. J. et al. STAT5 is a potent negative regulator of TFH cell differentiation. J. Exp. Med. 209, 243\u2013250 (2012).","journal-title":"J. Exp. Med."},{"key":"1471_CR151","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1158\/2326-6066.CIR-16-0193","volume":"4","author":"G Plitas","year":"2016","unstructured":"Plitas, G. & Rudensky, A. Y. Regulatory T cells: differentiation and function. Cancer Immunol. Res. 4, 721\u2013725 (2016).","journal-title":"Cancer Immunol. Res."},{"key":"1471_CR152","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41577-021-00598-9","volume":"21","author":"S Hori","year":"2021","unstructured":"Hori, S. FOXP3 as a master regulator of T(reg) cells. Nat. Rev. Immunol. 21, 618\u2013619 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR153","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","volume":"30","author":"SZ Josefowicz","year":"2012","unstructured":"Josefowicz, S. Z., Lu, L. F. & Rudensky, A. Y. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531\u2013564 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"1471_CR154","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.it.2016.08.012","volume":"37","author":"M Kanamori","year":"2016","unstructured":"Kanamori, M. et al. Induced regulatory T cells: their development, stability, and applications. Trends Immunol. 37, 803\u2013811 (2016).","journal-title":"Trends Immunol."},{"key":"1471_CR155","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057\u20131061 (2003).","journal-title":"Science"},{"key":"1471_CR156","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4\u2009+\u2009CD25+ regulatory T cells. Nat. Immunol. 4, 330\u2013336 (2003).","journal-title":"Nat. Immunol."},{"key":"1471_CR157","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2012.09.010","volume":"37","author":"N Ohkura","year":"2012","unstructured":"Ohkura, N. et al. T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 37, 785\u2013799 (2012).","journal-title":"Immunity"},{"key":"1471_CR158","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/imr.12174","volume":"259","author":"H Morikawa","year":"2014","unstructured":"Morikawa, H. & Sakaguchi, S. Genetic and epigenetic basis of Treg cell development and function: from a FoxP3-centered view to an epigenome-defined view of natural Treg cells. Immunol. Rev. 259, 192\u2013205 (2014).","journal-title":"Immunol. Rev."},{"key":"1471_CR159","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.immuni.2009.09.022","volume":"31","author":"M Long","year":"2009","unstructured":"Long, M. et al. Nuclear factor-kappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor. Immunity 31, 921\u2013931 (2009).","journal-title":"Immunity"},{"key":"1471_CR160","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1084\/jem.20091411","volume":"206","author":"I Isomura","year":"2009","unstructured":"Isomura, I. et al. c-Rel is required for the development of thymic Foxp3\u2009+\u2009CD4 regulatory T cells. J. Exp. Med. 206, 3001\u20133014 (2009).","journal-title":"J. Exp. Med."},{"key":"1471_CR161","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/imr.12172","volume":"259","author":"J Barbi","year":"2014","unstructured":"Barbi, J., Pardoll, D. & Pan, F. Treg functional stability and its responsiveness to the microenvironment. Immunol. Rev. 259, 115\u2013139 (2014).","journal-title":"Immunol. Rev."},{"key":"1471_CR162","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.smim.2011.06.005","volume":"23","author":"T Maruyama","year":"2011","unstructured":"Maruyama, T., Konkel, J. E., Zamarron, B. F. & Chen, W. The molecular mechanisms of Foxp3 gene regulation. Semin. Immunol. 23, 418\u2013423 (2011).","journal-title":"Semin. Immunol."},{"key":"1471_CR163","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.immuni.2021.03.020","volume":"54","author":"S Dikiy","year":"2021","unstructured":"Dikiy, S. et al. A distal Foxp3 enhancer enables interleukin-2 dependent thymic Treg cell lineage commitment for robust immune tolerance. Immunity 54, 931\u2013946.e911 (2021).","journal-title":"Immunity"},{"key":"1471_CR164","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/ni.3540","volume":"17","author":"T Chinen","year":"2016","unstructured":"Chinen, T. et al. An essential role for the IL-2 receptor in T(reg) cell function. Nat. Immunol. 17, 1322\u20131333 (2016).","journal-title":"Nat. Immunol."},{"key":"1471_CR165","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.immuni.2007.08.007","volume":"27","author":"SM Kaech","year":"2007","unstructured":"Kaech, S. M. & Wherry, E. J. Heterogeneity and cell-fate decisions in effector and memory CD8\u2009+\u2009T cell differentiation during viral infection. Immunity 27, 393\u2013405 (2007).","journal-title":"Immunity"},{"key":"1471_CR166","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","volume":"27","author":"NS Joshi","year":"2007","unstructured":"Joshi, N. S. et al. Inflammation directs memory precursor and short-lived effector CD8(\u2009+\u2009) T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281\u2013295 (2007).","journal-title":"Immunity"},{"key":"1471_CR167","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/ni1009","volume":"4","author":"SM Kaech","year":"2003","unstructured":"Kaech, S. M. et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4, 1191\u20131198 (2003).","journal-title":"Nat. Immunol."},{"key":"1471_CR168","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ni1268","volume":"6","author":"AM Intlekofer","year":"2005","unstructured":"Intlekofer, A. M. et al. Effector and memory CD8\u2009+\u2009T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6, 1236\u20131244 (2005).","journal-title":"Nat. Immunol."},{"key":"1471_CR169","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri3307","volume":"12","author":"SM Kaech","year":"2012","unstructured":"Kaech, S. M. & Cui, W. Transcriptional control of effector and memory CD8\u2009+\u2009T cell differentiation. Nat. Rev. Immunol. 12, 749\u2013761 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR170","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.immuni.2009.06.021","volume":"31","author":"A Kallies","year":"2009","unstructured":"Kallies, A., Xin, A., Belz, G. T. & Nutt, S. L. Blimp-1 transcription factor is required for the differentiation of effector CD8(\u2009+\u2009) T cells and memory responses. Immunity 31, 283\u2013295 (2009).","journal-title":"Immunity"},{"key":"1471_CR171","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/ni.3410","volume":"17","author":"A Xin","year":"2016","unstructured":"Xin, A. et al. A molecular threshold for effector CD8(\u2009+\u2009) T cell differentiation controlled by transcription factors Blimp-1 and T-bet. Nat. Immunol. 17, 422\u2013432 (2016).","journal-title":"Nat. Immunol."},{"key":"1471_CR172","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/ni802","volume":"3","author":"H Ichii","year":"2002","unstructured":"Ichii, H. et al. Role for Bcl-6 in the generation and maintenance of memory CD8\u2009+\u2009T cells. Nat. Immunol. 3, 558\u2013563 (2002).","journal-title":"Nat. Immunol."},{"key":"1471_CR173","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.3389\/fimmu.2018.02826","volume":"9","author":"Y Chen","year":"2018","unstructured":"Chen, Y. et al. Transcriptional and epigenetic regulation of effector and memory CD8 T cell differentiation. Front. Immunol. 9, 2826 (2018).","journal-title":"Front. Immunol."},{"key":"1471_CR174","doi-asserted-by":"publisher","first-page":"935764","DOI":"10.1155\/2010\/935764","volume":"2010","author":"E Cavalcanti","year":"2010","unstructured":"Cavalcanti, E. et al. JAK3\/STAT5\/6 pathway alterations are associated with immune deviation in CD8 T cells in renal cell carcinoma patients. J. Biomed. Biotechnol. 2010, 935764 (2010).","journal-title":"J. Biomed. Biotechnol."},{"key":"1471_CR175","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.4161\/cc.5.22.3449","volume":"5","author":"AE Schade","year":"2006","unstructured":"Schade, A. E., Wlodarski, M. W. & Maciejewski, J. P. Pathophysiology defined by altered signal transduction pathways: the role of JAK-STAT and PI3K signaling in leukemic large granular lymphocytes. Cell Cycle 5, 2571\u20132574 (2006).","journal-title":"Cell Cycle"},{"key":"1471_CR176","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.7150\/ijbs.41852","volume":"16","author":"C Yang","year":"2020","unstructured":"Yang, C. et al. STAT4: an immunoregulator contributing to diverse human diseases. Int. J. Biol. Sci. 16, 1575\u20131585 (2020).","journal-title":"Int. J. Biol. Sci."},{"key":"1471_CR177","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1084\/jem.20171352","volume":"215","author":"T Guan","year":"2018","unstructured":"Guan, T. et al. ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8(\u2009+\u2009) T cell fates. J. Exp. Med. 215, 1153\u20131168 (2018).","journal-title":"J. Exp. Med."},{"key":"1471_CR178","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.4049\/jimmunol.174.8.4465","volume":"174","author":"JM Curtsinger","year":"2005","unstructured":"Curtsinger, J. M. et al. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174, 4465\u20134469 (2005).","journal-title":"J. Immunol."},{"key":"1471_CR179","doi-asserted-by":"publisher","first-page":"659","DOI":"10.4049\/jimmunol.1102727","volume":"189","author":"JM Curtsinger","year":"2012","unstructured":"Curtsinger, J. M., Agarwal, P., Lins, D. C. & Mescher, M. F. Autocrine IFN-gamma promotes naive CD8 T cell differentiation and synergizes with IFN-alpha to stimulate strong function. J. Immunol. 189, 659\u2013668 (2012).","journal-title":"J. Immunol."},{"key":"1471_CR180","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","volume":"35","author":"N Zhang","year":"2011","unstructured":"Zhang, N. & Bevan, M. J. CD8(\u2009+\u2009) T cells: foot soldiers of the immune system. Immunity 35, 161\u2013168 (2011).","journal-title":"Immunity"},{"key":"1471_CR181","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/ni.1837","volume":"11","author":"S Crotty","year":"2010","unstructured":"Crotty, S., Johnston, R. J. & Schoenberger, S. P. Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation. Nat. Immunol. 11, 114\u2013120 (2010).","journal-title":"Nat. Immunol."},{"key":"1471_CR182","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41577-021-00563-6","volume":"22","author":"X Zhao","year":"2022","unstructured":"Zhao, X., Shan, Q. & Xue, H. H. TCF1 in T cell immunity: a broadened frontier. Nat. Rev. Immunol. 22, 147\u2013157 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR183","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s42255-020-00280-9","volume":"2","author":"F Franco","year":"2020","unstructured":"Franco, F. et al. Metabolic and epigenetic regulation of T-cell exhaustion. Nat. Metab. 2, 1001\u20131012 (2020).","journal-title":"Nat. Metab."},{"key":"1471_CR184","doi-asserted-by":"publisher","first-page":"937","DOI":"10.4049\/jimmunol.1601102","volume":"198","author":"RM Rodriguez","year":"2017","unstructured":"Rodriguez, R. M. et al. Epigenetic networks regulate the transcriptional program in memory and terminally differentiated CD8\u2009+\u2009T Cells. J. Immunol. 198, 937\u2013949 (2017).","journal-title":"J. Immunol."},{"key":"1471_CR185","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.4049\/jimmunol.1301395","volume":"191","author":"CD Scharer","year":"2013","unstructured":"Scharer, C. D. et al. Global DNA methylation remodeling accompanies CD8 T cell effector function. J. Immunol. 191, 3419\u20133429 (2013).","journal-title":"J. Immunol."},{"key":"1471_CR186","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.4049\/jimmunol.1500877","volume":"195","author":"MS Shin","year":"2015","unstructured":"Shin, M. S. et al. DNA methylation regulates the differential expression of CX3CR1 on human IL-7Ralphalow and IL-7Ralphahigh effector memory CD8\u2009+\u2009T cells with distinct migratory capacities to the fractalkine. J. Immunol. 195, 2861\u20132869 (2015).","journal-title":"J. Immunol."},{"key":"1471_CR187","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1084\/jem.20161760","volume":"214","author":"HA Abdelsamed","year":"2017","unstructured":"Abdelsamed, H. A. et al. Human memory CD8 T cell effector potential is epigenetically preserved during in vivo homeostasis. J. Exp. Med. 214, 1593\u20131606 (2017).","journal-title":"J. Exp. Med"},{"key":"1471_CR188","doi-asserted-by":"publisher","first-page":"10631","DOI":"10.1073\/pnas.1524490113","volume":"113","author":"BH Ladle","year":"2016","unstructured":"Ladle, B. H. et al. De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8\u2009+\u2009T-cell fate decisions following activation. Proc. Natl Acad. Sci. USA 113, 10631\u201310636 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR189","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4049\/jimmunol.1700559","volume":"200","author":"SA Carty","year":"2018","unstructured":"Carty, S. A. et al. The loss of TET2 promotes CD8(\u2009+\u2009) T cell memory differentiation. J. Immunol. 200, 82\u201391 (2018).","journal-title":"J. Immunol."},{"key":"1471_CR190","doi-asserted-by":"publisher","first-page":"109796","DOI":"10.1016\/j.celrep.2021.109796","volume":"37","author":"CC Zebley","year":"2021","unstructured":"Zebley, C. C. et al. Proinflammatory cytokines promote TET2-mediated DNA demethylation during CD8 T cell effector differentiation. Cell Rep. 37, 109796 (2021).","journal-title":"Cell Rep."},{"key":"1471_CR191","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/47412","volume":"403","author":"BD Strahl","year":"2000","unstructured":"Strahl, B. D. & Allis, C. D. The language of covalent histone modifications. Nature 403, 41\u201345 (2000).","journal-title":"Nature"},{"key":"1471_CR192","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.immuni.2016.11.009","volume":"45","author":"B He","year":"2016","unstructured":"He, B. et al. CD8(\u2009+\u2009) T cells utilize highly dynamic enhancer repertoires and regulatory circuitry in response to infections. Immunity 45, 1341\u20131354 (2016).","journal-title":"Immunity"},{"key":"1471_CR193","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nri.2017.146","volume":"18","author":"AN Henning","year":"2018","unstructured":"Henning, A. N., Roychoudhuri, R. & Restifo, N. P. Epigenetic control of CD8(\u2009+\u2009) T cell differentiation. Nat. Rev. Immunol. 18, 340\u2013356 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR194","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.immuni.2013.08.032","volume":"39","author":"HM Shin","year":"2013","unstructured":"Shin, H. M. et al. Epigenetic modifications induced by Blimp-1 Regulate CD8(\u2009+\u2009) T cell memory progression during acute virus infection. Immunity 39, 661\u2013675 (2013).","journal-title":"Immunity"},{"key":"1471_CR195","doi-asserted-by":"publisher","first-page":"14885","DOI":"10.1073\/pnas.1105133108","volume":"108","author":"S Kuroda","year":"2011","unstructured":"Kuroda, S. et al. Basic leucine zipper transcription factor, ATF-like (BATF) regulates epigenetically and energetically effector CD8 T-cell differentiation via Sirt1 expression. Proc. Natl Acad. Sci. USA 108, 14885\u201314889 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR196","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S1074-7613(01)00205-9","volume":"15","author":"S Krauss","year":"2001","unstructured":"Krauss, S., Brand, M. D. & Buttgereit, F. Signaling takes a breath-new quantitative perspectives on bioenergetics and signal transduction. Immunity 15, 497\u2013502 (2001).","journal-title":"Immunity"},{"key":"1471_CR197","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.celrep.2018.01.040","volume":"22","author":"AV Menk","year":"2018","unstructured":"Menk, A. V. et al. Early TCR signaling induces rapid aerobic glycolysis enabling distinct acute T cell effector functions. Cell Rep. 22, 1509\u20131521 (2018).","journal-title":"Cell Rep."},{"key":"1471_CR198","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","volume":"35","author":"R Wang","year":"2011","unstructured":"Wang, R. et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35, 871\u2013882 (2011).","journal-title":"Immunity"},{"key":"1471_CR199","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.immuni.2007.07.008","volume":"27","author":"RG Jones","year":"2007","unstructured":"Jones, R. G. & Thompson, C. B. Revving the engine: signal transduction fuels T cell activation. Immunity 27, 173\u2013178 (2007).","journal-title":"Immunity"},{"key":"1471_CR200","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S1074-7613(02)00323-0","volume":"16","author":"KA Frauwirth","year":"2002","unstructured":"Frauwirth, K. A. et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 16, 769\u2013777 (2002).","journal-title":"Immunity"},{"key":"1471_CR201","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1600-065X.2012.01152.x","volume":"249","author":"AT Waickman","year":"2012","unstructured":"Waickman, A. T. & Powell, J. D. mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunol. Rev. 249, 43\u201358 (2012).","journal-title":"Immunol. Rev."},{"key":"1471_CR202","doi-asserted-by":"publisher","first-page":"25227","DOI":"10.1074\/jbc.M114.554881","volume":"289","author":"HC Dan","year":"2014","unstructured":"Dan, H. C. et al. Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IkappaB kinase alpha (IKKalpha). J. Biol. Chem. 289, 25227\u201325240 (2014).","journal-title":"J. Biol. Chem."},{"key":"1471_CR203","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.it.2012.01.010","volume":"33","author":"VA Gerriets","year":"2012","unstructured":"Gerriets, V. A. & Rathmell, J. C. Metabolic pathways in T cell fate and function. Trends Immunol. 33, 168\u2013173 (2012).","journal-title":"Trends Immunol."},{"key":"1471_CR204","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00612-6","volume":"8","author":"S Klein-Hessling","year":"2017","unstructured":"Klein-Hessling, S. et al. NFATc1 controls the cytotoxicity of CD8(\u2009+\u2009) T cells. Nat. Commun. 8, 511 (2017).","journal-title":"Nat. Commun."},{"key":"1471_CR205","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.immuni.2017.09.003","volume":"47","author":"M Vaeth","year":"2017","unstructured":"Vaeth, M. et al. Store-operated Ca(2\u2009+\u2009) entry controls clonal expansion of T cells through metabolic reprogramming. Immunity 47, 664\u2013679 e666 (2017).","journal-title":"Immunity"},{"key":"1471_CR206","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature08097","volume":"460","author":"EL Pearce","year":"2009","unstructured":"Pearce, E. L. et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460, 103\u2013107 (2009).","journal-title":"Nature"},{"key":"1471_CR207","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.immuni.2014.06.005","volume":"41","author":"D O\u2019Sullivan","year":"2014","unstructured":"O\u2019Sullivan, D. et al. Memory CD8(\u2009+\u2009) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity 41, 75\u201388 (2014).","journal-title":"Immunity"},{"key":"1471_CR208","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1016\/j.celrep.2019.10.032","volume":"29","author":"SS Gupta","year":"2019","unstructured":"Gupta, S. S. et al. NIX-mediated mitophagy promotes effector memory formation in antigen-specific CD8(\u2009+\u2009) T cells. Cell Rep. 29, 1862\u20131877 e1867 (2019).","journal-title":"Cell Rep."},{"key":"1471_CR209","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","volume":"36","author":"GJ van der Windt","year":"2012","unstructured":"van der Windt, G. J. et al. Mitochondrial respiratory capacity is a critical regulator of CD8\u2009+\u2009T cell memory development. Immunity 36, 68\u201378 (2012).","journal-title":"Immunity"},{"key":"1471_CR210","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41590-022-01131-3","volume":"23","author":"Q Shan","year":"2022","unstructured":"Shan, Q. et al. Tcf1 preprograms the mobilization of glycolysis in central memory CD8(\u2009+\u2009) T cells during recall responses. Nat. Immunol. 23, 386\u2013398 (2022).","journal-title":"Nat. Immunol."},{"key":"1471_CR211","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cell.2012.09.016","volume":"151","author":"M Ciofani","year":"2012","unstructured":"Ciofani, M. et al. A validated regulatory network for Th17 cell specification. Cell 151, 289\u2013303 (2012).","journal-title":"Cell"},{"key":"1471_CR212","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/ni.3706","volume":"18","author":"B Yu","year":"2017","unstructured":"Yu, B. et al. Epigenetic landscapes reveal transcription factors that regulate CD8(\u2009+\u2009) T cell differentiation. Nat. Immunol. 18, 573\u2013582 (2017).","journal-title":"Nat. Immunol."},{"key":"1471_CR213","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.immuni.2014.11.001","volume":"41","author":"BE Russ","year":"2014","unstructured":"Russ, B. E. et al. Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8(\u2009+\u2009) T cell differentiation. Immunity 41, 853\u2013865 (2014).","journal-title":"Immunity"},{"key":"1471_CR214","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3389\/fimmu.2020.01013","volume":"11","author":"SS Gupta","year":"2020","unstructured":"Gupta, S. S., Wang, J. & Chen, M. Metabolic reprogramming in CD8(\u2009+\u2009) T cells during acute viral infections. Front Immunol. 11, 1013 (2020).","journal-title":"Front Immunol."},{"key":"1471_CR215","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.virusres.2011.09.022","volume":"162","author":"JH Kreijtz","year":"2011","unstructured":"Kreijtz, J. H., Fouchier, R. A. & Rimmelzwaan, G. F. Immune responses to influenza virus infection. Virus Res. 162, 19\u201330 (2011).","journal-title":"Virus Res."},{"key":"1471_CR216","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/ni.3025","volume":"15","author":"X Xu","year":"2014","unstructured":"Xu, X. et al. Autophagy is essential for effector CD8(\u2009+\u2009) T cell survival and memory formation. Nat. Immunol. 15, 1152\u20131161 (2014).","journal-title":"Nat. Immunol."},{"key":"1471_CR217","doi-asserted-by":"publisher","first-page":"eaba6006","DOI":"10.1126\/scitranslmed.aba6006","volume":"13","author":"V Kalia","year":"2021","unstructured":"Kalia, V. et al. Metabolic regulation by PD-1 signaling promotes long-lived quiescent CD8 T cell memory in mice. Sci. Transl. Med. 13, eaba6006 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1471_CR218","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1084\/jem.20150186","volume":"212","author":"CX Dominguez","year":"2015","unstructured":"Dominguez, C. X. et al. The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection. J. Exp. Med. 212, 2041\u20132056 (2015).","journal-title":"J. Exp. Med."},{"key":"1471_CR219","doi-asserted-by":"publisher","first-page":"e20201730","DOI":"10.1084\/jem.20201730","volume":"218","author":"HK Chung","year":"2021","unstructured":"Chung, H. K., McDonald, B. & Kaech, S. M. The architectural design of CD8 + T cell responses in acute and chronic infection: Parallel structures with divergent fates. J. Exp. Med. 218, e20201730 (2021).","journal-title":"J. Exp. Med"},{"key":"1471_CR220","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41586-022-04849-0","volume":"607","author":"A Guo","year":"2022","unstructured":"Guo, A. et al. cBAF complex components and MYC cooperate early in CD8(\u2009+\u2009) T cell fate. Nature 607, 135\u2013141 (2022).","journal-title":"Nature"},{"key":"1471_CR221","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9306","volume":"6","author":"JP Bottcher","year":"2015","unstructured":"Bottcher, J. P. et al. Functional classification of memory CD8(\u2009+\u2009) T cells by CX3CR1 expression. Nat. Commun. 6, 8306 (2015).","journal-title":"Nat. Commun."},{"key":"1471_CR222","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.immuni.2016.10.018","volume":"45","author":"C Gerlach","year":"2016","unstructured":"Gerlach, C. et al. The chemokine receptor CX3CR1 defines three antigen-experienced CD8 T cell subsets with distinct roles in immune surveillance and homeostasis. Immunity 45, 1270\u20131284 (2016).","journal-title":"Immunity"},{"key":"1471_CR223","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.immunol.21.120601.141114","volume":"21","author":"P Wong","year":"2003","unstructured":"Wong, P. & Pamer, E. G. CD8 T cell responses to infectious pathogens. Annu. Rev. Immunol. 21, 29\u201370 (2003).","journal-title":"Annu. Rev. Immunol."},{"key":"1471_CR224","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.3389\/fimmu.2019.01896","volume":"10","author":"F Perdomo-Celis","year":"2019","unstructured":"Perdomo-Celis, F., Taborda, N. A. & Rugeles, M. T. CD8(\u2009+\u2009) T-cell response to HIV infection in the era of antiretroviral therapy. Front. Immunol. 10, 1896 (2019).","journal-title":"Front. Immunol."},{"key":"1471_CR225","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00281-015-0482-8","volume":"37","author":"MM Moretto","year":"2015","unstructured":"Moretto, M. M., Harrow, D. I. & Khan, I. A. Effector CD8 T cell immunity in microsporidial infection: a lone defense mechanism. Semin. Immunopathol. 37, 281\u2013287 (2015).","journal-title":"Semin. Immunopathol."},{"key":"1471_CR226","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fimmu.2014.00266","volume":"5","author":"PS Sung","year":"2014","unstructured":"Sung, P. S., Racanelli, V. & Shin, E. C. CD8(\u2009+\u2009) T-cell responses in acute hepatitis C virus infection. Front. Immunol. 5, 266 (2014).","journal-title":"Front. Immunol."},{"key":"1471_CR227","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1038\/s41423-021-00750-4","volume":"18","author":"MS Rha","year":"2021","unstructured":"Rha, M. S. & Shin, E. C. Activation or exhaustion of CD8(\u2009+\u2009) T cells in patients with COVID-19. Cell Mol. Immunol. 18, 2325\u20132333 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"1471_CR228","doi-asserted-by":"publisher","first-page":"eabc8511","DOI":"10.1126\/science.abc8511","volume":"369","author":"D Mathew","year":"2020","unstructured":"Mathew, D. et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 369, eabc8511 (2020).","journal-title":"Science"},{"key":"1471_CR229","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","volume":"183","author":"T Sekine","year":"2020","unstructured":"Sekine, T. et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell 183, 158\u2013168 e114 (2020).","journal-title":"Cell"},{"key":"1471_CR230","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17240-2","volume":"11","author":"JW Song","year":"2020","unstructured":"Song, J. W. et al. Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat. Commun. 11, 3410 (2020).","journal-title":"Nat. Commun."},{"key":"1471_CR231","doi-asserted-by":"publisher","first-page":"eabd7114","DOI":"10.1126\/sciimmunol.abd7114","volume":"5","author":"L Kuri-Cervantes","year":"2020","unstructured":"Kuri-Cervantes, L. et al. Comprehensive mapping of immune perturbations associated with severe COVID-19. Sci. Immunol. 5, eabd7114 (2020).","journal-title":"Sci. Immunol"},{"key":"1471_CR232","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1111\/all.14866","volume":"76","author":"S Adamo","year":"2021","unstructured":"Adamo, S. et al. Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19. Allergy 76, 2866\u20132881 (2021).","journal-title":"Allergy"},{"key":"1471_CR233","doi-asserted-by":"publisher","first-page":"eabe4782","DOI":"10.1126\/sciimmunol.abe4782","volume":"6","author":"A Kusnadi","year":"2021","unstructured":"Kusnadi, A. et al. Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8(+) T cells. Sci. Immunol. 6, eabe4782 (2021).","journal-title":"Sci. Immunol"},{"key":"1471_CR234","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S1471-4906(01)01975-5","volume":"22","author":"D Jankovic","year":"2001","unstructured":"Jankovic, D., Liu, Z. & Gause, W. C. Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways. Trends Immunol. 22, 450\u2013457 (2001).","journal-title":"Trends Immunol."},{"key":"1471_CR235","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nri3152","volume":"12","author":"SL Swain","year":"2012","unstructured":"Swain, S. L., McKinstry, K. K. & Strutt, T. M. Expanding roles for CD4(\u2009+\u2009) T cells in immunity to viruses. Nat. Rev. Immunol. 12, 136\u2013148 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR236","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.coi.2005.06.006","volume":"17","author":"P Salgame","year":"2005","unstructured":"Salgame, P. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. Curr. Opin. Immunol. 17, 374\u2013380 (2005).","journal-title":"Curr. Opin. Immunol."},{"key":"1471_CR237","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3389\/fimmu.2020.00406","volume":"11","author":"SM Miller","year":"2020","unstructured":"Miller, S. M. et al. Novel lipidated imidazoquinoline TLR7\/8 adjuvants elicit influenza-specific Th1 immune responses and protect against heterologous H3N2 influenza challenge in mice. Front. Immunol. 11, 406 (2020).","journal-title":"Front. Immunol."},{"key":"1471_CR238","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489\u20131501 e1415 (2020).","journal-title":"Cell"},{"key":"1471_CR239","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/intimm\/dxaa047","volume":"32","author":"A Alhetheel","year":"2020","unstructured":"Alhetheel, A. et al. Assessment of Th1\/Th2 cytokines among patients with Middle East respiratory syndrome coronavirus infection. Int. Immunol. 32, 799\u2013804 (2020).","journal-title":"Int. Immunol."},{"key":"1471_CR240","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/ar290","volume":"3","author":"AN Theofilopoulos","year":"2001","unstructured":"Theofilopoulos, A. N., Koundouris, S., Kono, D. H. & Lawson, B. R. The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1\/Th2 paradigm in autoimmunity. Arthritis Res. 3, 136\u2013141 (2001).","journal-title":"Arthritis Res."},{"key":"1471_CR241","doi-asserted-by":"publisher","first-page":"101495","DOI":"10.1016\/j.trim.2021.101495","volume":"70","author":"E Aleebrahim-Dehkordi","year":"2022","unstructured":"Aleebrahim-Dehkordi, E. et al. T helper type (Th1\/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: from cytokines produced to immune responses. Transpl. Immunol. 70, 101495 (2022).","journal-title":"Transpl. Immunol."},{"key":"1471_CR242","doi-asserted-by":"crossref","unstructured":"Shanmugasundaram, U. et al. Pulmonary Mycobacterium tuberculosis control associates with CXCR3- and CCR6-expressing antigen-specific Th1 and Th17 cell recruitment. JCI Insight. 5, e137858 (2020).","DOI":"10.1172\/jci.insight.137858"},{"key":"1471_CR243","doi-asserted-by":"publisher","first-page":"e1010430","DOI":"10.1371\/journal.ppat.1010430","volume":"18","author":"P Bartsch","year":"2022","unstructured":"Bartsch, P. et al. Th17 cell plasticity towards a T-bet-dependent Th1 phenotype is required for bacterial control in Staphylococcus aureus infection. PLoS Pathog. 18, e1010430 (2022).","journal-title":"PLoS Pathog."},{"key":"1471_CR244","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cyto.2018.01.025","volume":"104","author":"WH Mahallawi","year":"2018","unstructured":"Mahallawi, W. H. et al. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine 104, 8\u201313 (2018).","journal-title":"Cytokine"},{"key":"1471_CR245","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12985-016-0548-9","volume":"13","author":"D Kuczera","year":"2016","unstructured":"Kuczera, D. et al. Isolation of dengue virus serotype 4 genotype II from a patient with high viral load and a mixed Th1\/Th17 inflammatory cytokine profile in South Brazil. Virol. J. 13, 93 (2016).","journal-title":"Virol. J."},{"key":"1471_CR246","doi-asserted-by":"publisher","first-page":"e100166","DOI":"10.1371\/journal.pone.0100166","volume":"9","author":"I Schiavoni","year":"2014","unstructured":"Schiavoni, I. et al. Live attenuated B. pertussis BPZE1 rescues the immune functions of Respiratory Syncytial virus infected human dendritic cells by promoting Th1\/Th17 responses. PLoS ONE 9, e100166 (2014).","journal-title":"PLoS ONE"},{"key":"1471_CR247","doi-asserted-by":"publisher","first-page":"e96080","DOI":"10.1371\/journal.pone.0096080","volume":"9","author":"J Yan","year":"2014","unstructured":"Yan, J. et al. Prevalence and clinical relevance of T-helper cells, Th17 and Th1, in hepatitis B virus-related hepatocellular carcinoma. PLoS ONE 9, e96080 (2014).","journal-title":"PLoS ONE"},{"key":"1471_CR248","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s40009-022-01123-9","volume":"45","author":"G Gupta","year":"2022","unstructured":"Gupta, G. et al. Th1\/Th2\/Th17 cytokine profile among different stages of COVID-19 infection. Natl Acad. Sci. Lett. 45, 363\u2013369 (2022).","journal-title":"Natl Acad. Sci. Lett."},{"key":"1471_CR249","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1128\/IAI.01329-06","volume":"75","author":"XL Rudner","year":"2007","unstructured":"Rudner, X. L., Happel, K. I., Young, E. A. & Shellito, J. E. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect. Immun. 75, 3055\u20133061 (2007).","journal-title":"Infect. Immun."},{"key":"1471_CR250","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1086\/422329","volume":"190","author":"W Huang","year":"2004","unstructured":"Huang, W., Na, L., Fidel, P. L. & Schwarzenberger, P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190, 624\u2013631 (2004).","journal-title":"J. Infect. Dis."},{"key":"1471_CR251","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/ni.1770","volume":"10","author":"S Trifari","year":"2009","unstructured":"Trifari, S. et al. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat. Immunol. 10, 864\u2013871 (2009).","journal-title":"Nat. Immunol."},{"key":"1471_CR252","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/mi.2009.100","volume":"2","author":"SA Khader","year":"2009","unstructured":"Khader, S. A., Gaffen, S. L. & Kolls, J. K. Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol. 2, 403\u2013411 (2009).","journal-title":"Mucosal Immunol."},{"key":"1471_CR253","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jdermsci.2013.04.028","volume":"72","author":"H Fujita","year":"2013","unstructured":"Fujita, H. The role of IL-22 and Th22 cells in human skin diseases. J. Dermatol. Sci. 72, 3\u20138 (2013).","journal-title":"J. Dermatol. Sci."},{"key":"1471_CR254","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1767","volume":"10","author":"T Duhen","year":"2009","unstructured":"Duhen, T. et al. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 10, 857\u2013863 (2009).","journal-title":"Nat. Immunol."},{"key":"1471_CR255","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fimmu.2017.00194","volume":"8","author":"A Takeuchi","year":"2017","unstructured":"Takeuchi, A. & Saito, T. CD4 CTL, a cytotoxic subset of CD4(\u2009+\u2009) T cells, their differentiation and function. Front. Immunol. 8, 194 (2017).","journal-title":"Front. Immunol."},{"key":"1471_CR256","doi-asserted-by":"publisher","first-page":"951900","DOI":"10.3389\/fimmu.2022.951900","volume":"13","author":"C Hoeks","year":"2022","unstructured":"Hoeks, C., Duran, G., Hellings, N. & Broux, B. When helpers go above and beyond: development and characterization of cytotoxic CD4(\u2009+\u2009) T cells. Front. Immunol. 13, 951900 (2022).","journal-title":"Front. Immunol."},{"key":"1471_CR257","doi-asserted-by":"publisher","first-page":"24242","DOI":"10.1073\/pnas.1907883116","volume":"116","author":"K Hashimoto","year":"2019","unstructured":"Hashimoto, K. et al. Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians. Proc. Natl Acad. Sci. USA 116, 24242\u201324251 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR258","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.coi.2021.09.005","volume":"74","author":"L Poncette","year":"2022","unstructured":"Poncette, L., Bluhm, J. & Blankenstein, T. The role of CD4 T cells in rejection of solid tumors. Curr. Opin. Immunol. 74, 18\u201324 (2022).","journal-title":"Curr. Opin. Immunol."},{"key":"1471_CR259","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1084\/jem.20091921","volume":"207","author":"Y Xie","year":"2010","unstructured":"Xie, Y. et al. Naive tumor-specific CD4(\u2009+\u2009) T cells differentiated in vivo eradicate established melanoma. J. Exp. Med. 207, 651\u2013667 (2010).","journal-title":"J. Exp. Med."},{"key":"1471_CR260","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1182\/blood-2003-08-2765","volume":"103","author":"JJ Zaunders","year":"2004","unstructured":"Zaunders, J. J. et al. Identification of circulating antigen-specific CD4\u2009+\u2009T lymphocytes with a CCR5\u2009+\u2009, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection. Blood 103, 2238\u20132247 (2004).","journal-title":"Blood"},{"key":"1471_CR261","doi-asserted-by":"publisher","first-page":"123ra125","DOI":"10.1126\/scitranslmed.3003165","volume":"4","author":"DZ Soghoian","year":"2012","unstructured":"Soghoian, D. Z. et al. HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci. Transl. Med. 4, 123ra125 (2012).","journal-title":"Sci. Transl. Med."},{"key":"1471_CR262","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2893.2006.00723.x","volume":"13","author":"N Aslan","year":"2006","unstructured":"Aslan, N. et al. Cytotoxic CD4 T cells in viral hepatitis. J. Viral Hepat. 13, 505\u2013514 (2006).","journal-title":"J. Viral Hepat."},{"key":"1471_CR263","doi-asserted-by":"publisher","first-page":"E686","DOI":"10.1073\/pnas.1713607115","volume":"115","author":"IK Choi","year":"2018","unstructured":"Choi, I. K. et al. Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4(+) and CD8(\u2009+\u2009) T cell responses. Proc. Natl Acad. Sci. USA 115, E686\u2013E695 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR264","doi-asserted-by":"publisher","first-page":"E4256","DOI":"10.1073\/pnas.1505956112","volume":"112","author":"D Weiskopf","year":"2015","unstructured":"Weiskopf, D. et al. Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4\u2009+\u2009T cells associated with protective immunity. Proc. Natl Acad. Sci. USA 112, E4256\u2013E4263 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR265","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nm.2612","volume":"18","author":"TM Wilkinson","year":"2012","unstructured":"Wilkinson, T. M. et al. Preexisting influenza-specific CD4\u2009+\u2009T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 18, 274\u2013280 (2012).","journal-title":"Nat. Med."},{"key":"1471_CR266","doi-asserted-by":"publisher","first-page":"11884","DOI":"10.1128\/JVI.01461-13","volume":"87","author":"L Hua","year":"2013","unstructured":"Hua, L. et al. Cytokine-dependent induction of CD4\u2009+\u2009T cells with cytotoxic potential during influenza virus infection. J. Virol. 87, 11884\u201311893 (2013).","journal-title":"J. Virol."},{"key":"1471_CR267","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.cell.2020.10.001","volume":"183","author":"BJ Meckiff","year":"2020","unstructured":"Meckiff, B. J. et al. Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4(\u2009+\u2009) T cells in COVID-19. Cell 183, 1340\u20131353 e1316 (2020).","journal-title":"Cell"},{"key":"1471_CR268","doi-asserted-by":"crossref","unstructured":"Cachot, A. et al. Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer. Sci Adv. 7, eabe3348 (2021).","DOI":"10.1126\/sciadv.abe3348"},{"key":"1471_CR269","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1600-6143.2007.02128.x","volume":"8","author":"LG Hidalgo","year":"2008","unstructured":"Hidalgo, L. G., Einecke, G., Allanach, K. & Halloran, P. F. The transcriptome of human cytotoxic T cells: similarities and disparities among allostimulated CD4(\u2009+\u2009) CTL, CD8(\u2009+\u2009) CTL and NK cells. Am. J. Transpl. 8, 627\u2013636 (2008).","journal-title":"Am. J. Transpl."},{"key":"1471_CR270","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.4049\/jimmunol.167.5.2734","volume":"167","author":"DH Canaday","year":"2001","unstructured":"Canaday, D. H. et al. CD4(+) and CD8(\u2009+\u2009) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas\/Fas ligand-independent mechanism. J. Immunol. 167, 2734\u20132742 (2001).","journal-title":"J. Immunol."},{"key":"1471_CR271","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/ni.2523","volume":"14","author":"D Mucida","year":"2013","unstructured":"Mucida, D. et al. Transcriptional reprogramming of mature CD4(+) helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes. Nat. Immunol. 14, 281\u2013289 (2013).","journal-title":"Nat. Immunol."},{"key":"1471_CR272","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/ni.2518","volume":"14","author":"BS Reis","year":"2013","unstructured":"Reis, B. S. et al. Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4(\u2009+\u2009) T cell immunity. Nat. Immunol. 14, 271\u2013280 (2013).","journal-title":"Nat. Immunol."},{"key":"1471_CR273","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.imlet.2012.02.013","volume":"144","author":"K Eshima","year":"2012","unstructured":"Eshima, K. et al. Ectopic expression of a T-box transcription factor, eomesodermin, renders CD4(+) Th cells cytotoxic by activating both perforin- and FasL-pathways. Immunol. Lett. 144, 7\u201315 (2012).","journal-title":"Immunol. Lett."},{"key":"1471_CR274","doi-asserted-by":"publisher","first-page":"e89010","DOI":"10.1371\/journal.pone.0089010","volume":"9","author":"AM Workman","year":"2014","unstructured":"Workman, A. M. et al. Inflammation enhances IL-2 driven differentiation of cytolytic CD4 T cells. PLoS ONE 9, e89010 (2014).","journal-title":"PLoS ONE"},{"key":"1471_CR275","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fimmu.2016.00093","volume":"7","author":"DM Brown","year":"2016","unstructured":"Brown, D. M., Lampe, A. T. & Workman, A. M. The differentiation and protective function of cytolytic CD4 T cells in influenza infection. Front. Immunol. 7, 93 (2016).","journal-title":"Front. Immunol."},{"key":"1471_CR276","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.imlet.2022.05.001","volume":"247","author":"T Preglej","year":"2022","unstructured":"Preglej, T. & Ellmeier, W. CD4(+) cytotoxic T cells - Phenotype, function and transcriptional networks controlling their differentiation pathways. Immunol. Lett. 247, 27\u201342 (2022).","journal-title":"Immunol. Lett."},{"key":"1471_CR277","doi-asserted-by":"crossref","unstructured":"Patil, V. S. et al. Precursors of human CD4(+) cytotoxic T lymphocytes identified by single-cell transcriptome analysis. Sci. Immunol. 3, eaan8664 (2018).","DOI":"10.1126\/sciimmunol.aan8664"},{"key":"1471_CR278","doi-asserted-by":"publisher","first-page":"779961","DOI":"10.3389\/fimmu.2021.779961","volume":"12","author":"M Lyu","year":"2021","unstructured":"Lyu, M. et al. Dissecting the landscape of activated CMV-stimulated CD4\u2009+\u2009T cells in humans by linking single-cell RNA-seq with T-cell receptor sequencing. Front. Immunol. 12, 779961 (2021).","journal-title":"Front. Immunol."},{"key":"1471_CR279","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fimmu.2017.00019","volume":"8","author":"JA Juno","year":"2017","unstructured":"Juno, J. A. et al. Cytotoxic CD4 T cells-friend or foe during viral infection? Front. Immunol. 8, 19 (2017).","journal-title":"Front. Immunol."},{"key":"1471_CR280","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jcv.2019.08.004","volume":"119","author":"A Sanchez-Martinez","year":"2019","unstructured":"Sanchez-Martinez, A. et al. Cytotoxic CD4(\u2009+\u2009) T-cells during HIV infection: targets or weapons? J. Clin. Virol. 119, 17\u201323 (2019).","journal-title":"J. Clin. Virol."},{"key":"1471_CR281","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3389\/fimmu.2016.00531","volume":"7","author":"Y Tian","year":"2016","unstructured":"Tian, Y., Sette, A. & Weiskopf, D. Cytotoxic CD4 T cells: differentiation, function, and application to dengue virus infection. Front. Immunol. 7, 531 (2016).","journal-title":"Front. Immunol."},{"key":"1471_CR282","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/s41590-020-0762-x","volume":"21","author":"JY Zhang","year":"2020","unstructured":"Zhang, J. Y. et al. Single-cell landscape of immunological responses in patients with COVID-19. Nat. Immunol. 21, 1107\u20131118 (2020).","journal-title":"Nat. Immunol."},{"key":"1471_CR283","doi-asserted-by":"publisher","first-page":"108991","DOI":"10.1016\/j.clim.2022.108991","volume":"237","author":"N Kaneko","year":"2022","unstructured":"Kaneko, N. et al. Temporal changes in T cell subsets and expansion of cytotoxic CD4+ T cells in the lungs in severe COVID-19. Clin. Immunol. 237, 108991 (2022).","journal-title":"Clin. Immunol"},{"key":"1471_CR284","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/08830185.2019.1632842","volume":"38","author":"F Abebe","year":"2019","unstructured":"Abebe, F. Synergy between Th1 and Th2 responses during Mycobacterium tuberculosis infection: a review of current understanding. Int. Rev. Immunol. 38, 172\u2013179 (2019).","journal-title":"Int. Rev. Immunol."},{"key":"1471_CR285","doi-asserted-by":"publisher","first-page":"854507","DOI":"10.1155\/2015\/854507","volume":"2015","author":"IV Lyadova","year":"2015","unstructured":"Lyadova, I. V. & Panteleev, A. V. Th1 and Th17 cells in tuberculosis: protection, pathology, and biomarkers. Mediators Inflamm. 2015, 854507 (2015).","journal-title":"Mediators Inflamm."},{"key":"1471_CR286","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3892\/mmr.2014.2170","volume":"10","author":"X Ma","year":"2014","unstructured":"Ma, X. et al. Th17 cells are associated with the Th1\/Th2cell balance during Echinococcus multilocularis infection. Mol. Med. Rep. 10, 236\u2013240 (2014).","journal-title":"Mol. Med. Rep."},{"key":"1471_CR287","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1128\/IAI.00508-10","volume":"79","author":"BJ Murdock","year":"2011","unstructured":"Murdock, B. J. et al. Coevolution of TH1, TH2, and TH17 responses during repeated pulmonary exposure to Aspergillus fumigatus conidia. Infect. Immun. 79, 125\u2013135 (2011).","journal-title":"Infect. Immun."},{"key":"1471_CR288","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.micpath.2016.06.008","volume":"97","author":"L Gorenec","year":"2016","unstructured":"Gorenec, L. et al. The comparison of Th1, Th2, Th9, Th17 and Th22 cytokine profiles in acute and chronic HIV-1 infection. Micro. Pathog. 97, 125\u2013130 (2016).","journal-title":"Micro. Pathog."},{"key":"1471_CR289","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.3389\/fimmu.2019.02139","volume":"10","author":"P Cardona","year":"2019","unstructured":"Cardona, P. & Cardona, P. J. Regulatory T cells in Mycobacterium tuberculosis infection. Front. Immunol. 10, 2139 (2019).","journal-title":"Front. Immunol."},{"key":"1471_CR290","doi-asserted-by":"publisher","first-page":"916411","DOI":"10.3389\/fimmu.2022.916411","volume":"13","author":"Z Xu","year":"2022","unstructured":"Xu, Z., Jiang, X., Dai, X. & Li, B. The dynamic role of FOXP3(+) tregs and their potential therapeutic applications during SARS-CoV-2 infection. Front. Immunol. 13, 916411 (2022).","journal-title":"Front. Immunol."},{"key":"1471_CR291","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/imm.13190","volume":"160","author":"MPJ White","year":"2020","unstructured":"White, M. P. J., McManus, C. M. & Maizels, R. M. Regulatory T-cells in helminth infection: induction, function and therapeutic potential. Immunology 160, 248\u2013260 (2020).","journal-title":"Immunology"},{"key":"1471_CR292","doi-asserted-by":"publisher","first-page":"e12873","DOI":"10.1111\/sji.12873","volume":"91","author":"Z Wan","year":"2020","unstructured":"Wan, Z. et al. Regulatory T cells and T helper 17 cells in viral infection. Scand. J. Immunol. 91, e12873 (2020).","journal-title":"Scand. J. Immunol."},{"key":"1471_CR293","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/BF00812260","volume":"21","author":"C Infante-Duarte","year":"1999","unstructured":"Infante-Duarte, C. & Kamradt, T. Th1\/Th2 balance in infection. Springe. Semin Immunopathol. 21, 317\u2013338 (1999).","journal-title":"Springe. Semin Immunopathol."},{"key":"1471_CR294","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev-immunol-093019-111748","volume":"39","author":"N Cox","year":"2021","unstructured":"Cox, N., Pokrovskii, M., Vicario, R. & Geissmann, F. Origins, biology, and diseases of tissue macrophages. Annu. Rev. Immunol. 39, 313\u2013344 (2021).","journal-title":"Annu. Rev. Immunol."},{"key":"1471_CR295","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00011-015-0874-1","volume":"65","author":"S Bashir","year":"2016","unstructured":"Bashir, S., Sharma, Y., Elahi, A. & Khan, F. Macrophage polarization: the link between inflammation and related diseases. Inflamm. Res. 65, 1\u201311 (2016).","journal-title":"Inflamm. Res."},{"key":"1471_CR296","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1128\/jvi.68.7.4700-4704.1994","volume":"68","author":"M Battegay","year":"1994","unstructured":"Battegay, M. et al. Enhanced establishment of a virus carrier state in adult CD4\u2009+\u2009T-cell-deficient mice. J. Virol. 68, 4700\u20134704 (1994).","journal-title":"J. Virol."},{"key":"1471_CR297","doi-asserted-by":"publisher","first-page":"5603","DOI":"10.4049\/jimmunol.167.10.5603","volume":"167","author":"SE Hamilton","year":"2001","unstructured":"Hamilton, S. E., Tvinnereim, A. R. & Harty, J. T. Listeria monocytogenes infection overcomes the requirement for CD40 ligand in exogenous antigen presentation to CD8(\u2009+\u2009) T cells. J. Immunol. 167, 5603\u20135609 (2001).","journal-title":"J. Immunol."},{"key":"1471_CR298","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1128\/IAI.00086-07","volume":"75","author":"CM Krawczyk","year":"2007","unstructured":"Krawczyk, C. M., Shen, H. & Pearce, E. J. Memory CD4 T cells enhance primary CD8 T-cell responses. Infect. Immun. 75, 3556\u20133560 (2007).","journal-title":"Infect. Immun."},{"key":"1471_CR299","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/eji.200526193","volume":"36","author":"K Serre","year":"2006","unstructured":"Serre, K. et al. CD4 T cell help is required for primary CD8 T cell responses to vesicular antigen delivered to dendritic cells in vivo. Eur. J. Immunol. 36, 1386\u20131397 (2006).","journal-title":"Eur. J. Immunol."},{"key":"1471_CR300","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1128\/JVI.01850-14","volume":"89","author":"TW Flinsenberg","year":"2015","unstructured":"Flinsenberg, T. W. et al. Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantation. J. Virol. 89, 1058\u20131069 (2015).","journal-title":"J. Virol."},{"key":"1471_CR301","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.4049\/jimmunol.171.12.6339","volume":"171","author":"JC Wang","year":"2003","unstructured":"Wang, J. C. & Livingstone, A. M. Cutting edge: CD4\u2009+\u2009T cell help can be essential for primary CD8\u2009+\u2009T cell responses in vivo. J. Immunol. 171, 6339\u20136343 (2003).","journal-title":"J. Immunol."},{"key":"1471_CR302","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1126\/science.1082305","volume":"300","author":"DJ Shedlock","year":"2003","unstructured":"Shedlock, D. J. & Shen, H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300, 337\u2013339 (2003).","journal-title":"Science"},{"key":"1471_CR303","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1126\/science.1072615","volume":"297","author":"C Bourgeois","year":"2002","unstructured":"Bourgeois, C., Rocha, B. & Tanchot, C. A role for CD40 expression on CD8\u2009+\u2009T cells in the generation of CD8\u2009+\u2009T cell memory. Science 297, 2060\u20132063 (2002).","journal-title":"Science"},{"key":"1471_CR304","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/nature01441","volume":"421","author":"EM Janssen","year":"2003","unstructured":"Janssen, E. M. et al. CD4\u2009+\u2009T cells are required for secondary expansion and memory in CD8\u2009+\u2009T lymphocytes. Nature 421, 852\u2013856 (2003).","journal-title":"Nature"},{"key":"1471_CR305","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nature04790","volume":"441","author":"MA Williams","year":"2006","unstructured":"Williams, M. A., Tyznik, A. J. & Bevan, M. J. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature 441, 890\u2013893 (2006).","journal-title":"Nature"},{"key":"1471_CR306","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1002\/eji.200939939","volume":"40","author":"BR Barker","year":"2010","unstructured":"Barker, B. R. et al. Critical role for IL-21 in both primary and memory anti-viral CD8\u2009+\u2009T-cell responses. Eur. J. Immunol. 40, 3085\u20133096 (2010).","journal-title":"Eur. J. Immunol."},{"key":"1471_CR307","doi-asserted-by":"publisher","first-page":"e47004","DOI":"10.1371\/journal.pone.0047004","volume":"7","author":"C Sokke Umeshappa","year":"2012","unstructured":"Sokke Umeshappa, C. et al. CD154 and IL-2 signaling of CD4\u2009+\u2009T cells play a critical role in multiple phases of CD8\u2009+\u2009CTL responses following adenovirus vaccination. PLoS ONE 7, e47004 (2012).","journal-title":"PLoS ONE"},{"key":"1471_CR308","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1073\/pnas.0909945107","volume":"107","author":"JJ Obar","year":"2010","unstructured":"Obar, J. J. et al. CD4\u2009+\u2009T cell regulation of CD25 expression controls development of short-lived effector CD8\u2009+\u2009T cells in primary and secondary responses. Proc. Natl Acad. Sci. USA 107, 193\u2013198 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR309","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.4049\/jimmunol.0802041","volume":"182","author":"S Fuse","year":"2009","unstructured":"Fuse, S. et al. Recall responses by helpless memory CD8\u2009+\u2009T cells are restricted by the up-regulation of PD-1. J. Immunol. 182, 4244\u20134254 (2009).","journal-title":"J. Immunol."},{"key":"1471_CR310","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fimmu.2019.00249","volume":"10","author":"Q Huang","year":"2019","unstructured":"Huang, Q. et al. Molecular basis of the differentiation and function of virus specific follicular helper CD4(\u2009+\u2009) T cells. Front. Immunol. 10, 249 (2019).","journal-title":"Front. Immunol."},{"key":"1471_CR311","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.immuni.2013.08.031","volume":"39","author":"M Locci","year":"2013","unstructured":"Locci, M. et al. Human circulating PD-1\u2009+\u2009CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 39, 758\u2013769 (2013).","journal-title":"Immunity"},{"key":"1471_CR312","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/s41591-020-0995-0","volume":"26","author":"JA Juno","year":"2020","unstructured":"Juno, J. A. et al. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19. Nat. Med. 26, 1428\u20131434 (2020).","journal-title":"Nat. Med."},{"key":"1471_CR313","doi-asserted-by":"publisher","first-page":"e1009761","DOI":"10.1371\/journal.ppat.1009761","volume":"17","author":"S Boppana","year":"2021","unstructured":"Boppana, S. et al. SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence. PLoS Pathog. 17, e1009761 (2021).","journal-title":"PLoS Pathog."},{"key":"1471_CR314","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cell.2020.08.025","volume":"183","author":"N Kaneko","year":"2020","unstructured":"Kaneko, N. et al. Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19. Cell 183, 143\u2013157 e113 (2020).","journal-title":"Cell"},{"key":"1471_CR315","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/icb.2013.54","volume":"92","author":"LM Kato","year":"2014","unstructured":"Kato, L. M., Kawamoto, S., Maruya, M. & Fagarasan, S. Gut TFH and IgA: key players for regulation of bacterial communities and immune homeostasis. Immunol. Cell Biol. 92, 49\u201356 (2014).","journal-title":"Immunol. Cell Biol."},{"key":"1471_CR316","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","volume":"19","author":"CU Blank","year":"2019","unstructured":"Blank, C. U. et al. Defining \u2018T cell exhaustion\u2019. Nat. Rev. Immunol. 19, 665\u2013674 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR317","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry, E. J. T cell exhaustion. Nat. Immunol. 12, 492\u2013499 (2011).","journal-title":"Nat. Immunol."},{"key":"1471_CR318","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1084\/jem.20011723","volume":"195","author":"S Reignat","year":"2002","unstructured":"Reignat, S. et al. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J. Exp. Med. 195, 1089\u20131101 (2002).","journal-title":"J. Exp. Med."},{"key":"1471_CR319","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1182\/blood.V96.9.3094.h8003094_3094_3101","volume":"96","author":"P Shankar","year":"2000","unstructured":"Shankar, P. et al. Impaired function of circulating HIV-specific CD8(\u2009+\u2009) T cells in chronic human immunodeficiency virus infection. Blood 96, 3094\u20133101 (2000).","journal-title":"Blood"},{"key":"1471_CR320","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.1128\/JVI.75.12.5550-5558.2001","volume":"75","author":"NH Gruener","year":"2001","unstructured":"Gruener, N. H. et al. Sustained dysfunction of antiviral CD8\u2009+\u2009T lymphocytes after infection with hepatitis C virus. J. Virol. 75, 5550\u20135558 (2001).","journal-title":"J. Virol."},{"key":"1471_CR321","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.virol.2014.12.033","volume":"479-480","author":"SM Kahan","year":"2015","unstructured":"Kahan, S. M., Wherry, E. J. & Zajac, A. J. T cell exhaustion during persistent viral infections. Virology 479-480, 180\u2013193 (2015).","journal-title":"Virology"},{"key":"1471_CR322","doi-asserted-by":"publisher","first-page":"abe6474","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).","journal-title":"Science"},{"key":"1471_CR323","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","volume":"37","author":"LM McLane","year":"2019","unstructured":"McLane, L. M., Abdel-Hakeem, M. S. & Wherry, E. J. CD8 T cell exhaustion during chronic viral infection and cancer. Annu. Rev. Immunol. 37, 457\u2013495 (2019).","journal-title":"Annu. Rev. Immunol."},{"key":"1471_CR324","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","volume":"169","author":"C Zheng","year":"2017","unstructured":"Zheng, C. et al. Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell 169, 1342\u20131356 e1316 (2017).","journal-title":"Cell"},{"key":"1471_CR325","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-med-012017-043208","volume":"69","author":"M Hashimoto","year":"2018","unstructured":"Hashimoto, M. et al. CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions. Annu. Rev. Med 69, 301\u2013318 (2018).","journal-title":"Annu. Rev. Med"},{"key":"1471_CR326","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486\u2013499 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR327","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","volume":"77","author":"EJ Wherry","year":"2003","unstructured":"Wherry, E. J. et al. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77, 4911\u20134927 (2003).","journal-title":"J. Virol."},{"key":"1471_CR328","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.4049\/jimmunol.1000841","volume":"185","author":"KJ Mackerness","year":"2010","unstructured":"Mackerness, K. J. et al. Pronounced virus-dependent activation drives exhaustion but sustains IFN-gamma transcript levels. J. Immunol. 185, 3643\u20133651 (2010).","journal-title":"J. Immunol."},{"key":"1471_CR329","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry, E. J. et al. Molecular signature of CD8\u2009+\u2009T cell exhaustion during chronic viral infection. Immunity 27, 670\u2013684 (2007).","journal-title":"Immunity"},{"key":"1471_CR330","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.immuni.2008.11.002","volume":"29","author":"CD Surh","year":"2008","unstructured":"Surh, C. D. & Sprent, J. Homeostasis of naive and memory T cells. Immunity 29, 848\u2013862 (2008).","journal-title":"Immunity"},{"key":"1471_CR331","doi-asserted-by":"publisher","first-page":"16004","DOI":"10.1073\/pnas.0407192101","volume":"101","author":"EJ Wherry","year":"2004","unstructured":"Wherry, E. J. et al. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc. Natl Acad. Sci. USA 101, 16004\u201316009 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR332","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1128\/JVI.02021-06","volume":"81","author":"H Radziewicz","year":"2007","unstructured":"Radziewicz, H. et al. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J. Virol. 81, 2545\u20132553 (2007).","journal-title":"J. Virol."},{"key":"1471_CR333","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1084\/jem.20061937","volume":"204","author":"H Shin","year":"2007","unstructured":"Shin, H., Blackburn, S. D., Blattman, J. N. & Wherry, E. J. Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection. J. Exp. Med. 204, 941\u2013949 (2007).","journal-title":"J. Exp. Med."},{"key":"1471_CR334","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1229620","volume":"338","author":"MA Paley","year":"2012","unstructured":"Paley, M. A. et al. Progenitor and terminal subsets of CD8\u2009+\u2009T cells cooperate to contain chronic viral infection. Science 338, 1220\u20131225 (2012).","journal-title":"Science"},{"key":"1471_CR335","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ni.1679","volume":"10","author":"SD Blackburn","year":"2009","unstructured":"Blackburn, S. D. et al. Coregulation of CD8\u2009+\u2009T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10, 29\u201337 (2009).","journal-title":"Nat. Immunol."},{"key":"1471_CR336","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1158\/2326-6066.CIR-15-0097","volume":"3","author":"DS Thommen","year":"2015","unstructured":"Thommen, D. S. et al. Progression of lung cancer is associated with increased dysfunction of T cells defined by coexpression of multiple inhibitory receptors. Cancer Immunol. Res. 3, 1344\u20131355 (2015).","journal-title":"Cancer Immunol. Res."},{"key":"1471_CR337","doi-asserted-by":"publisher","first-page":"6168","DOI":"10.1128\/JVI.02205-10","volume":"85","author":"P Penaloza-MacMaster","year":"2011","unstructured":"Penaloza-MacMaster, P. et al. Opposing effects of CD70 costimulation during acute and chronic lymphocytic choriomeningitis virus infection of mice. J. Virol. 85, 6168\u20136174 (2011).","journal-title":"J. Virol."},{"key":"1471_CR338","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.immuni.2016.04.020","volume":"44","author":"JH Esensten","year":"2016","unstructured":"Esensten, J. H. et al. CD28 costimulation: from mechanism to therapy. Immunity 44, 973\u2013988 (2016).","journal-title":"Immunity"},{"key":"1471_CR339","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1126\/science.aaf1292","volume":"355","author":"E Hui","year":"2017","unstructured":"Hui, E. et al. T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition. Science 355, 1428\u20131433 (2017).","journal-title":"Science"},{"key":"1471_CR340","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","volume":"22","author":"M Philip","year":"2022","unstructured":"Philip, M. & Schietinger, A. CD8(\u2009+\u2009) T cell differentiation and dysfunction in cancer. Nat. Rev. Immunol. 22, 209\u2013223 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR341","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.immuni.2016.07.011","volume":"45","author":"A Schietinger","year":"2016","unstructured":"Schietinger, A. et al. Tumor-specific T cell dysfunction is a dynamic antigen-driven differentiation program initiated early during tumorigenesis. Immunity 45, 389\u2013401 (2016).","journal-title":"Immunity"},{"key":"1471_CR342","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature22367","volume":"545","author":"M Philip","year":"2017","unstructured":"Philip, M. et al. Chromatin states define tumour-specific T cell dysfunction and reprogramming. Nature 545, 452\u2013456 (2017).","journal-title":"Nature"},{"key":"1471_CR343","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1128\/JVI.00889-12","volume":"86","author":"JM Angelosanto","year":"2012","unstructured":"Angelosanto, J. M., Blackburn, S. D., Crawford, A. & Wherry, E. J. Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection. J. Virol. 86, 8161\u20138170 (2012).","journal-title":"J. Virol."},{"key":"1471_CR344","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/s41590-019-0403-4","volume":"20","author":"C Yao","year":"2019","unstructured":"Yao, C. et al. Single-cell RNA-seq reveals TOX as a key regulator of CD8(\u2009+\u2009) T cell persistence in chronic infection. Nat. Immunol. 20, 890\u2013901 (2019).","journal-title":"Nat. Immunol."},{"key":"1471_CR345","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41591-018-0045-3","volume":"24","author":"X Guo","year":"2018","unstructured":"Guo, X. et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat. Med. 24, 978\u2013985 (2018).","journal-title":"Nat. Med."},{"key":"1471_CR346","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189\u2013196 (2016).","journal-title":"Science"},{"key":"1471_CR347","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41392-021-00864-1","volume":"7","author":"Y Lu","year":"2022","unstructured":"Lu, Y., Ye, C. & Yuan, Y. Phenotypic characteristics and T cell receptor properties in melanoma: deciphering the correlation at single-cell resolution. Signal Transduct. Target Ther. 7, 5 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"1471_CR348","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","volume":"174","author":"E Azizi","year":"2018","unstructured":"Azizi, E. et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell 174, 1293\u20131308 e1236 (2018).","journal-title":"Cell"},{"key":"1471_CR349","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","volume":"564","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature 564, 268\u2013272 (2018).","journal-title":"Nature"},{"key":"1471_CR350","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","volume":"20","author":"AM van der Leun","year":"2020","unstructured":"van der Leun, A. M., Thommen, D. S. & Schumacher, T. N. CD8(+) T cell states in human cancer: insights from single-cell analysis. Nat. Rev. Cancer 20, 218\u2013232 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"1471_CR351","doi-asserted-by":"crossref","unstructured":"Hudson, W. H. & Wieland, A. Technology meets TILs: deciphering T cell function in the -omics era. Cancer Cell 41, 41\u201357. (2022).","DOI":"10.1016\/j.ccell.2022.09.011"},{"key":"1471_CR352","doi-asserted-by":"publisher","first-page":"715234","DOI":"10.3389\/fimmu.2021.715234","volume":"12","author":"JS Dolina","year":"2021","unstructured":"Dolina, J. S., Van Braeckel-Budimir, N., Thomas, G. D. & Salek-Ardakani, S. CD8(+) T cell exhaustion in cancer. Front. Immunol. 12, 715234 (2021).","journal-title":"Front. Immunol."},{"key":"1471_CR353","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature19330","volume":"537","author":"SJ Im","year":"2016","unstructured":"Im, S. J. et al. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature 537, 417\u2013421 (2016).","journal-title":"Nature"},{"key":"1471_CR354","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","volume":"45","author":"DT Utzschneider","year":"2016","unstructured":"Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8(+) T cells sustain the immune response to chronic viral infections. Immunity 45, 415\u2013427 (2016).","journal-title":"Immunity"},{"key":"1471_CR355","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","volume":"52","author":"JC Beltra","year":"2020","unstructured":"Beltra, J. C. et al. Developmental relationships of four exhausted CD8(+) T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms. Immunity 52, 825\u2013841 e828 (2020).","journal-title":"Immunity"},{"key":"1471_CR356","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41586-022-05105-1","volume":"609","author":"C Tsui","year":"2022","unstructured":"Tsui, C. et al. MYB orchestrates T cell exhaustion and response to checkpoint inhibition. Nature 609, 354\u2013360 (2022).","journal-title":"Nature"},{"key":"1471_CR357","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/s41590-020-0791-5","volume":"21","author":"G Galletti","year":"2020","unstructured":"Galletti, G. et al. Two subsets of stem-like CD8(+) memory T cell progenitors with distinct fate commitments in humans. Nat. Immunol. 21, 1552\u20131562 (2020).","journal-title":"Nat. Immunol."},{"key":"1471_CR358","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41590-020-00810-3","volume":"22","author":"F Baharom","year":"2021","unstructured":"Baharom, F. et al. Intravenous nanoparticle vaccination generates stem-like TCF1(+) neoantigen-specific CD8(+) T cells. Nat. Immunol. 22, 41\u201352 (2021).","journal-title":"Nat. Immunol."},{"key":"1471_CR359","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.immuni.2019.11.002","volume":"51","author":"WH Hudson","year":"2019","unstructured":"Hudson, W. H. et al. Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1(+) stem-like CD8(+) T cells during chronic infection. Immunity 51, 1043\u20131058 e1044 (2019).","journal-title":"Immunity"},{"key":"1471_CR360","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.immuni.2019.10.009","volume":"51","author":"R Zander","year":"2019","unstructured":"Zander, R. et al. CD4(+) T cell help is required for the formation of a cytolytic CD8(+) T cell subset that protects against chronic infection and cancer. Immunity 51, 1028\u20131042 e1024 (2019).","journal-title":"Immunity"},{"key":"1471_CR361","doi-asserted-by":"publisher","first-page":"20070","DOI":"10.1073\/pnas.1902701116","volume":"116","author":"K Kanev","year":"2019","unstructured":"Kanev, K. et al. Proliferation-competent Tcf1+ CD8 T cells in dysfunctional populations are CD4 T cell help independent. Proc. Natl Acad. Sci. USA 116, 20070\u201320076 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR362","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41590-022-01338-4","volume":"23","author":"JR Giles","year":"2022","unstructured":"Giles, J. R. et al. Shared and distinct biological circuits in effector, memory and exhausted CD8(+) T cells revealed by temporal single-cell transcriptomics and epigenetics. Nat. Immunol. 23, 1600\u20131613 (2022).","journal-title":"Nat. Immunol."},{"key":"1471_CR363","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41586-021-03862-z","volume":"597","author":"CS Eberhardt","year":"2021","unstructured":"Eberhardt, C. S. et al. Functional HPV-specific PD-1(+) stem-like CD8 T cells in head and neck cancer. Nature 597, 279\u2013284 (2021).","journal-title":"Nature"},{"key":"1471_CR364","doi-asserted-by":"publisher","first-page":"108078","DOI":"10.1016\/j.celrep.2020.108078","volume":"32","author":"I Sandu","year":"2020","unstructured":"Sandu, I. et al. Landscape of exhausted virus-specific CD8 T cells in chronic LCMV infection. Cell Rep. 32, 108078 (2020).","journal-title":"Cell Rep."},{"key":"1471_CR365","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.immuni.2018.04.026","volume":"48","author":"B Bengsch","year":"2018","unstructured":"Bengsch, B. et al. Epigenomic-guided mass cytometry profiling reveals disease-specific features of exhausted CD8 T cells. Immunity 48, 1029\u20131045 e1025 (2018).","journal-title":"Immunity"},{"key":"1471_CR366","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1126\/science.abl5447","volume":"375","author":"FJ Lowery","year":"2022","unstructured":"Lowery, F. J. et al. Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers. Science 375, 877\u2013884 (2022).","journal-title":"Science"},{"key":"1471_CR367","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.immuni.2019.09.013","volume":"51","author":"Z Chen","year":"2019","unstructured":"Chen, Z. et al. TCF-1-centered transcriptional network drives an effector versus exhausted CD8 T cell-fate decision. Immunity 51, 840\u2013855 e845 (2019).","journal-title":"Immunity"},{"key":"1471_CR368","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.immuni.2020.09.005","volume":"53","author":"D Pais Ferreira","year":"2020","unstructured":"Pais Ferreira, D. et al. Central memory CD8(+) T cells derive from stem-like Tcf7(hi) effector cells in the absence of cytotoxic differentiation. Immunity 53, 985\u20131000 e1011 (2020).","journal-title":"Immunity"},{"key":"1471_CR369","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/s41423-020-0436-5","volume":"18","author":"Q Shan","year":"2021","unstructured":"Shan, Q. et al. Ectopic Tcf1 expression instills a stem-like program in exhausted CD8(+) T cells to enhance viral and tumor immunity. Cell Mol. Immunol. 18, 1262\u20131277 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"1471_CR370","first-page":"e21549","volume":"35","author":"J Zhang","year":"2021","unstructured":"Zhang, J., Lyu, T., Cao, Y. & Feng, H. Role of TCF-1 in differentiation, exhaustion, and memory of CD8(+) T cells: a review. FASEB J. 35, e21549 (2021).","journal-title":"FASEB J."},{"key":"1471_CR371","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.coi.2020.02.001","volume":"63","author":"N Marcel","year":"2020","unstructured":"Marcel, N. & Hedrick, S. M. A key control point in the T cell response to chronic infection and neoplasia: FOXO1. Curr. Opin. Immunol. 63, 51\u201360 (2020).","journal-title":"Curr. Opin. Immunol."},{"key":"1471_CR372","doi-asserted-by":"crossref","unstructured":"Wu, T. et al. The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness. Sci Immunol. 1, eaai8593 (2016).","DOI":"10.1126\/sciimmunol.aai8593"},{"key":"1471_CR373","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41590-018-0311-z","volume":"20","author":"S Gautam","year":"2019","unstructured":"Gautam, S. et al. The transcription factor c-Myb regulates CD8(+) T cell stemness and antitumor immunity. Nat. Immunol. 20, 337\u2013349 (2019).","journal-title":"Nat. Immunol."},{"key":"1471_CR374","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41590-021-00868-7","volume":"22","author":"C Yao","year":"2021","unstructured":"Yao, C. et al. BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8(+) T cells. Nat. Immunol. 22, 370\u2013380 (2021).","journal-title":"Nat. Immunol."},{"key":"1471_CR375","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-019-1326-9","volume":"571","author":"F Alfei","year":"2019","unstructured":"Alfei, F. et al. TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection. Nature 571, 265\u2013269 (2019).","journal-title":"Nature"},{"key":"1471_CR376","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","volume":"571","author":"O Khan","year":"2019","unstructured":"Khan, O. et al. TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion. Nature 571, 211\u2013218 (2019).","journal-title":"Nature"},{"key":"1471_CR377","doi-asserted-by":"crossref","unstructured":"Sekine, T. et al. TOX is expressed by exhausted and polyfunctional human effector memory CD8(+) T cells. Sci Immunol. 5, eaba7918 (2020).","DOI":"10.1126\/sciimmunol.aba7918"},{"key":"1471_CR378","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1324-y","volume":"571","author":"AC Scott","year":"2019","unstructured":"Scott, A. C. et al. TOX is a critical regulator of tumour-specific T cell differentiation. Nature 571, 270\u2013274 (2019).","journal-title":"Nature"},{"key":"1471_CR379","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41586-019-0979-8","volume":"567","author":"X Liu","year":"2019","unstructured":"Liu, X. et al. Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction. Nature 567, 525\u2013529 (2019).","journal-title":"Nature"},{"key":"1471_CR380","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41392-019-0041-1","volume":"4","author":"F Li","year":"2019","unstructured":"Li, F. & Zhang, Y. Targeting NR4As, a new strategy to fine-tune CAR-T cells against solid tumors. Signal Transduct. Target Ther. 4, 7 (2019).","journal-title":"Signal Transduct. Target Ther."},{"key":"1471_CR381","doi-asserted-by":"publisher","first-page":"12410","DOI":"10.1073\/pnas.1905675116","volume":"116","author":"H Seo","year":"2019","unstructured":"Seo, H. et al. TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8(+) T cell exhaustion. Proc. Natl Acad. Sci. USA 116, 12410\u201312415 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR382","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/s41590-021-00965-7","volume":"22","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. BATF regulates progenitor to cytolytic effector CD8(+) T cell transition during chronic viral infection. Nat. Immunol. 22, 996\u20131007 (2021).","journal-title":"Nat. Immunol."},{"key":"1471_CR383","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41590-021-00964-8","volume":"22","author":"H Seo","year":"2021","unstructured":"Seo, H. et al. BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells. Nat. Immunol. 22, 983\u2013995 (2021).","journal-title":"Nat. Immunol."},{"key":"1471_CR384","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.2232","volume":"16","author":"M Quigley","year":"2010","unstructured":"Quigley, M. et al. Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nat. Med. 16, 1147\u20131151 (2010).","journal-title":"Nat. Med."},{"key":"1471_CR385","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41586-019-1821-z","volume":"576","author":"J Wei","year":"2019","unstructured":"Wei, J. et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature 576, 471\u2013476 (2019).","journal-title":"Nature"},{"key":"1471_CR386","doi-asserted-by":"crossref","unstructured":"Zhang, X. et al. Depletion of BATF in CAR-T cells enhances antitumor activity by inducing resistance against exhaustion and formation of central memory cells. Cancer Cell 40, 1407\u20131422.e7 (2022).","DOI":"10.1016\/j.ccell.2022.09.013"},{"key":"1471_CR387","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.immuni.2012.08.021","volume":"37","author":"TA Doering","year":"2012","unstructured":"Doering, T. A. et al. Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory. Immunity 37, 1130\u20131144 (2012).","journal-title":"Immunity"},{"key":"1471_CR388","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.3389\/fimmu.2018.02981","volume":"9","author":"J Li","year":"2018","unstructured":"Li, J. et al. High levels of Eomes promote exhaustion of anti-tumor CD8(+) T cells. Front. Immunol. 9, 2981 (2018).","journal-title":"Front. Immunol."},{"key":"1471_CR389","doi-asserted-by":"publisher","first-page":"e1004251","DOI":"10.1371\/journal.ppat.1004251","volume":"10","author":"M Buggert","year":"2014","unstructured":"Buggert, M. et al. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS Pathog. 10, e1004251 (2014).","journal-title":"PLoS Pathog."},{"key":"1471_CR390","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ni.2046","volume":"12","author":"C Kao","year":"2011","unstructured":"Kao, C. et al. Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection. Nat. Immunol. 12, 663\u2013671 (2011).","journal-title":"Nat. Immunol."},{"key":"1471_CR391","doi-asserted-by":"publisher","first-page":"109120","DOI":"10.1016\/j.celrep.2021.109120","volume":"35","author":"LM McLane","year":"2021","unstructured":"McLane, L. M. et al. Role of nuclear localization in the regulation and function of T-bet and Eomes in exhausted CD8 T cells. Cell Rep. 35, 109120 (2021).","journal-title":"Cell Rep."},{"key":"1471_CR392","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1016\/S0092-8674(02)00699-2","volume":"109","author":"GR Crabtree","year":"2002","unstructured":"Crabtree, G. R. & Olson, E. N. NFAT signaling: choreographing the social lives of cells. Cell 109, S67\u2013S79 (2002).","journal-title":"Cell"},{"key":"1471_CR393","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.immuni.2015.01.006","volume":"42","author":"GJ Martinez","year":"2015","unstructured":"Martinez, G. J. et al. The transcription factor NFAT promotes exhaustion of activated CD8(+) T cells. Immunity 42, 265\u2013278 (2015).","journal-title":"Immunity"},{"key":"1471_CR394","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/s41556-022-00942-8","volume":"24","author":"L Zhu","year":"2022","unstructured":"Zhu, L. et al. Dapl1 controls NFATc2 activation to regulate CD8(+) T cell exhaustion and responses in chronic infection and cancer. Nat. Cell Biol. 24, 1165\u20131176 (2022).","journal-title":"Nat. Cell Biol."},{"key":"1471_CR395","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/s41590-021-00975-5","volume":"22","author":"MS Abdel-Hakeem","year":"2021","unstructured":"Abdel-Hakeem, M. S. et al. Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation. Nat. Immunol. 22, 1008\u20131019 (2021).","journal-title":"Nat. Immunol."},{"key":"1471_CR396","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.immuni.2016.10.028","volume":"45","author":"JP Scott-Browne","year":"2016","unstructured":"Scott-Browne, J. P. et al. Dynamic changes in chromatin accessibility occur in CD8(+) T cells responding to viral infection. Immunity 45, 1327\u20131340 (2016).","journal-title":"Immunity"},{"key":"1471_CR397","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.immuni.2011.06.015","volume":"35","author":"B Youngblood","year":"2011","unstructured":"Youngblood, B. et al. Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells. Immunity 35, 400\u2013412 (2011).","journal-title":"Immunity"},{"key":"1471_CR398","doi-asserted-by":"publisher","first-page":"14113","DOI":"10.1073\/pnas.1903520116","volume":"116","author":"RR Jadhav","year":"2019","unstructured":"Jadhav, R. R. et al. Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade. Proc. Natl Acad. Sci. USA 116, 14113\u201314118 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR399","doi-asserted-by":"crossref","unstructured":"TCF-1 mediates chromatin intermingling during T cell development. Nat. Immunol. 23, 1000\u20131001, (2022).","DOI":"10.1038\/s41590-022-01237-8"},{"key":"1471_CR400","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41590-022-01232-z","volume":"23","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. TCF-1 promotes chromatin interactions across topologically associating domains in T cell progenitors. Nat. Immunol. 23, 1052\u20131062 (2022).","journal-title":"Nat. Immunol."},{"key":"1471_CR401","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/ni.2606","volume":"14","author":"DT Utzschneider","year":"2013","unstructured":"Utzschneider, D. T. et al. T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion. Nat. Immunol. 14, 603\u2013610 (2013).","journal-title":"Nat. Immunol."},{"key":"1471_CR402","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41590-022-01224-z","volume":"23","author":"JA Belk","year":"2022","unstructured":"Belk, J. A., Daniel, B. & Satpathy, A. T. Epigenetic regulation of T cell exhaustion. Nat. Immunol. 23, 848\u2013860 (2022).","journal-title":"Nat. Immunol."},{"key":"1471_CR403","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.aaf2807","volume":"354","author":"KE Pauken","year":"2016","unstructured":"Pauken, K. E. et al. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science 354, 1160\u20131165 (2016).","journal-title":"Science"},{"key":"1471_CR404","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cell.2017.06.007","volume":"170","author":"HE Ghoneim","year":"2017","unstructured":"Ghoneim, H. E. et al. De novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation. Cell 170, 142\u2013157 e119 (2017).","journal-title":"Cell"},{"key":"1471_CR405","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41591-018-0266-5","volume":"25","author":"W Scheper","year":"2019","unstructured":"Scheper, W. et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat. Med. 25, 89\u201394 (2019).","journal-title":"Nat. Med."},{"key":"1471_CR406","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas, A. & Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. Science 359, 1350\u20131355 (2018).","journal-title":"Science"},{"key":"1471_CR407","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"Topalian, S. L., Drake, C. G. & Pardoll, D. M. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 27, 450\u2013461 (2015).","journal-title":"Cancer Cell"},{"key":"1471_CR408","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1158\/2326-6066.CIR-17-0057","volume":"5","author":"N Lonberg","year":"2017","unstructured":"Lonberg, N. & Korman, A. J. Masterful antibodies: checkpoint blockade. Cancer Immunol. Res. 5, 275\u2013281 (2017).","journal-title":"Cancer Immunol. Res"},{"key":"1471_CR409","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2020.07.004","volume":"38","author":"M de Miguel","year":"2020","unstructured":"de Miguel, M. & Calvo, E. Clinical challenges of immune checkpoint inhibitors. Cancer Cell 38, 326\u2013333 (2020).","journal-title":"Cancer Cell"},{"key":"1471_CR410","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","volume":"20","author":"A Kalbasi","year":"2020","unstructured":"Kalbasi, A. & Ribas, A. Tumour-intrinsic resistance to immune checkpoint blockade. Nat. Rev. Immunol. 20, 25\u201339 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR411","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","volume":"50","author":"I Siddiqui","year":"2019","unstructured":"Siddiqui, I. et al. Intratumoral Tcf1(+)PD-1(+)CD8(+) T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity 50, 195\u2013211 e110 (2019).","journal-title":"Immunity"},{"key":"1471_CR412","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2018.12.034","volume":"176","author":"M Sade-Feldman","year":"2019","unstructured":"Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 176, 404 (2019).","journal-title":"Cell"},{"key":"1471_CR413","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1084\/jem.20180684","volume":"215","author":"J Brummelman","year":"2018","unstructured":"Brummelman, J. et al. High-dimensional single cell analysis identifies stem-like cytotoxic CD8(+) T cells infiltrating human tumors. J. Exp. Med. 215, 2520\u20132535 (2018).","journal-title":"J. Exp. Med."},{"key":"1471_CR414","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.cell.2020.08.053","volume":"183","author":"PA Ott","year":"2020","unstructured":"Ott, P. A. et al. A phase Ib trial of personalized neoantigen therapy plus anti-PD-1 in patients with advanced melanoma, non-small cell lung cancer, or bladder cancer. Cell 183, 347\u2013362 e324 (2020).","journal-title":"Cell"},{"key":"1471_CR415","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-021-03752-4","volume":"596","author":"JX Caushi","year":"2021","unstructured":"Caushi, J. X. et al. Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers. Nature 596, 126\u2013132 (2021).","journal-title":"Nature"},{"key":"1471_CR416","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-021-03704-y","volume":"596","author":"G Oliveira","year":"2021","unstructured":"Oliveira, G. et al. Phenotype, specificity and avidity of antitumour CD8(+) T cells in melanoma. Nature 596, 119\u2013125 (2021).","journal-title":"Nature"},{"key":"1471_CR417","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/s41590-019-0480-4","volume":"20","author":"MW LaFleur","year":"2019","unstructured":"LaFleur, M. W. et al. PTPN2 regulates the generation of exhausted CD8(+) T cell subpopulations and restrains tumor immunity. Nat. Immunol. 20, 1335\u20131347 (2019).","journal-title":"Nat. Immunol."},{"key":"1471_CR418","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1084\/jem.20190249","volume":"216","author":"J Clarke","year":"2019","unstructured":"Clarke, J. et al. Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancer. J. Exp. Med. 216, 2128\u20132149 (2019).","journal-title":"J. Exp. Med."},{"key":"1471_CR419","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","volume":"24","author":"DS Thommen","year":"2018","unstructured":"Thommen, D. S. et al. A transcriptionally and functionally distinct PD-1(+) CD8(+) T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade. Nat. Med. 24, 994\u20131004 (2018).","journal-title":"Nat. Med."},{"key":"1471_CR420","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1172\/JCI87324","volume":"126","author":"AI Daud","year":"2016","unstructured":"Daud, A. I. et al. Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma. J. Clin. Invest. 126, 3447\u20133452 (2016).","journal-title":"J. Clin. Invest."},{"key":"1471_CR421","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","volume":"168","author":"MH Spitzer","year":"2017","unstructured":"Spitzer, M. H. et al. Systemic immunity is required for effective cancer immunotherapy. Cell 168, 487\u2013502 e415 (2017).","journal-title":"Cell"},{"key":"1471_CR422","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s43018-021-00292-8","volume":"3","author":"B Liu","year":"2022","unstructured":"Liu, B. et al. Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer. Nat. Cancer 3, 108\u2013121 (2022).","journal-title":"Nat. Cancer"},{"key":"1471_CR423","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","volume":"25","author":"KE Yost","year":"2019","unstructured":"Yost, K. E. et al. Clonal replacement of tumor-specific T cells following PD-1 blockade. Nat. Med. 25, 1251\u20131259 (2019).","journal-title":"Nat. Med."},{"key":"1471_CR424","doi-asserted-by":"publisher","first-page":"643291","DOI":"10.3389\/fimmu.2021.643291","volume":"12","author":"KM van Pul","year":"2021","unstructured":"van Pul, K. M., Fransen, M. F., van de Ven, R. & de Gruijl, T. D. Immunotherapy goes local: the central role of lymph nodes in driving tumor infiltration and efficacy. Front. Immunol. 12, 643291 (2021).","journal-title":"Front. Immunol."},{"key":"1471_CR425","doi-asserted-by":"publisher","first-page":"eabg7836","DOI":"10.1126\/sciimmunol.abg7836","volume":"6","author":"KA Connolly","year":"2021","unstructured":"Connolly, K. A. et al. A reservoir of stem-like CD8(+) T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response. Sci. Immunol. 6, eabg7836 (2021).","journal-title":"Sci. Immunol."},{"key":"1471_CR426","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/j.immuni.2021.08.026","volume":"54","author":"JM Schenkel","year":"2021","unstructured":"Schenkel, J. M. et al. Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1(+) CD8(+) T cells in tumor-draining lymph nodes. Immunity 54, 2338\u20132353 e2336 (2021).","journal-title":"Immunity"},{"key":"1471_CR427","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nature22079","volume":"545","author":"AC Huang","year":"2017","unstructured":"Huang, A. C. et al. T-cell invigoration to tumour burden ratio associated with anti-PD-1 response. Nature 545, 60\u201365 (2017).","journal-title":"Nature"},{"key":"1471_CR428","doi-asserted-by":"crossref","unstructured":"Huang, Q. et al. The primordial differentiation of tumor-specific memory CD8(+) T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes. Cell 185, 4049\u20134066.e25 (2022).","DOI":"10.1016\/j.cell.2022.09.020"},{"key":"1471_CR429","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ccell.2020.09.001","volume":"38","author":"F Dammeijer","year":"2020","unstructured":"Dammeijer, F. et al. The PD-1\/PD-L1-checkpoint restrains T cell immunity in tumor-draining lymph nodes. Cancer Cell 38, 685\u2013700 e688 (2020).","journal-title":"Cancer Cell"},{"key":"1471_CR430","doi-asserted-by":"crossref","unstructured":"Francis, D. M. et al. Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy. Sci. Transl. Med. 12, eaay3575 (2020).","DOI":"10.1126\/scitranslmed.aay3575"},{"key":"1471_CR431","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1038\/s41590-021-01060-7","volume":"22","author":"LM Snell","year":"2021","unstructured":"Snell, L. M. et al. Dynamic CD4(+) T cell heterogeneity defines subset-specific suppression and PD-L1-blockade-driven functional restoration in chronic infection. Nat. Immunol. 22, 1524\u20131537 (2021).","journal-title":"Nat. Immunol."},{"key":"1471_CR432","doi-asserted-by":"publisher","first-page":"10514","DOI":"10.1128\/JVI.79.16.10514-10527.2005","volume":"79","author":"DG Brooks","year":"2005","unstructured":"Brooks, D. G., Teyton, L., Oldstone, M. B. & McGavern, D. B. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J. Virol. 79, 10514\u201310527 (2005).","journal-title":"J. Virol."},{"key":"1471_CR433","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S1074-7613(00)80628-7","volume":"9","author":"A Oxenius","year":"1998","unstructured":"Oxenius, A., Zinkernagel, R. M. & Hengartner, H. Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection. Immunity 9, 449\u2013457 (1998).","journal-title":"Immunity"},{"key":"1471_CR434","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1126\/science.1174182","volume":"324","author":"H Elsaesser","year":"2009","unstructured":"Elsaesser, H., Sauer, K. & Brooks, D. G. IL-21 is required to control chronic viral infection. Science 324, 1569\u20131572 (2009).","journal-title":"Science"},{"key":"1471_CR435","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/nm1492","volume":"12","author":"DG Brooks","year":"2006","unstructured":"Brooks, D. G. et al. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12, 1301\u20131309 (2006).","journal-title":"Nat. Med."},{"key":"1471_CR436","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1126\/science.1175194","volume":"324","author":"JS Yi","year":"2009","unstructured":"Yi, J. S., Du, M. & Zajac, A. J. A vital role for interleukin-21 in the control of a chronic viral infection. Science 324, 1572\u20131576 (2009).","journal-title":"Science"},{"key":"1471_CR437","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1172\/JCI66108","volume":"124","author":"IA Parish","year":"2014","unstructured":"Parish, I. A. et al. Chronic viral infection promotes sustained Th1-derived immunoregulatory IL-10 via BLIMP-1. J. Clin. Invest. 124, 3455\u20133468 (2014).","journal-title":"J. Clin. Invest."},{"key":"1471_CR438","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1126\/science.1172815","volume":"324","author":"A Frohlich","year":"2009","unstructured":"Frohlich, A. et al. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 324, 1576\u20131580 (2009).","journal-title":"Science"},{"key":"1471_CR439","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.immuni.2014.01.005","volume":"40","author":"A Crawford","year":"2014","unstructured":"Crawford, A. et al. Molecular and transcriptional basis of CD4(+) T cell dysfunction during chronic infection. Immunity 40, 289\u2013302 (2014).","journal-title":"Immunity"},{"key":"1471_CR440","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1016\/j.celrep.2016.08.065","volume":"16","author":"LM Snell","year":"2016","unstructured":"Snell, L. M. et al. Overcoming CD4 Th1 cell fate restrictions to sustain antiviral CD8 T cells and control persistent virus infection. Cell Rep. 16, 3286\u20133296 (2016).","journal-title":"Cell Rep."},{"key":"1471_CR441","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.immuni.2022.05.003","volume":"55","author":"Y Xia","year":"2022","unstructured":"Xia, Y. et al. BCL6-dependent TCF-1(+) progenitor cells maintain effector and helper CD4(+) T cell responses to persistent antigen. Immunity 55, 1200\u20131215 e1206 (2022).","journal-title":"Immunity"},{"key":"1471_CR442","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/jid.2012.283","volume":"133","author":"GJ Mann","year":"2013","unstructured":"Mann, G. J. et al. BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma. J. Invest. Dermatol. 133, 509\u2013517 (2013).","journal-title":"J. Invest. Dermatol."},{"key":"1471_CR443","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346\u2013352 (2012).","journal-title":"Nature"},{"key":"1471_CR444","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s10549-011-1470-x","volume":"131","author":"ML Ascierto","year":"2012","unstructured":"Ascierto, M. L. et al. A signature of immune function genes associated with recurrence-free survival in breast cancer patients. Breast Cancer Res. Treat. 131, 871\u2013880 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"1471_CR445","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/sj.bjc.6605820","volume":"103","author":"N Leffers","year":"2010","unstructured":"Leffers, N. et al. Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer. Br. J. Cancer 103, 685\u2013692 (2010).","journal-title":"Br. J. Cancer"},{"key":"1471_CR446","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41416-019-0531-5","volume":"121","author":"C Laheurte","year":"2019","unstructured":"Laheurte, C. et al. Distinct prognostic value of circulating anti-telomerase CD4(+) Th1 immunity and exhausted PD-1(+)\/TIM-3(+) T cells in lung cancer. Br. J. Cancer 121, 405\u2013416 (2019).","journal-title":"Br. J. Cancer"},{"key":"1471_CR447","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-10-2907","volume":"71","author":"M Tosolini","year":"2011","unstructured":"Tosolini, M. et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res. 71, 1263\u20131271 (2011).","journal-title":"Cancer Res."},{"key":"1471_CR448","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3892\/ol.2016.4854","volume":"12","author":"X Xu","year":"2016","unstructured":"Xu, X. et al. Expression of Th1- Th2- and Th17-associated cytokines in laryngeal carcinoma. Oncol. Lett. 12, 1941\u20131948 (2016).","journal-title":"Oncol. Lett."},{"key":"1471_CR449","doi-asserted-by":"publisher","first-page":"8368","DOI":"10.1158\/0008-5472.CAN-10-1322","volume":"70","author":"R Bos","year":"2010","unstructured":"Bos, R. & Sherman, L. A. CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes. Cancer Res. 70, 8368\u20138377 (2010).","journal-title":"Cancer Res."},{"key":"1471_CR450","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/CJI.0b013e3181fb045d","volume":"33","author":"LT Dengel","year":"2010","unstructured":"Dengel, L. T. et al. Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma. J. Immunother. 33, 965\u2013974 (2010).","journal-title":"J. Immunother."},{"key":"1471_CR451","doi-asserted-by":"publisher","first-page":"586907","DOI":"10.3389\/fimmu.2020.586907","volume":"11","author":"M Zuazo","year":"2020","unstructured":"Zuazo, M. et al. Systemic CD4 immunity as a key contributor to PD-L1\/PD-1 blockade immunotherapy efficacy. Front. Immunol. 11, 586907 (2020).","journal-title":"Front. Immunol."},{"key":"1471_CR452","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","volume":"26","author":"IG House","year":"2020","unstructured":"House, I. G. et al. Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade. Clin. Cancer Res. 26, 487\u2013504 (2020).","journal-title":"Clin. Cancer Res."},{"key":"1471_CR453","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","volume":"69","author":"H Harlin","year":"2009","unstructured":"Harlin, H. et al. Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Cancer Res 69, 3077\u20133085 (2009).","journal-title":"Cancer Res"},{"key":"1471_CR454","doi-asserted-by":"publisher","first-page":"8437","DOI":"10.1158\/0008-5472.CAN-08-1440","volume":"68","author":"M Wendel","year":"2008","unstructured":"Wendel, M., Galani, I. E., Suri-Payer, E. & Cerwenka, A. Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands. Cancer Res. 68, 8437\u20138445 (2008).","journal-title":"Cancer Res."},{"key":"1471_CR455","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cyto.2019.02.001","volume":"117","author":"GM Konjevic","year":"2019","unstructured":"Konjevic, G. M. et al. The role of cytokines in the regulation of NK cells in the tumor environment. Cytokine 117, 30\u201340 (2019).","journal-title":"Cytokine"},{"key":"1471_CR456","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/ijc.2910450630","volume":"45","author":"N Jabrane-Ferrat","year":"1990","unstructured":"Jabrane-Ferrat, N. et al. Effect of gamma interferon on HLA class-I and -II transcription and protein expression in human breast adenocarcinoma cell lines. Int. J. Cancer 45, 1169\u20131176 (1990).","journal-title":"Int. J. Cancer"},{"key":"1471_CR457","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/35074122","volume":"410","author":"V Shankaran","year":"2001","unstructured":"Shankaran, V. et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410, 1107\u20131111 (2001).","journal-title":"Nature"},{"key":"1471_CR458","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/JLB.MR0318-097R","volume":"105","author":"D Chraa","year":"2019","unstructured":"Chraa, D., Naim, A., Olive, D. & Badou, A. T lymphocyte subsets in cancer immunity: friends or foes. J. Leukoc. Biol. 105, 243\u2013255 (2019).","journal-title":"J. Leukoc. Biol."},{"key":"1471_CR459","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1084\/jem.20101876","volume":"208","author":"L De Monte","year":"2011","unstructured":"De Monte, L. et al. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J. Exp. Med. 208, 469\u2013478 (2011).","journal-title":"J. Exp. Med."},{"key":"1471_CR460","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.humpath.2010.06.010","volume":"41","author":"NK Yoon","year":"2010","unstructured":"Yoon, N. K. et al. Higher levels of GATA3 predict better survival in women with breast cancer. Hum. Pathol. 41, 1794\u20131801 (2010).","journal-title":"Hum. Pathol."},{"key":"1471_CR461","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1126\/science.1636093","volume":"257","author":"RI Tepper","year":"1992","unstructured":"Tepper, R. I., Coffman, R. L. & Leder, P. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 257, 548\u2013551 (1992).","journal-title":"Science"},{"key":"1471_CR462","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1084\/jem.188.12.2357","volume":"188","author":"K Hung","year":"1998","unstructured":"Hung, K. et al. The central role of CD4(+) T cells in the antitumor immune response. J. Exp. Med. 188, 2357\u20132368 (1998).","journal-title":"J. Exp. Med."},{"key":"1471_CR463","doi-asserted-by":"publisher","first-page":"6864","DOI":"10.1158\/0008-5472.CAN-16-1219","volume":"76","author":"KB Lorvik","year":"2016","unstructured":"Lorvik, K. B. et al. Adoptive transfer of tumor-specific Th2 cells eradicates tumors by triggering an in situ inflammatory immune response. Cancer Res. 76, 6864\u20136876 (2016).","journal-title":"Cancer Res."},{"key":"1471_CR464","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1158\/0008-5472.CAN-10-1572","volume":"71","author":"M Kitajima","year":"2011","unstructured":"Kitajima, M. et al. Memory type 2 helper T cells induce long-lasting antitumor immunity by activating natural killer cells. Cancer Res. 71, 4790\u20134798 (2011).","journal-title":"Cancer Res."},{"key":"1471_CR465","doi-asserted-by":"crossref","unstructured":"Boieri, M. et al. CD4+ T helper 2 cells suppress breast cancer by inducing terminal differentiation. J. Exp. Med. 219, e20201963 (2022).","DOI":"10.1084\/jem.20201963"},{"key":"1471_CR466","doi-asserted-by":"crossref","unstructured":"Rodriguez-Tirado, C. et al. Interleukin 4 controls the pro-tumoral role of macrophages in mammary cancer pulmonary metastasis in mice. Cancers 14, 4336 (2022).","DOI":"10.3390\/cancers14174336"},{"key":"1471_CR467","doi-asserted-by":"publisher","first-page":"e71949","DOI":"10.1371\/journal.pone.0071949","volume":"8","author":"CA Lazarski","year":"2013","unstructured":"Lazarski, C. A. et al. IL-4 attenuates Th1-associated chemokine expression and Th1 trafficking to inflamed tissues and limits pathogen clearance. PLoS ONE 8, e71949 (2013).","journal-title":"PLoS ONE"},{"key":"1471_CR468","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11803-y","volume":"7","author":"RE Mitchell","year":"2017","unstructured":"Mitchell, R. E. et al. IL-4 enhances IL-10 production in Th1 cells: implications for Th1 and Th2 regulation. Sci. Rep. 7, 11315 (2017).","journal-title":"Sci. Rep."},{"key":"1471_CR469","first-page":"1153","volume":"13","author":"T Kusuda","year":"2005","unstructured":"Kusuda, T. et al. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer. Oncol. Rep. 13, 1153\u20131158 (2005).","journal-title":"Oncol. Rep."},{"key":"1471_CR470","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02467-4","volume":"22","author":"H Qin","year":"2022","unstructured":"Qin, H. et al. Pan-cancer analysis identifies LMNB1 as a target to redress Th1\/Th2 imbalance and enhance PARP inhibitor response in human cancers. Cancer Cell Int. 22, 101 (2022).","journal-title":"Cancer Cell Int"},{"key":"1471_CR471","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40078-8","volume":"9","author":"HL Lee","year":"2019","unstructured":"Lee, H. L. et al. Inflammatory cytokines and change of Th1\/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization. Sci. Rep. 9, 3260 (2019).","journal-title":"Sci. Rep."},{"key":"1471_CR472","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-065X.2008.00600.x","volume":"222","author":"M Johansson","year":"2008","unstructured":"Johansson, M., Denardo, D. G. & Coussens, L. M. Polarized immune responses differentially regulate cancer development. Immunol. Rev. 222, 145\u2013154 (2008).","journal-title":"Immunol. Rev."},{"key":"1471_CR473","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cellimm.2017.10.015","volume":"322","author":"Z Asadzadeh","year":"2017","unstructured":"Asadzadeh, Z. et al. The paradox of Th17 cell functions in tumor immunity. Cell Immunol. 322, 15\u201325 (2017).","journal-title":"Cell Immunol."},{"key":"1471_CR474","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1182\/blood-2009-03-208249","volume":"114","author":"I Kryczek","year":"2009","unstructured":"Kryczek, I. et al. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114, 1141\u20131149 (2009).","journal-title":"Blood"},{"key":"1471_CR475","doi-asserted-by":"publisher","first-page":"15505","DOI":"10.1073\/pnas.0710686105","volume":"105","author":"Y Miyahara","year":"2008","unstructured":"Miyahara, Y. et al. Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc. Natl Acad. Sci. USA 105, 15505\u201315510 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR476","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1182\/blood-2008-04-149260","volume":"112","author":"V Bronte","year":"2008","unstructured":"Bronte, V. Th17 and cancer: friends or foes? Blood 112, 214 (2008).","journal-title":"Blood"},{"key":"1471_CR477","doi-asserted-by":"publisher","first-page":"e984547","DOI":"10.4161\/2162402X.2014.984547","volume":"4","author":"S Punt","year":"2015","unstructured":"Punt, S. et al. The correlations between IL-17 vs. Th17 cells and cancer patient survival: a systematic review. Oncoimmunology 4, e984547 (2015).","journal-title":"Oncoimmunology"},{"key":"1471_CR478","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/carcin\/bgr019","volume":"32","author":"CM Wilke","year":"2011","unstructured":"Wilke, C. M. et al. Th17 cells in cancer: help or hindrance? Carcinogenesis 32, 643\u2013649 (2011).","journal-title":"Carcinogenesis"},{"key":"1471_CR479","doi-asserted-by":"crossref","unstructured":"Ben Khelil, M. et al. Harnessing antitumor CD4(+) T cells for cancer immunotherapy. Cancers 14, 260 (2022).","DOI":"10.3390\/cancers14010260"},{"key":"1471_CR480","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/aam.aam_56_18","volume":"18","author":"N Singh","year":"2019","unstructured":"Singh, N. et al. Inflammation and cancer. Ann. Afr. Med. 18, 121\u2013126 (2019).","journal-title":"Ann. Afr. Med."},{"key":"1471_CR481","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s12026-021-09211-6","volume":"69","author":"Y Qianmei","year":"2021","unstructured":"Qianmei, Y. et al. Recent advances in the role of Th17\/Treg cells in tumor immunity and tumor therapy. Immunol. Res. 69, 398\u2013414 (2021).","journal-title":"Immunol. Res."},{"key":"1471_CR482","doi-asserted-by":"crossref","unstructured":"Fabre, J. A. S. et al. The interleukin-17 family of cytokines in breast cancer. Int. J. Mol. Sci. 19, 3880 (2018).","DOI":"10.3390\/ijms19123880"},{"key":"1471_CR483","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1084\/jem.20090207","volume":"206","author":"L Wang","year":"2009","unstructured":"Wang, L. et al. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J. Exp. Med. 206, 1457\u20131464 (2009).","journal-title":"J. Exp. Med."},{"key":"1471_CR484","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0894-9","volume":"14","author":"L Bi","year":"2016","unstructured":"Bi, L. et al. Increased Th17 cells and IL-17A exist in patients with B cell acute lymphoblastic leukemia and promote proliferation and resistance to daunorubicin through activation of Akt signaling. J. Transl. Med. 14, 132 (2016).","journal-title":"J. Transl. Med."},{"key":"1471_CR485","doi-asserted-by":"publisher","first-page":"536","DOI":"10.14348\/molcells.2016.0048","volume":"39","author":"VA Do Thi","year":"2016","unstructured":"Do Thi, V. A., Park, S. M., Lee, H. & Kim, Y. S. The membrane-bound form of IL-17A promotes the growth and tumorigenicity of colon cancer cells. Mol. Cells 39, 536\u2013542 (2016).","journal-title":"Mol. Cells"},{"key":"1471_CR486","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.imlet.2019.07.001","volume":"213","author":"A Shahid","year":"2019","unstructured":"Shahid, A. & Bharadwaj, M. The connection between the Th17 cell related cytokines and cancer stem cells in cancer: Novel therapeutic targets. Immunol. Lett. 213, 9\u201320 (2019).","journal-title":"Immunol. Lett."},{"key":"1471_CR487","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/onc.2013.537","volume":"34","author":"T Xiang","year":"2015","unstructured":"Xiang, T. et al. Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer. Oncogene 34, 165\u2013176 (2015).","journal-title":"Oncogene"},{"key":"1471_CR488","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1172\/JCI124037","volume":"130","author":"Y Salazar","year":"2020","unstructured":"Salazar, Y. et al. Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer. J. Clin. Invest. 130, 3560\u20133575 (2020).","journal-title":"J. Clin. Invest"},{"key":"1471_CR489","doi-asserted-by":"publisher","first-page":"e21816","DOI":"10.1371\/journal.pone.0021816","volume":"6","author":"J Li","year":"2011","unstructured":"Li, J. et al. Interleukin 17\u2009A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. PLoS ONE 6, e21816 (2011).","journal-title":"PLoS ONE"},{"key":"1471_CR490","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1084\/jem.20141702","volume":"212","author":"HH Wu","year":"2015","unstructured":"Wu, H. H. et al. Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines. J. Exp. Med. 212, 333\u2013349 (2015).","journal-title":"J. Exp. Med."},{"key":"1471_CR491","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1182\/blood-2002-05-1461","volume":"101","author":"M Numasaki","year":"2003","unstructured":"Numasaki, M. et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood 101, 2620\u20132627 (2003).","journal-title":"Blood"},{"key":"1471_CR492","doi-asserted-by":"publisher","DOI":"10.1038\/srep16053","volume":"5","author":"B Pan","year":"2015","unstructured":"Pan, B. et al. Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3\/GIV signaling pathway in non-small-cell lung cancer. Sci. Rep. 5, 16053 (2015).","journal-title":"Sci. Rep."},{"key":"1471_CR493","doi-asserted-by":"publisher","DOI":"10.1038\/srep36551","volume":"6","author":"Q Huang","year":"2016","unstructured":"Huang, Q. et al. IL-17 promotes angiogenic factors IL-6, IL-8, and Vegf production via Stat1 in lung adenocarcinoma. Sci. Rep. 6, 36551 (2016).","journal-title":"Sci. Rep."},{"key":"1471_CR494","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.4049\/jimmunol.0902574","volume":"184","author":"D He","year":"2010","unstructured":"He, D. et al. IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells. J. Immunol. 184, 2281\u20132288 (2010).","journal-title":"J. Immunol."},{"key":"1471_CR495","doi-asserted-by":"publisher","first-page":"35490","DOI":"10.18632\/oncotarget.8204","volume":"7","author":"L Wen","year":"2016","unstructured":"Wen, L. et al. Interplay between myeloid-derived suppressor cells (MDSCs) and Th17 cells: foe or friend? Oncotarget 7, 35490\u201335496 (2016).","journal-title":"Oncotarget"},{"key":"1471_CR496","doi-asserted-by":"publisher","first-page":"12223","DOI":"10.1007\/s13277-016-5085-z","volume":"37","author":"H Mao","year":"2016","unstructured":"Mao, H. et al. Feedback mechanisms between M2 macrophages and Th17 cells in colorectal cancer patients. Tumour Biol. 37, 12223\u201312230 (2016).","journal-title":"Tumour Biol."},{"key":"1471_CR497","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.2147\/CMAR.S174899","volume":"10","author":"J Shen","year":"2018","unstructured":"Shen, J. et al. IL-17 induces macrophages to M2-like phenotype via NF-kappaB. Cancer Manag. Res. 10, 4217\u20134228 (2018).","journal-title":"Cancer Manag. Res."},{"key":"1471_CR498","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s13402-020-00510-y","volume":"43","author":"N Ferreira","year":"2020","unstructured":"Ferreira, N. et al. IL-17A and IL-17F orchestrate macrophages to promote lung cancer. Cell Oncol. 43, 643\u2013654 (2020).","journal-title":"Cell Oncol."},{"key":"1471_CR499","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.4049\/jimmunol.162.4.2347","volume":"162","author":"M Laan","year":"1999","unstructured":"Laan, M. et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J. Immunol. 162, 2347\u20132352 (1999).","journal-title":"J. Immunol."},{"key":"1471_CR500","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1182\/blood-2009-04-216085","volume":"115","author":"M Pelletier","year":"2010","unstructured":"Pelletier, M. et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115, 335\u2013343 (2010).","journal-title":"Blood"},{"key":"1471_CR501","doi-asserted-by":"publisher","first-page":"17409","DOI":"10.1073\/pnas.1904125116","volume":"116","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. IL-17 constrains natural killer cell activity by restraining IL-15-driven cell maturation via SOCS3. Proc. Natl Acad. Sci. USA 116, 17409\u201317418 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR502","doi-asserted-by":"publisher","first-page":"1758606","DOI":"10.1080\/2162402X.2020.1758606","volume":"9","author":"G Dadaglio","year":"2020","unstructured":"Dadaglio, G. et al. IL-17 suppresses the therapeutic activity of cancer vaccines through the inhibition of CD8(+) T-cell responses. Oncoimmunology 9, 1758606 (2020).","journal-title":"Oncoimmunology"},{"key":"1471_CR503","doi-asserted-by":"crossref","unstructured":"Kim, B. S. et al. Type 17 immunity promotes the exhaustion of CD8(+) T cells in cancer. J. Immunother. Cancer. 9, e002603 (2021).","DOI":"10.1136\/jitc-2021-002603"},{"key":"1471_CR504","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3892\/or.2010.1118","volume":"25","author":"T Iida","year":"2011","unstructured":"Iida, T. et al. Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer. Oncol. Rep. 25, 1271\u20131277 (2011).","journal-title":"Oncol. Rep."},{"key":"1471_CR505","doi-asserted-by":"crossref","unstructured":"Chung, A. S. et al. An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy. Nat. Med. 19, 1114\u20131123 (2013).","DOI":"10.1038\/nm.3291"},{"key":"1471_CR506","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1084\/jem.20150204","volume":"212","author":"L Wu","year":"2015","unstructured":"Wu, L. et al. A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis. J. Exp. Med. 212, 1571\u20131587 (2015).","journal-title":"J. Exp. Med."},{"key":"1471_CR507","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-59","volume":"13","author":"R Jiang","year":"2013","unstructured":"Jiang, R. et al. IL-22 is related to development of human colon cancer by activation of STAT3. BMC Cancer 13, 59 (2013).","journal-title":"BMC Cancer"},{"key":"1471_CR508","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19685-x","volume":"11","author":"LG Perez","year":"2020","unstructured":"Perez, L. G. et al. Publisher Correction: TGF-beta signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer. Nat. Commun. 11, 5740 (2020).","journal-title":"Nat. Commun."},{"key":"1471_CR509","doi-asserted-by":"publisher","first-page":"53","DOI":"10.7150\/ijbs.7.53","volume":"7","author":"JG Chen","year":"2011","unstructured":"Chen, J. G. et al. Intratumoral expression of IL-17 and its prognostic role in gastric adenocarcinoma patients. Int. J. Biol. Sci. 7, 53\u201360 (2011).","journal-title":"Int. J. Biol. Sci."},{"key":"1471_CR510","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12094-014-1197-3","volume":"17","author":"Y Lin","year":"2015","unstructured":"Lin, Y. et al. Interleukin-17 is a favorable prognostic marker for colorectal cancer. Clin. Transl. Oncol. 17, 50\u201356 (2015).","journal-title":"Clin. Transl. Oncol."},{"key":"1471_CR511","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00262-015-1678-4","volume":"64","author":"S Punt","year":"2015","unstructured":"Punt, S. et al. FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma. Cancer Immunol. Immunother. 64, 745\u2013753 (2015).","journal-title":"Cancer Immunol. Immunother."},{"key":"1471_CR512","doi-asserted-by":"publisher","first-page":"78ra31","DOI":"10.1126\/scitranslmed.3001374","volume":"3","author":"S Furuta","year":"2011","unstructured":"Furuta, S. et al. IL-25 causes apoptosis of IL-25R-expressing breast cancer cells without toxicity to nonmalignant cells. Sci. Transl. Med. 3, 78ra31 (2011).","journal-title":"Sci. Transl. Med."},{"key":"1471_CR513","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cyto.2013.02.005","volume":"62","author":"S Al Omar","year":"2013","unstructured":"Al Omar, S., Flanagan, B. F., Almehmadi, M. & Christmas, S. E. The effects of IL-17 upon human natural killer cells. Cytokine 62, 123\u2013130 (2013).","journal-title":"Cytokine"},{"key":"1471_CR514","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/CJI.0b013e3182a802cf","volume":"36","author":"L Lu","year":"2013","unstructured":"Lu, L. et al. IL-17A promotes immune cell recruitment in human esophageal cancers and the infiltrating dendritic cells represent a positive prognostic marker for patient survival. J. Immunother. 36, 451\u2013458 (2013).","journal-title":"J. Immunother."},{"key":"1471_CR515","doi-asserted-by":"publisher","first-page":"e1373234","DOI":"10.1080\/2162402X.2017.1373234","volume":"7","author":"CL Chen","year":"2017","unstructured":"Chen, C. L. et al. IL-17 induces antitumor immunity by promoting beneficial neutrophil recruitment and activation in esophageal squamous cell carcinoma. Oncoimmunology 7, e1373234 (2017).","journal-title":"Oncoimmunology"},{"key":"1471_CR516","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.4049\/jimmunol.160.7.3513","volume":"160","author":"DV Jovanovic","year":"1998","unstructured":"Jovanovic, D. V. et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J. Immunol. 160, 3513\u20133521 (1998).","journal-title":"J. Immunol."},{"key":"1471_CR517","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1182\/blood-2008-09-177360","volume":"114","author":"I Kryczek","year":"2009","unstructured":"Kryczek, I. et al. Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 114, 357\u2013359 (2009).","journal-title":"Blood"},{"key":"1471_CR518","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00262-016-1797-6","volume":"65","author":"K Majchrzak","year":"2016","unstructured":"Majchrzak, K. et al. Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic. Cancer Immunol. Immunother. 65, 247\u2013259 (2016).","journal-title":"Cancer Immunol. Immunother."},{"key":"1471_CR519","doi-asserted-by":"publisher","first-page":"314620","DOI":"10.1155\/2015\/314620","volume":"2015","author":"L Guery","year":"2015","unstructured":"Guery, L. & Hugues, S. Th17 cell plasticity and functions in cancer immunity. Biomed. Res. Int. 2015, 314620 (2015).","journal-title":"Biomed. Res. Int."},{"key":"1471_CR520","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10889-4","volume":"10","author":"Y Shen","year":"2019","unstructured":"Shen, Y. et al. Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions. Nat. Commun. 10, 2924 (2019).","journal-title":"Nat. Commun."},{"key":"1471_CR521","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/nm.2856","volume":"18","author":"R Purwar","year":"2012","unstructured":"Purwar, R. et al. Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat. Med. 18, 1248\u20131253 (2012).","journal-title":"Nat. Med."},{"key":"1471_CR522","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/ni.2925","volume":"15","author":"F Vegran","year":"2014","unstructured":"Vegran, F. et al. The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells. Nat. Immunol. 15, 758\u2013766 (2014).","journal-title":"Nat. Immunol."},{"key":"1471_CR523","doi-asserted-by":"publisher","first-page":"106019","DOI":"10.1016\/j.intimp.2019.106019","volume":"78","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. Th9 cells are subjected to PD-1\/PD-L1-mediated inhibition and are capable of promoting CD8 T cell expansion through IL-9R in colorectal cancer. Int. Immunopharmacol. 78, 106019 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"1471_CR524","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1172\/JCI65459","volume":"122","author":"Y Lu","year":"2012","unstructured":"Lu, Y. et al. Th9 cells promote antitumor immune responses in vivo. J. Clin. Invest. 122, 4160\u20134171 (2012).","journal-title":"J. Clin. Invest."},{"key":"1471_CR525","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/nm.3922","volume":"21","author":"IK Kim","year":"2015","unstructured":"Kim, I. K. et al. Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells. Nat. Med. 21, 1010\u20131017 (2015).","journal-title":"Nat. Med."},{"key":"1471_CR526","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.ccell.2021.09.011","volume":"39","author":"G Xue","year":"2021","unstructured":"Xue, G. et al. Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells. Cancer Cell 39, 1610\u20131622 e1619 (2021).","journal-title":"Cancer Cell"},{"key":"1471_CR527","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/ijc.30121","volume":"139","author":"A Abdul-Wahid","year":"2016","unstructured":"Abdul-Wahid, A. et al. Induction of antigen-specific TH 9 immunity accompanied by mast cell activation blocks tumor cell engraftment. Int. J. Cancer 139, 841\u2013853 (2016).","journal-title":"Int. J. Cancer"},{"key":"1471_CR528","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.ccell.2018.05.004","volume":"33","author":"Y Lu","year":"2018","unstructured":"Lu, Y. et al. Th9 cells represent a unique subset of CD4(+) T cells endowed with the ability to eradicate advanced tumors. Cancer Cell 33, 1048\u20131060 e1047 (2018).","journal-title":"Cancer Cell"},{"key":"1471_CR529","doi-asserted-by":"crossref","unstructured":"Benoit-Lizon, I. et al. CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of TH1 and TH9 cells. J. Immunother. Cancer. 10, e003459 (2022).","DOI":"10.1136\/jitc-2021-003459"},{"key":"1471_CR530","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.ccell.2021.10.013","volume":"39","author":"K Sek","year":"2021","unstructured":"Sek, K., Chan, C. W., Beavis, P. A. & Darcy, P. K. Adoptive transfer of tumor-specific Th9 cells eradicates heterogeneous antigen-expressing tumor cells. Cancer Cell 39, 1564\u20131566 (2021).","journal-title":"Cancer Cell"},{"key":"1471_CR531","doi-asserted-by":"crossref","unstructured":"Gerlach, K. et al. PU.1-driven Th9 cells promote colorectal cancer in experimental colitis models through IL-6 effects in intestinal epithelial cells. J. Crohns Colitis 16, 1893\u20131910 (2022).","DOI":"10.1093\/ecco-jcc\/jjac097"},{"key":"1471_CR532","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/1440-1681.12689","volume":"44","author":"H Tan","year":"2017","unstructured":"Tan, H., Wang, S. & Zhao, L. A tumour-promoting role of Th9 cells in hepatocellular carcinoma through CCL20 and STAT3 pathways. Clin. Exp. Pharm. Physiol. 44, 213\u2013221 (2017).","journal-title":"Clin. Exp. Pharm. Physiol."},{"key":"1471_CR533","first-page":"3971","volume":"60","author":"JB Demoulin","year":"2000","unstructured":"Demoulin, J. B. et al. STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells. Cancer Res. 60, 3971\u20133977 (2000).","journal-title":"Cancer Res."},{"key":"1471_CR534","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1164\/rccm.201207-1307OC","volume":"186","author":"ZJ Ye","year":"2012","unstructured":"Ye, Z. J. et al. Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion. Am. J. Respir. Crit. Care Med. 186, 1168\u20131179 (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1471_CR535","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/25785826.2019.1700747","volume":"43","author":"SA Sabry","year":"2020","unstructured":"Sabry, S. A. et al. Oxidative stress in CLL patients leads to activation of Th9 cells: an experimental and comprehensive survey. Immunol. Med. 43, 36\u201346 (2020).","journal-title":"Immunol. Med."},{"key":"1471_CR536","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1158\/1541-7786.MCR-19-0894","volume":"18","author":"S Kumar","year":"2020","unstructured":"Kumar, S. et al. The Th9 axis reduces the oxidative stress and promotes the survival of malignant T cells in cutaneous T-cell lymphoma patients. Mol. Cancer Res. 18, 657\u2013668 (2020).","journal-title":"Mol. Cancer Res."},{"key":"1471_CR537","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1007\/s10875-011-9584-9","volume":"31","author":"LL Feng","year":"2011","unstructured":"Feng, L. L., Gao, J. M., Li, P. P. & Wang, X. IL-9 contributes to immunosuppression mediated by regulatory T cells and mast cells in B-cell non-hodgkin\u2019s lymphoma. J. Clin. Immunol. 31, 1084\u20131094 (2011).","journal-title":"J. Clin. Immunol."},{"key":"1471_CR538","doi-asserted-by":"publisher","first-page":"6845","DOI":"10.1158\/0008-5472.CAN-14-0836","volume":"74","author":"DB Hoelzinger","year":"2014","unstructured":"Hoelzinger, D. B., Dominguez, A. L., Cohen, P. A. & Gendler, S. J. Inhibition of adaptive immunity by IL9 can be disrupted to achieve rapid T-cell sensitization and rejection of progressive tumor challenges. Cancer Res. 74, 6845\u20136855 (2014).","journal-title":"Cancer Res."},{"key":"1471_CR539","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","volume":"20","author":"C Raffin","year":"2020","unstructured":"Raffin, C., Vo, L. T. & Bluestone, J. A. Treg cell-based therapies: challenges and perspectives. Nat. Rev. Immunol. 20, 158\u2013172 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR540","doi-asserted-by":"publisher","first-page":"940052","DOI":"10.3389\/fimmu.2022.940052","volume":"13","author":"BR McRitchie","year":"2022","unstructured":"McRitchie, B. R. & Akkaya, B. Exhaust the exhausters: targeting regulatory T cells in the tumor microenvironment. Front. Immunol. 13, 940052 (2022).","journal-title":"Front. Immunol."},{"key":"1471_CR541","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","volume":"16","author":"Y Togashi","year":"2019","unstructured":"Togashi, Y., Shitara, K. & Nishikawa, H. Regulatory T cells in cancer immunosuppression - implications for anticancer therapy. Nat. Rev. Clin. Oncol. 16, 356\u2013371 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1471_CR542","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/cr.2016.151","volume":"27","author":"A Tanaka","year":"2017","unstructured":"Tanaka, A. & Sakaguchi, S. Regulatory T cells in cancer immunotherapy. Cell Res. 27, 109\u2013118 (2017).","journal-title":"Cell Res."},{"key":"1471_CR543","doi-asserted-by":"publisher","DOI":"10.1038\/srep15179","volume":"5","author":"B Shang","year":"2015","unstructured":"Shang, B., Liu, Y., Jiang, S. J. & Liu, Y. Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis. Sci. Rep. 5, 15179 (2015).","journal-title":"Sci. Rep."},{"key":"1471_CR544","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2020.07.022","volume":"490","author":"R Saleh","year":"2020","unstructured":"Saleh, R. & Elkord, E. FoxP3(+) T regulatory cells in cancer: prognostic biomarkers and therapeutic targets. Cancer Lett. 490, 174\u2013185 (2020).","journal-title":"Cancer Lett."},{"key":"1471_CR545","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.trecan.2022.06.008","volume":"8","author":"F Shan","year":"2022","unstructured":"Shan, F. et al. Therapeutic targeting of regulatory T cells in cancer. Trends Cancer 8, 944\u2013961 (2022).","journal-title":"Trends Cancer"},{"key":"1471_CR546","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1136\/gutjnl-2011-300970","volume":"61","author":"G Betts","year":"2012","unstructured":"Betts, G. et al. Suppression of tumour-specific CD4(+) T cells by regulatory T cells is associated with progression of human colorectal cancer. Gut 61, 1163\u20131171 (2012).","journal-title":"Gut"},{"key":"1471_CR547","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nm.4086","volume":"22","author":"T Saito","year":"2016","unstructured":"Saito, T. et al. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers. Nat. Med. 22, 679\u2013684 (2016).","journal-title":"Nat. Med."},{"key":"1471_CR548","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00262-011-1046-y","volume":"60","author":"S Ladoire","year":"2011","unstructured":"Ladoire, S., Martin, F. & Ghiringhelli, F. Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol. Immunother. 60, 909\u2013918 (2011).","journal-title":"Cancer Immunol. Immunother."},{"key":"1471_CR549","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.4049\/jimmunol.1003251","volume":"186","author":"I Kryczek","year":"2011","unstructured":"Kryczek, I. et al. IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. J. Immunol. 186, 4388\u20134395 (2011).","journal-title":"J. Immunol."},{"key":"1471_CR550","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1189\/jlb.0910506","volume":"89","author":"S Yang","year":"2011","unstructured":"Yang, S. et al. Foxp3+IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer. J. Leukoc. Biol. 89, 85\u201391 (2011).","journal-title":"J. Leukoc. Biol."},{"key":"1471_CR551","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman, W. H., Pages, F., Sautes-Fridman, C. & Galon, J. The immune contexture in human tumours: impact on clinical outcome. Nat. Rev. Cancer 12, 298\u2013306 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"1471_CR552","doi-asserted-by":"publisher","first-page":"833667","DOI":"10.3389\/fimmu.2022.833667","volume":"13","author":"R Gao","year":"2022","unstructured":"Gao, R., Shi, G. P. & Wang, J. Functional diversities of regulatory T cells in the context of cancer immunotherapy. Front. Immunol. 13, 833667 (2022).","journal-title":"Front. Immunol."},{"key":"1471_CR553","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/eji.201847659","volume":"49","author":"A Tanaka","year":"2019","unstructured":"Tanaka, A. & Sakaguchi, S. Targeting Treg cells in cancer immunotherapy. Eur. J. Immunol. 49, 1140\u20131146 (2019).","journal-title":"Eur. J. Immunol."},{"key":"1471_CR554","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.immuni.2007.08.014","volume":"27","author":"X Cao","year":"2007","unstructured":"Cao, X. et al. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27, 635\u2013646 (2007).","journal-title":"Immunity"},{"key":"1471_CR555","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fimmu.2016.00382","volume":"7","author":"E Volpe","year":"2016","unstructured":"Volpe, E., Sambucci, M., Battistini, L. & Borsellino, G. Fas-Fas ligand: checkpoint of T cell functions in multiple sclerosis. Front. Immunol. 7, 382 (2016).","journal-title":"Front. Immunol."},{"key":"1471_CR556","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.celrep.2017.10.090","volume":"21","author":"X Wei","year":"2017","unstructured":"Wei, X. et al. Reciprocal expression of IL-35 and IL-10 defines two distinct effector Treg subsets that are required for maintenance of immune tolerance. Cell Rep. 21, 1853\u20131869 (2017).","journal-title":"Cell Rep."},{"key":"1471_CR557","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1158\/2326-6066.CIR-17-0498","volume":"6","author":"D Sarhan","year":"2018","unstructured":"Sarhan, D. et al. Adaptive NK cells resist regulatory T-cell suppression driven by IL37. Cancer Immunol. Res. 6, 766\u2013775 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"1471_CR558","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41590-019-0555-2","volume":"21","author":"A Hatzioannou","year":"2020","unstructured":"Hatzioannou, A. et al. An intrinsic role of IL-33 in Treg cell-mediated tumor immunoevasion. Nat. Immunol. 21, 75\u201385 (2020).","journal-title":"Nat. Immunol."},{"key":"1471_CR559","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s41586-021-03326-4","volume":"591","author":"R Zappasodi","year":"2021","unstructured":"Zappasodi, R. et al. CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours. Nature 591, 652\u2013658 (2021).","journal-title":"Nature"},{"key":"1471_CR560","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/s41590-020-0801-7","volume":"21","author":"HI Aksoylar","year":"2020","unstructured":"Aksoylar, H. I. & Boussiotis, V. A. PD-1(+) Treg cells: a foe in cancer immunotherapy? Nat. Immunol. 21, 1311\u20131312 (2020).","journal-title":"Nat. Immunol."},{"key":"1471_CR561","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1172\/JCI81187","volume":"125","author":"S Kurtulus","year":"2015","unstructured":"Kurtulus, S. et al. TIGIT predominantly regulates the immune response via regulatory T cells. J. Clin. Invest. 125, 4053\u20134062 (2015).","journal-title":"J. Clin. Invest"},{"key":"1471_CR562","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1126\/science.1160062","volume":"322","author":"K Wing","year":"2008","unstructured":"Wing, K. et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322, 271\u2013275 (2008).","journal-title":"Science"},{"key":"1471_CR563","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1126\/science.1202947","volume":"332","author":"OS Qureshi","year":"2011","unstructured":"Qureshi, O. S. et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332, 600\u2013603 (2011).","journal-title":"Science"},{"key":"1471_CR564","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/cmi.2011.62","volume":"9","author":"P Gu","year":"2012","unstructured":"Gu, P. et al. Trogocytosis of CD80 and CD86 by induced regulatory T cells. Cell Mol. Immunol. 9, 136\u2013146 (2012).","journal-title":"Cell Mol. Immunol."},{"key":"1471_CR565","doi-asserted-by":"crossref","unstructured":"Tekguc, M. et al. Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells. Proc Natl Acad Sci USA. 118, e2023739118 (2021).","DOI":"10.1073\/pnas.2023739118"},{"key":"1471_CR566","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.immuni.2015.05.023","volume":"42","author":"V Kalia","year":"2015","unstructured":"Kalia, V. et al. Quiescence of memory CD8(+) T cells is mediated by regulatory T cells through inhibitory receptor CTLA-4. Immunity 42, 1116\u20131129 (2015).","journal-title":"Immunity"},{"key":"1471_CR567","doi-asserted-by":"publisher","first-page":"5916","DOI":"10.4049\/jimmunol.180.9.5916","volume":"180","author":"B Liang","year":"2008","unstructured":"Liang, B. et al. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J. Immunol. 180, 5916\u20135926 (2008).","journal-title":"J. Immunol."},{"key":"1471_CR568","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s00262-019-02417-6","volume":"68","author":"F Ihara","year":"2019","unstructured":"Ihara, F. et al. Regulatory T cells induce CD4(-) NKT cell anergy and suppress NKT cell cytotoxic function. Cancer Immunol. Immunother. 68, 1935\u20131947 (2019).","journal-title":"Cancer Immunol. Immunother."},{"key":"1471_CR569","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.4161\/onci.21176","volume":"1","author":"T Fujimura","year":"2012","unstructured":"Fujimura, T., Kambayashi, Y. & Aiba, S. Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growth. Oncoimmunology 1, 1433\u20131434 (2012).","journal-title":"Oncoimmunology"},{"key":"1471_CR570","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01234-1","volume":"19","author":"C Li","year":"2020","unstructured":"Li, C. et al. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects. Mol. Cancer 19, 116 (2020).","journal-title":"Mol. Cancer"},{"key":"1471_CR571","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","volume":"204","author":"S Deaglio","year":"2007","unstructured":"Deaglio, S. et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257\u20131265 (2007).","journal-title":"J. Exp. Med."},{"key":"1471_CR572","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1158\/2159-8290.CD-14-0341","volume":"4","author":"A Young","year":"2014","unstructured":"Young, A., Mittal, D., Stagg, J. & Smyth, M. J. Targeting cancer-derived adenosine: new therapeutic approaches. Cancer Disco. 4, 879\u2013888 (2014).","journal-title":"Cancer Disco."},{"key":"1471_CR573","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.4049\/jimmunol.1700433","volume":"200","author":"T Carmenate","year":"2018","unstructured":"Carmenate, T. et al. Blocking IL-2 signal in vivo with an IL-2 antagonist reduces tumor growth through the control of regulatory T cells. J. Immunol. 200, 3475\u20133484 (2018).","journal-title":"J. Immunol."},{"key":"1471_CR574","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40425-015-0094-9","volume":"3","author":"YW Moon","year":"2015","unstructured":"Moon, Y. W., Hajjar, J., Hwu, P. & Naing, A. Targeting the indoleamine 2,3-dioxygenase pathway in cancer. J. Immunother. Cancer 3, 51 (2015).","journal-title":"J. Immunother. Cancer"},{"key":"1471_CR575","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","volume":"18","author":"M Platten","year":"2019","unstructured":"Platten, M. et al. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat. Rev. Drug Disco. 18, 379\u2013401 (2019).","journal-title":"Nat. Rev. Drug Disco."},{"key":"1471_CR576","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1158\/2326-6066.CIR-18-0658","volume":"7","author":"L Zhang","year":"2019","unstructured":"Zhang, L. & Zhang, Z. Recharacterizing tumor-infiltrating lymphocytes by single-cell RNA sequencing. Cancer Immunol. Res. 7, 1040\u20131046 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"1471_CR577","doi-asserted-by":"crossref","unstructured":"Ahmadzadeh, M. et al. Tumor-infiltrating human CD4(+) regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity. Sci Immunol. 4, eaao4310 (2019).","DOI":"10.1126\/sciimmunol.aao4310"},{"key":"1471_CR578","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.cell.2020.05.017","volume":"181","author":"DY Oh","year":"2020","unstructured":"Oh, D. Y. et al. Intratumoral CD4(+) T cells mediate anti-tumor cytotoxicity in human bladder cancer. Cell 181, 1612\u20131625 e1613 (2020).","journal-title":"Cell"},{"key":"1471_CR579","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.immuni.2016.10.032","volume":"45","author":"G Plitas","year":"2016","unstructured":"Plitas, G. et al. Regulatory T cells exhibit distinct features in human breast cancer. Immunity 45, 1122\u20131134 (2016).","journal-title":"Immunity"},{"key":"1471_CR580","doi-asserted-by":"crossref","unstructured":"Cinier, J. et al. Recruitment and expansion of Tregs cells in the tumor environment-How to target them? Cancers 13, 1850 (2021).","DOI":"10.3390\/cancers13081850"},{"key":"1471_CR581","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-019-0131-5","volume":"6","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Deep single-cell RNA sequencing data of individual T cells from treatment-naive colorectal cancer patients. Sci. Data 6, 131 (2019).","journal-title":"Sci. Data"},{"key":"1471_CR582","doi-asserted-by":"publisher","first-page":"666","DOI":"10.7150\/ijms.23940","volume":"15","author":"Q Chen","year":"2018","unstructured":"Chen, Q. et al. ICOS signal facilitates Foxp3 transcription to favor suppressive function of regulatory T cells. Int. J. Med. Sci. 15, 666\u2013673 (2018).","journal-title":"Int. J. Med. Sci."},{"key":"1471_CR583","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s00262-021-02881-z","volume":"70","author":"D Rao","year":"2021","unstructured":"Rao, D. et al. Metabolic profiles of regulatory T cells in the tumour microenvironment. Cancer Immunol. Immunother. 70, 2417\u20132427 (2021).","journal-title":"Cancer Immunol. Immunother."},{"key":"1471_CR584","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","volume":"25","author":"A Angelin","year":"2017","unstructured":"Angelin, A. et al. Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab. 25, 1282\u20131293 e1287 (2017).","journal-title":"Cell Metab."},{"key":"1471_CR585","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.immuni.2017.10.017","volume":"47","author":"M Kishore","year":"2017","unstructured":"Kishore, M. et al. Regulatory T cell migration is dependent on glucokinase-mediated glycolysis. Immunity 47, 875\u2013889 e810 (2017).","journal-title":"Immunity"},{"key":"1471_CR586","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","volume":"40","author":"S Kumagai","year":"2022","unstructured":"Kumagai, S. et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell 40, 201\u2013218 e209 (2022).","journal-title":"Cancer Cell"},{"key":"1471_CR587","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson, M. J. et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature 591, 645\u2013651 (2021).","journal-title":"Nature"},{"key":"1471_CR588","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","volume":"21","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nat. Immunol. 21, 298\u2013308 (2020).","journal-title":"Nat. Immunol."},{"key":"1471_CR589","doi-asserted-by":"publisher","first-page":"E6546","DOI":"10.1073\/pnas.1720113115","volume":"115","author":"I Pacella","year":"2018","unstructured":"Pacella, I. et al. Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth. Proc. Natl Acad. Sci. USA 115, E6546\u2013E6555 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR590","doi-asserted-by":"publisher","first-page":"669474","DOI":"10.3389\/fimmu.2021.669474","volume":"12","author":"A Basu","year":"2021","unstructured":"Basu, A. et al. Differentiation and regulation of TH cells: a balancing act for cancer immunotherapy. Front. Immunol. 12, 669474 (2021).","journal-title":"Front. Immunol."},{"key":"1471_CR591","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1084\/jem.20101773","volume":"208","author":"LM Fahey","year":"2011","unstructured":"Fahey, L. M. et al. Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells. J. Exp. Med. 208, 987\u2013999 (2011).","journal-title":"J. Exp. Med."},{"key":"1471_CR592","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.molmed.2017.10.001","volume":"23","author":"LA Vella","year":"2017","unstructured":"Vella, L. A., Herati, R. S. & Wherry, E. J. CD4(+) T cell differentiation in chronic viral infections: the Tfh perspective. Trends Mol. Med. 23, 1072\u20131087 (2017).","journal-title":"Trends Mol. Med."},{"key":"1471_CR593","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","volume":"577","author":"R Cabrita","year":"2020","unstructured":"Cabrita, R. et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature 577, 561\u2013565 (2020).","journal-title":"Nature"},{"key":"1471_CR594","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1172\/JCI67428","volume":"123","author":"C Gu-Trantien","year":"2013","unstructured":"Gu-Trantien, C. et al. CD4(+) follicular helper T cell infiltration predicts breast cancer survival. J. Clin. Invest. 123, 2873\u20132892 (2013).","journal-title":"J. Clin. Invest."},{"key":"1471_CR595","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39, 782\u2013795 (2013).","journal-title":"Immunity"},{"key":"1471_CR596","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1016\/j.cell.2021.11.007","volume":"184","author":"C Cui","year":"2021","unstructured":"Cui, C. et al. Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses. Cell 184, 6101\u20136118 e6113 (2021).","journal-title":"Cell"},{"key":"1471_CR597","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1631\/jzus.B2200174","volume":"23","author":"J Chen","year":"2022","unstructured":"Chen, J., Chen, J. & Wang, L. Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes. J. Zhejiang Univ. Sci. B 23, 812\u2013822 (2022).","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"1471_CR598","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","volume":"19","author":"WH Fridman","year":"2022","unstructured":"Fridman, W. H. et al. B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome. Nat. Rev. Clin. Oncol. 19, 441\u2013457 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1471_CR599","doi-asserted-by":"crossref","unstructured":"Lin, X. et al. Follicular helper T cells remodel the immune microenvironment of pancreatic cancer via secreting CXCL13 and IL-21. Cancers 13, 3678 (2021).","DOI":"10.3390\/cancers13153678"},{"key":"1471_CR600","doi-asserted-by":"crossref","unstructured":"Noel, G. et al. Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity. J. Clin. Invest. 131, e139905 (2021).","DOI":"10.1172\/JCI139905"},{"key":"1471_CR601","doi-asserted-by":"crossref","unstructured":"Ukita, M. et al. CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer. JCI Insight 7, e157215 (2022).","DOI":"10.1172\/jci.insight.157215"},{"key":"1471_CR602","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.immuni.2022.01.018","volume":"55","author":"R Zander","year":"2022","unstructured":"Zander, R. et al. Tfh-cell-derived interleukin 21 sustains effector CD8(+) T cell responses during chronic viral infection. Immunity 55, 475\u2013493 e475 (2022).","journal-title":"Immunity"},{"key":"1471_CR603","doi-asserted-by":"crossref","unstructured":"Greczmiel, U. et al. Sustained T follicular helper cell response is essential for control of chronic viral infection. Sci. Immunol. 2, eaam8686 (2017).","DOI":"10.1126\/sciimmunol.aam8686"},{"key":"1471_CR604","doi-asserted-by":"publisher","first-page":"610303","DOI":"10.3389\/fonc.2021.610303","volume":"11","author":"V Salemme","year":"2021","unstructured":"Salemme, V. et al. The crosstalk between tumor cells and the immune microenvironment in breast cancer: implications for immunotherapy. Front. Oncol. 11, 610303 (2021).","journal-title":"Front. Oncol."},{"key":"1471_CR605","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.3389\/fimmu.2018.02660","volume":"9","author":"S Garaud","year":"2018","unstructured":"Garaud, S. et al. Antigen specificity and clinical significance of IgG and IgA autoantibodies produced in situ by tumor-infiltrating B cells in breast cancer. Front. Immunol. 9, 2660 (2018).","journal-title":"Front. Immunol."},{"key":"1471_CR606","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s10875-016-0257-6","volume":"36","author":"CS Ma","year":"2016","unstructured":"Ma, C. S. Human T follicular helper cells in primary immunodeficiency: quality just as important as quantity. J. Clin. Immunol. 36, 40\u201347 (2016).","journal-title":"J. Clin. Immunol."},{"key":"1471_CR607","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41577-019-0244-2","volume":"20","author":"M Akkaya","year":"2020","unstructured":"Akkaya, M., Kwak, K. & Pierce, S. K. B cell memory: building two walls of protection against pathogens. Nat. Rev. Immunol. 20, 229\u2013238 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR608","doi-asserted-by":"crossref","unstructured":"Baumjohann, D. & Brossart, P. T follicular helper cells: linking cancer immunotherapy and immune-related adverse events. J. Immunother. Cancer 9, e002588 (2021).","DOI":"10.1136\/jitc-2021-002588"},{"key":"1471_CR609","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.3389\/fimmu.2017.01412","volume":"8","author":"C Solinas","year":"2017","unstructured":"Solinas, C. et al. Immune checkpoint molecules on tumor-infiltrating lymphocytes and their association with tertiary lymphoid structures in human breast cancer. Front. Immunol. 8, 1412 (2017).","journal-title":"Front. Immunol."},{"key":"1471_CR610","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.immuni.2018.06.012","volume":"49","author":"J Shi","year":"2018","unstructured":"Shi, J. et al. PD-1 controls follicular T helper cell positioning and function. Immunity 49, 264\u2013274 e264 (2018).","journal-title":"Immunity"},{"key":"1471_CR611","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","volume":"577","author":"BA Helmink","year":"2020","unstructured":"Helmink, B. A. et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature 577, 549\u2013555 (2020).","journal-title":"Nature"},{"key":"1471_CR612","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","volume":"577","author":"F Petitprez","year":"2020","unstructured":"Petitprez, F. et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature 577, 556\u2013560 (2020).","journal-title":"Nature"},{"key":"1471_CR613","doi-asserted-by":"crossref","unstructured":"Niogret, J. et al. Follicular helper-T cells restore CD8(+)-dependent antitumor immunity and anti-PD-L1\/PD-1 efficacy. J. Immunother. Cancer 9, e002157 (2021).","DOI":"10.1136\/jitc-2020-002157"},{"key":"1471_CR614","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.lfs.2019.04.053","volume":"227","author":"M Hussain","year":"2019","unstructured":"Hussain, M. et al. CXCL13\/CXCR5 signaling axis in cancer. Life Sci. 227, 175\u2013186 (2019).","journal-title":"Life Sci."},{"key":"1471_CR615","doi-asserted-by":"crossref","unstructured":"Yang, M. et al. CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer. J. Immunother. Cancer 9, e001136 (2021).","DOI":"10.1136\/jitc-2020-001136"},{"key":"1471_CR616","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1089\/hum.2012.101","volume":"23","author":"K Oosterhuis","year":"2012","unstructured":"Oosterhuis, K. et al. Rational design of DNA vaccines for the induction of human papillomavirus type 16 E6- and E7-specific cytotoxic T-cell responses. Hum. Gene Ther. 23, 1301\u20131312 (2012).","journal-title":"Hum. Gene Ther."},{"key":"1471_CR617","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","volume":"18","author":"J Borst","year":"2018","unstructured":"Borst, J. et al. CD4(+) T cell help in cancer immunology and immunotherapy. Nat. Rev. Immunol. 18, 635\u2013647 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR618","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/j.celrep.2016.07.076","volume":"16","author":"S Calabro","year":"2016","unstructured":"Calabro, S. et al. Differential intrasplenic migration of dendritic cell subsets tailors adaptive immunity. Cell Rep. 16, 2472\u20132485 (2016).","journal-title":"Cell Rep."},{"key":"1471_CR619","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1084\/jem.20170335","volume":"214","author":"MY Gerner","year":"2017","unstructured":"Gerner, M. Y., Casey, K. A., Kastenmuller, W. & Germain, R. N. Dendritic cell and antigen dispersal landscapes regulate T cell immunity. J. Exp. Med. 214, 3105\u20133122 (2017).","journal-title":"J. Exp. Med."},{"key":"1471_CR620","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.cell.2015.08.004","volume":"162","author":"S Eickhoff","year":"2015","unstructured":"Eickhoff, S. et al. Robust anti-viral immunity requires multiple distinct T cell-dendritic cell interactions. Cell 162, 1322\u20131337 (2015).","journal-title":"Cell"},{"key":"1471_CR621","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.immuni.2015.07.020","volume":"43","author":"JL Hor","year":"2015","unstructured":"Hor, J. L. et al. Spatiotemporally distinct interactions with dendritic cell subsets facilitates CD4+ and CD8+ T cell activation to localized viral infection. Immunity 43, 554\u2013565 (2015).","journal-title":"Immunity"},{"key":"1471_CR622","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1084\/jem.20100348","volume":"207","author":"A Bachem","year":"2010","unstructured":"Bachem, A. et al. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J. Exp. Med. 207, 1273\u20131281 (2010).","journal-title":"J. Exp. Med."},{"key":"1471_CR623","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/30996","volume":"393","author":"SR Bennett","year":"1998","unstructured":"Bennett, S. R. et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393, 478\u2013480 (1998).","journal-title":"Nature"},{"key":"1471_CR624","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/31002","volume":"393","author":"SP Schoenberger","year":"1998","unstructured":"Schoenberger, S. P. et al. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393, 480\u2013483 (1998).","journal-title":"Nature"},{"key":"1471_CR625","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1084\/jem.192.1.145","volume":"192","author":"DH Schuurhuis","year":"2000","unstructured":"Schuurhuis, D. H. et al. Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli. J. Exp. Med. 192, 145\u2013150 (2000).","journal-title":"J. Exp. Med."},{"key":"1471_CR626","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.4049\/jimmunol.179.8.5033","volume":"179","author":"MS Bijker","year":"2007","unstructured":"Bijker, M. S. et al. CD8+ CTL priming by exact peptide epitopes in incomplete Freund\u2019s adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity. J. Immunol. 179, 5033\u20135040 (2007).","journal-title":"J. Immunol."},{"key":"1471_CR627","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1074-7613(00)00045-5","volume":"13","author":"O Schulz","year":"2000","unstructured":"Schulz, O. et al. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 13, 453\u2013462 (2000).","journal-title":"Immunity"},{"key":"1471_CR628","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.immuni.2017.10.009","volume":"47","author":"T Ahrends","year":"2017","unstructured":"Ahrends, T. et al. CD4(+) T cell help confers a cytotoxic T cell effector program including coinhibitory receptor downregulation and increased tissue invasiveness. Immunity 47, 848\u2013861 e845 (2017).","journal-title":"Immunity"},{"key":"1471_CR629","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.4049\/jimmunol.1600591","volume":"197","author":"NM Provine","year":"2016","unstructured":"Provine, N. M. et al. Immediate dysfunction of vaccine-elicited CD8+ T cells primed in the absence of CD4+ T cells. J. Immunol. 197, 1809\u20131822 (2016).","journal-title":"J. Immunol."},{"key":"1471_CR630","doi-asserted-by":"publisher","first-page":"21182","DOI":"10.1073\/pnas.1118450109","volume":"108","author":"RD Aubert","year":"2011","unstructured":"Aubert, R. D. et al. Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection. Proc. Natl Acad. Sci. USA 108, 21182\u201321187 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR631","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nri.2015.10","volume":"16","author":"BJ Laidlaw","year":"2016","unstructured":"Laidlaw, B. J., Craft, J. E. & Kaech, S. M. The multifaceted role of CD4(+) T cells in CD8(+) T cell memory. Nat. Rev. Immunol. 16, 102\u2013111 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR632","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13438-1","volume":"10","author":"T Ahrends","year":"2019","unstructured":"Ahrends, T. et al. CD4(+) T cell help creates memory CD8(+) T cells with innate and help-independent recall capacities. Nat. Commun. 10, 5531 (2019).","journal-title":"Nat. Commun."},{"key":"1471_CR633","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1002\/eji.200737824","volume":"38","author":"MS Matter","year":"2008","unstructured":"Matter, M. S., Claus, C. & Ochsenbein, A. F. CD4+ T cell help improves CD8+ T cell memory by retained CD27 expression. Eur. J. Immunol. 38, 1847\u20131856 (2008).","journal-title":"Eur. J. Immunol."},{"key":"1471_CR634","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature03337","volume":"434","author":"EM Janssen","year":"2005","unstructured":"Janssen, E. M. et al. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434, 88\u201393 (2005).","journal-title":"Nature"},{"key":"1471_CR635","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1073\/pnas.0801003105","volume":"105","author":"S Oh","year":"2008","unstructured":"Oh, S. et al. IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis. Proc. Natl Acad. Sci. USA 105, 5201\u20135206 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR636","doi-asserted-by":"publisher","first-page":"109696","DOI":"10.1016\/j.celrep.2021.109696","volume":"36","author":"YJ Lu","year":"2021","unstructured":"Lu, Y. J. et al. CD4 T cell help prevents CD8 T cell exhaustion and promotes control of Mycobacterium tuberculosis infection. Cell Rep. 36, 109696 (2021).","journal-title":"Cell Rep."},{"key":"1471_CR637","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1084\/jem.20030916","volume":"198","author":"J Hendriks","year":"2003","unstructured":"Hendriks, J., Xiao, Y. & Borst, J. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J. Exp. Med. 198, 1369\u20131380 (2003).","journal-title":"J. Exp. Med."},{"key":"1471_CR638","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1948","volume":"3","author":"S Feau","year":"2012","unstructured":"Feau, S. et al. The CD4(+) T-cell help signal is transmitted from APC to CD8(+) T-cells via CD27-CD70 interactions. Nat. Commun. 3, 948 (2012).","journal-title":"Nat. Commun."},{"key":"1471_CR639","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.4049\/jimmunol.169.8.4094","volume":"169","author":"KR Prilliman","year":"2002","unstructured":"Prilliman, K. R. et al. Cutting edge: a crucial role for B7-CD28 in transmitting T help from APC to CTL. J. Immunol. 169, 4094\u20134097 (2002).","journal-title":"J. Immunol."},{"key":"1471_CR640","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.4049\/jimmunol.171.10.5165","volume":"171","author":"JM Curtsinger","year":"2003","unstructured":"Curtsinger, J. M., Johnson, C. M. & Mescher, M. F. CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J. Immunol. 171, 5165\u20135171 (2003).","journal-title":"J. Immunol."},{"key":"1471_CR641","doi-asserted-by":"publisher","first-page":"710","DOI":"10.4049\/jimmunol.174.2.710","volume":"174","author":"TN Bullock","year":"2005","unstructured":"Bullock, T. N. & Yagita, H. Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells. J. Immunol. 174, 710\u2013717 (2005).","journal-title":"J. Immunol."},{"key":"1471_CR642","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2217\/imt.15.32","volume":"7","author":"K van de Ven","year":"2015","unstructured":"van de Ven, K. & Borst, J. Targeting the T-cell co-stimulatory CD27\/CD70 pathway in cancer immunotherapy: rationale and potential. Immunotherapy 7, 655\u2013667 (2015).","journal-title":"Immunotherapy"},{"key":"1471_CR643","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev.immunol.23.021704.115839","volume":"23","author":"TH Watts","year":"2005","unstructured":"Watts, T. H. TNF\/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23, 23\u201368 (2005).","journal-title":"Annu. Rev. Immunol."},{"key":"1471_CR644","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.4049\/jimmunol.175.3.1665","volume":"175","author":"J Hendriks","year":"2005","unstructured":"Hendriks, J. et al. During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion. J. Immunol. 175, 1665\u20131676 (2005).","journal-title":"J. Immunol."},{"key":"1471_CR645","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.4049\/jimmunol.0900592","volume":"183","author":"P Agarwal","year":"2009","unstructured":"Agarwal, P. et al. Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J. Immunol. 183, 1695\u20131704 (2009).","journal-title":"J. Immunol."},{"key":"1471_CR646","doi-asserted-by":"publisher","first-page":"7445","DOI":"10.4049\/jimmunol.181.11.7445","volume":"181","author":"EB Wilson","year":"2008","unstructured":"Wilson, E. B. & Livingstone, A. M. Cutting edge: CD4+ T cell-derived IL-2 is essential for help-dependent primary CD8+ T cell responses. J. Immunol. 181, 7445\u20137448 (2008).","journal-title":"J. Immunol."},{"key":"1471_CR647","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.immuni.2011.09.017","volume":"35","author":"W Cui","year":"2011","unstructured":"Cui, W. et al. An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. Immunity 35, 792\u2013805 (2011).","journal-title":"Immunity"},{"key":"1471_CR648","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.immuni.2018.08.002","volume":"49","author":"LM Snell","year":"2018","unstructured":"Snell, L. M. et al. CD8(+) T cell priming in established chronic viral infection preferentially directs differentiation of memory-like cells for sustained immunity. Immunity 49, 678\u2013694 e675 (2018).","journal-title":"Immunity"},{"key":"1471_CR649","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.it.2018.10.002","volume":"39","author":"D Yu","year":"2018","unstructured":"Yu, D. & Ye, L. A portrait of CXCR5(+) follicular cytotoxic CD8(+) T cells. Trends Immunol. 39, 965\u2013979 (2018).","journal-title":"Trends Immunol."},{"key":"1471_CR650","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jhep.2019.09.031","volume":"72","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. CXCL13-mediated recruitment of intrahepatic CXCR5(+)CD8(+) T cells favors viral control in chronic HBV infection. J. Hepatol. 72, 420\u2013430 (2020).","journal-title":"J. Hepatol."},{"key":"1471_CR651","doi-asserted-by":"crossref","unstructured":"Gu-Trantien, C. et al. CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer. JCI Insight 2, e91487 (2017).","DOI":"10.1172\/jci.insight.91487"},{"key":"1471_CR652","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cell.2020.03.007","volume":"181","author":"L Fugger","year":"2020","unstructured":"Fugger, L., Jensen, L. T. & Rossjohn, J. Challenges, progress, and prospects of developing therapies to treat autoimmune diseases. Cell 181, 63\u201380 (2020).","journal-title":"Cell"},{"key":"1471_CR653","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-pathol-052920-040318","volume":"17","author":"S Rodriguez Murua","year":"2022","unstructured":"Rodriguez Murua, S., Farez, M. F. & Quintana, F. J. The immune response in multiple sclerosis. Annu. Rev. Pathol. 17, 121\u2013139 (2022).","journal-title":"Annu. Rev. Pathol."},{"key":"1471_CR654","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3109\/08916939309043888","volume":"15","author":"RR Voskuhl","year":"1993","unstructured":"Voskuhl, R. R. et al. T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity 15, 137\u2013143 (1993).","journal-title":"Autoimmunity"},{"key":"1471_CR655","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm0502-500","volume":"8","author":"C Lock","year":"2002","unstructured":"Lock, C. et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500\u2013508 (2002).","journal-title":"Nat. Med."},{"key":"1471_CR656","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1084\/jem.177.1.57","volume":"177","author":"JL Baron","year":"1993","unstructured":"Baron, J. L. et al. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177, 57\u201368 (1993).","journal-title":"J. Exp. Med."},{"key":"1471_CR657","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.bbi.2014.01.001","volume":"37","author":"CK Prajeeth","year":"2014","unstructured":"Prajeeth, C. K. et al. Effector molecules released by Th1 but not Th17 cells drive an M1 response in microglia. Brain Behav. Immun. 37, 248\u2013259 (2014).","journal-title":"Brain Behav. Immun."},{"key":"1471_CR658","doi-asserted-by":"publisher","first-page":"7104","DOI":"10.4049\/jimmunol.169.12.7104","volume":"169","author":"B Gran","year":"2002","unstructured":"Gran, B. et al. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 169, 7104\u20137110 (2002).","journal-title":"J. Immunol."},{"key":"1471_CR659","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.4049\/jimmunol.170.4.2153","volume":"170","author":"GX Zhang","year":"2003","unstructured":"Zhang, G. X. et al. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J. Immunol. 170, 2153\u20132160 (2003).","journal-title":"J. Immunol."},{"key":"1471_CR660","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nature01355","volume":"421","author":"DJ Cua","year":"2003","unstructured":"Cua, D. J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744\u2013748 (2003).","journal-title":"Nature"},{"key":"1471_CR661","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","volume":"13","author":"B Oppmann","year":"2000","unstructured":"Oppmann, B. et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13, 715\u2013725 (2000).","journal-title":"Immunity"},{"key":"1471_CR662","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","volume":"168","author":"C Parham","year":"2002","unstructured":"Parham, C. et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699\u20135708 (2002).","journal-title":"J. Immunol."},{"key":"1471_CR663","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1146\/annurev-immunol-101819-092536","volume":"39","author":"S Majumder","year":"2021","unstructured":"Majumder, S. & McGeachy, M. J. IL-17 in the pathogenesis of disease: good intentions gone awry. Annu. Rev. Immunol. 39, 537\u2013556 (2021).","journal-title":"Annu. Rev. Immunol."},{"key":"1471_CR664","doi-asserted-by":"publisher","first-page":"5314541","DOI":"10.1155\/2016\/5314541","volume":"2016","author":"GR Dos Passos","year":"2016","unstructured":"Dos Passos, G. R., Sato, D. K., Becker, J. & Fujihara, K. Th17 cells pathways in multiple sclerosis and neuromyelitis optica spectrum disorders: pathophysiological and therapeutic implications. Mediators Inflamm. 2016, 5314541 (2016).","journal-title":"Mediators Inflamm."},{"key":"1471_CR665","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1093\/brain\/awp289","volume":"132","author":"V Brucklacher-Waldert","year":"2009","unstructured":"Brucklacher-Waldert, V. et al. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 132, 3329\u20133341 (2009).","journal-title":"Brain"},{"key":"1471_CR666","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","volume":"172","author":"JS Tzartos","year":"2008","unstructured":"Tzartos, J. S. et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172, 146\u2013155 (2008).","journal-title":"Am. J. Pathol."},{"key":"1471_CR667","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm1651","volume":"13","author":"H Kebir","year":"2007","unstructured":"Kebir, H. et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13, 1173\u20131175 (2007).","journal-title":"Nat. Med."},{"key":"1471_CR668","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbi.2010.01.014","volume":"24","author":"AC Murphy","year":"2010","unstructured":"Murphy, A. C., Lalor, S. J., Lynch, M. A. & Mills, K. H. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav. Immun. 24, 641\u2013651 (2010).","journal-title":"Brain Behav. Immun."},{"key":"1471_CR669","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0978-3","volume":"14","author":"CK Prajeeth","year":"2017","unstructured":"Prajeeth, C. K. et al. Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties. J. Neuroinflammation 14, 204 (2017).","journal-title":"J. Neuroinflammation"},{"key":"1471_CR670","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.immuni.2010.03.004","volume":"32","author":"Z Kang","year":"2010","unstructured":"Kang, Z. et al. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 32, 414\u2013425 (2010).","journal-title":"Immunity"},{"key":"1471_CR671","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jneuroim.2019.04.011","volume":"332","author":"AF Setiadi","year":"2019","unstructured":"Setiadi, A. F. et al. IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis. J. Neuroimmunol. 332, 147\u2013154 (2019).","journal-title":"J. Neuroimmunol."},{"key":"1471_CR672","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbrc.2018.11.021","volume":"507","author":"MT Rahman","year":"2018","unstructured":"Rahman, M. T. et al. IFN-gamma, IL-17A, or zonulin rapidly increase the permeability of the blood-brain and small intestinal epithelial barriers: relevance for neuro-inflammatory diseases. Biochem. Biophys. Res. Commun. 507, 274\u2013279 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1471_CR673","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1471-4159.2010.07136.x","volume":"116","author":"MK Paintlia","year":"2011","unstructured":"Paintlia, M. K., Paintlia, A. S., Singh, A. K. & Singh, I. Synergistic activity of interleukin-17 and tumor necrosis factor-alpha enhances oxidative stress-mediated oligodendrocyte apoptosis. J. Neurochem. 116, 508\u2013521 (2011).","journal-title":"J. Neurochem."},{"key":"1471_CR674","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-3-319-47861-6_7","volume":"958","author":"AO Dulamea","year":"2017","unstructured":"Dulamea, A. O. Role of oligodendrocyte dysfunction in demyelination, remyelination and neurodegeneration in multiple sclerosis. Adv. Exp. Med. Biol. 958, 91\u2013127 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1471_CR675","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ni.2053","volume":"12","author":"J Rangel-Moreno","year":"2011","unstructured":"Rangel-Moreno, J. et al. The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat. Immunol. 12, 639\u2013646 (2011).","journal-title":"Nat. Immunol."},{"key":"1471_CR676","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.immuni.2015.11.010","volume":"43","author":"NB Pikor","year":"2015","unstructured":"Pikor, N. B. et al. Integration of Th17- and lymphotoxin-derived signals initiates meningeal-resident stromal cell remodeling to propagate neuroinflammation. Immunity 43, 1160\u20131173 (2015).","journal-title":"Immunity"},{"key":"1471_CR677","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.immuni.2011.10.015","volume":"35","author":"A Peters","year":"2011","unstructured":"Peters, A. et al. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 35, 986\u2013996 (2011).","journal-title":"Immunity"},{"key":"1471_CR678","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/ni.2027","volume":"12","author":"L Codarri","year":"2011","unstructured":"Codarri, L. et al. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12, 560\u2013567 (2011).","journal-title":"Nat. Immunol."},{"key":"1471_CR679","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2017.06.005","volume":"84","author":"I Ifergan","year":"2017","unstructured":"Ifergan, I. et al. Targeting the GM-CSF receptor for the treatment of CNS autoimmunity. J. Autoimmun. 84, 1\u201311 (2017).","journal-title":"J. Autoimmun."},{"key":"1471_CR680","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1084\/jem.20071119","volume":"205","author":"I Sonderegger","year":"2008","unstructured":"Sonderegger, I. et al. GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J. Exp. Med. 205, 2281\u20132294 (2008).","journal-title":"J. Exp. Med."},{"key":"1471_CR681","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.4049\/jimmunol.1403243","volume":"194","author":"J Rasouli","year":"2015","unstructured":"Rasouli, J. et al. Expression of GM-CSF in T cells is increased in multiple sclerosis and suppressed by IFN-beta therapy. J. Immunol. 194, 5085\u20135093 (2015).","journal-title":"J. Immunol."},{"key":"1471_CR682","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/08923979809034820","volume":"20","author":"PB Carrieri","year":"1998","unstructured":"Carrieri, P. B. et al. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity. Immunopharmacol. Immunotoxicol. 20, 373\u2013382 (1998).","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"1471_CR683","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.immuni.2015.08.010","volume":"43","author":"AL Croxford","year":"2015","unstructured":"Croxford, A. L. et al. The cytokine GM-CSF drives the inflammatory signature of CCR2+ monocytes and licenses autoimmunity. Immunity 43, 502\u2013514 (2015).","journal-title":"Immunity"},{"key":"1471_CR684","first-page":"73","volume":"53","author":"A Rosu","year":"2012","unstructured":"Rosu, A. et al. IL-17 patterns in synovium, serum and synovial fluid from treatment-naive, early rheumatoid arthritis patients. Rom. J. Morphol. Embryol. 53, 73\u201380 (2012).","journal-title":"Rom. J. Morphol. Embryol."},{"key":"1471_CR685","doi-asserted-by":"publisher","first-page":"R93","DOI":"10.1186\/ar2477","volume":"10","author":"S Shahrara","year":"2008","unstructured":"Shahrara, S., Huang, Q., Mandelin, A. M. 2nd & Pope, R. M. TH-17 cells in rheumatoid arthritis. Arthritis Res. Ther. 10, R93 (2008).","journal-title":"Arthritis Res. Ther."},{"key":"1471_CR686","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3343\/alm.2013.33.1.52","volume":"33","author":"J Kim","year":"2013","unstructured":"Kim, J. et al. Elevated levels of T helper 17 cells are associated with disease activity in patients with rheumatoid arthritis. Ann. Lab Med. 33, 52\u201359 (2013).","journal-title":"Ann. Lab Med."},{"key":"1471_CR687","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10067-011-1737-y","volume":"30","author":"SA Metawi","year":"2011","unstructured":"Metawi, S. A., Abbas, D., Kamal, M. M. & Ibrahim, M. K. Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clin. Rheumatol. 30, 1201\u20131207 (2011).","journal-title":"Clin. Rheumatol."},{"key":"1471_CR688","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00281-019-00733-8","volume":"41","author":"K Yasuda","year":"2019","unstructured":"Yasuda, K., Takeuchi, Y. & Hirota, K. The pathogenicity of Th17 cells in autoimmune diseases. Semin. Immunopathol. 41, 283\u2013297 (2019).","journal-title":"Semin. Immunopathol."},{"key":"1471_CR689","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1084\/jem.20071397","volume":"204","author":"K Hirota","year":"2007","unstructured":"Hirota, K. et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204, 2803\u20132812 (2007).","journal-title":"J. Exp. Med."},{"key":"1471_CR690","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1186\/ar3238","volume":"13","author":"H Ito","year":"2011","unstructured":"Ito, H. et al. Dual role of interleukin-17 in pannus growth and osteoclastogenesis in rheumatoid arthritis. Arthritis Res. Ther. 13, R14 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"1471_CR691","doi-asserted-by":"publisher","first-page":"R246","DOI":"10.1186\/ar4089","volume":"14","author":"YM Moon","year":"2012","unstructured":"Moon, Y. M. et al. IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis. Arthritis Res. Ther. 14, R246 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"1471_CR692","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.4049\/jimmunol.0903271","volume":"184","author":"SR Pickens","year":"2010","unstructured":"Pickens, S. R. et al. IL-17 contributes to angiogenesis in rheumatoid arthritis. J. Immunol. 184, 3233\u20133241 (2010).","journal-title":"J. Immunol."},{"key":"1471_CR693","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1084\/jem.20061775","volume":"203","author":"K Sato","year":"2006","unstructured":"Sato, K. et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203, 2673\u20132682 (2006).","journal-title":"J. Exp. Med."},{"key":"1471_CR694","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/art.30278","volume":"63","author":"A Saxena","year":"2011","unstructured":"Saxena, A., Raychaudhuri, S. K. & Raychaudhuri, S. P. Interleukin-17-induced proliferation of fibroblast-like synovial cells is mTOR dependent. Arthritis Rheum. 63, 1465\u20131466 (2011).","journal-title":"Arthritis Rheum."},{"key":"1471_CR695","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.immuni.2018.04.009","volume":"48","author":"K Hirota","year":"2018","unstructured":"Hirota, K. et al. Autoimmune Th17 cells induced synovial stromal and innate lymphoid cell secretion of the cytokine GM-CSF to initiate and augment autoimmune arthritis. Immunity 48, 1220\u20131232 e1225 (2018).","journal-title":"Immunity"},{"key":"1471_CR696","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos, G. C. Systemic lupus erythematosus. N. Engl. J. Med. 365, 2110\u20132121 (2011).","journal-title":"N. Engl. J. Med."},{"key":"1471_CR697","doi-asserted-by":"crossref","unstructured":"Fava, A. & Rao, D. A. Cellular and molecular heterogeneity in systemic lupus erythematosus. Semin. Immunol. 58, 101653 (2022).","DOI":"10.1016\/j.smim.2022.101653"},{"key":"1471_CR698","doi-asserted-by":"publisher","first-page":"624971","DOI":"10.3389\/fimmu.2020.624971","volume":"11","author":"T Koga","year":"2020","unstructured":"Koga, T., Ichinose, K., Kawakami, A. & Tsokos, G. C. Current insights and future prospects for targeting IL-17 to treat patients with systemic lupus erythematosus. Front. Immunol. 11, 624971 (2020).","journal-title":"Front. Immunol."},{"key":"1471_CR699","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1172\/JCI78085","volume":"125","author":"PR Burkett","year":"2015","unstructured":"Burkett, P. R., Meyer zu Horste, G. & Kuchroo, V. K. Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity. J. Clin. Invest. 125, 2211\u20132219 (2015).","journal-title":"J. Clin. Invest."},{"key":"1471_CR700","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.clim.2008.01.019","volume":"127","author":"CK Wong","year":"2008","unstructured":"Wong, C. K. et al. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin. Immunol. 127, 385\u2013393 (2008).","journal-title":"Clin. Immunol."},{"key":"1471_CR701","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cellimm.2010.05.004","volume":"264","author":"A Henriques","year":"2010","unstructured":"Henriques, A. et al. Frequency and functional activity of Th17, Tc17 and other T-cell subsets in systemic lupus erythematosus. Cell Immunol. 264, 97\u2013103 (2010).","journal-title":"Cell Immunol."},{"key":"1471_CR702","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10875-009-9365-x","volume":"30","author":"XQ Chen","year":"2010","unstructured":"Chen, X. Q. et al. Plasma IL-17A is increased in new-onset SLE patients and associated with disease activity. J. Clin. Immunol. 30, 221\u2013225 (2010).","journal-title":"J. Clin. Immunol."},{"key":"1471_CR703","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12865-015-0070-7","volume":"16","author":"A Zickert","year":"2015","unstructured":"Zickert, A. et al. IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment. BMC Immunol. 16, 7 (2015).","journal-title":"BMC Immunol."},{"key":"1471_CR704","first-page":"819467","volume":"2012","author":"JC Waite","year":"2012","unstructured":"Waite, J. C. & Skokos, D. Th17 response and inflammatory autoimmune diseases. Int. J. Inflam. 2012, 819467 (2012).","journal-title":"Int. J. Inflam."},{"key":"1471_CR705","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.immuni.2012.08.014","volume":"37","author":"P Pisitkun","year":"2012","unstructured":"Pisitkun, P. et al. Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity 37, 1104\u20131115 (2012).","journal-title":"Immunity"},{"key":"1471_CR706","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrrheum.2015.53","volume":"11","author":"E Lubberts","year":"2015","unstructured":"Lubberts, E. The IL-23-IL-17 axis in inflammatory arthritis. Nat. Rev. Rheumatol. 11, 415\u2013429 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1471_CR707","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.it.2012.05.004","volume":"33","author":"F Annunziato","year":"2012","unstructured":"Annunziato, F. et al. Defining the human T helper 17 cell phenotype. Trends Immunol. 33, 505\u2013512 (2012).","journal-title":"Trends Immunol."},{"key":"1471_CR708","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni.2416","volume":"13","author":"Y Lee","year":"2012","unstructured":"Lee, Y. et al. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13, 991\u2013999 (2012).","journal-title":"Nat. Immunol."},{"key":"1471_CR709","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.molimm.2018.11.015","volume":"105","author":"AN Kamali","year":"2019","unstructured":"Kamali, A. N. et al. A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders. Mol. Immunol. 105, 107\u2013115 (2019).","journal-title":"Mol. Immunol."},{"key":"1471_CR710","doi-asserted-by":"publisher","first-page":"14751","DOI":"10.1073\/pnas.1003852107","volume":"107","author":"K Nistala","year":"2010","unstructured":"Nistala, K. et al. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc. Natl Acad. Sci. USA 107, 14751\u201314756 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR711","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1172\/JCI37865","volume":"119","author":"D Bending","year":"2009","unstructured":"Bending, D. et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD\/SCID recipient mice. J. Clin. Invest. 119, 565\u2013572 (2009).","journal-title":"J. Clin. Invest."},{"key":"1471_CR712","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.jaci.2016.11.045","volume":"140","author":"M Paroni","year":"2017","unstructured":"Paroni, M. et al. Recognition of viral and self-antigens by TH1 and TH1\/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses. J. Allergy Clin. Immunol. 140, 797\u2013808 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1471_CR713","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.cell.2015.11.009","volume":"163","author":"JT Gaublomme","year":"2015","unstructured":"Gaublomme, J. T. et al. Single-cell genomics unveils critical regulators of Th17 cell pathogenicity. Cell 163, 1400\u20131412 (2015).","journal-title":"Cell"},{"key":"1471_CR714","doi-asserted-by":"publisher","first-page":"819224","DOI":"10.3389\/fimmu.2022.819224","volume":"13","author":"L Hou","year":"2022","unstructured":"Hou, L. & Yuki, K. CCR6 and CXCR6 identify the Th17 cells with cytotoxicity in experimental autoimmune encephalomyelitis. Front. Immunol. 13, 819224 (2022).","journal-title":"Front. Immunol."},{"key":"1471_CR715","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1016\/j.cell.2021.11.018","volume":"184","author":"A Schnell","year":"2021","unstructured":"Schnell, A. et al. Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity. Cell 184, 6281\u20136298 e6223 (2021).","journal-title":"Cell"},{"key":"1471_CR716","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0335-3","volume":"12","author":"G Perriard","year":"2015","unstructured":"Perriard, G. et al. Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes. J. Neuroinflammation 12, 119 (2015).","journal-title":"J. Neuroinflammation"},{"key":"1471_CR717","first-page":"400","volume":"37","author":"X Yang","year":"2019","unstructured":"Yang, X. et al. Increased interleukin-22 levels in lupus nephritis and its associated with disease severity: a study in both patients and lupus-like mice model. Clin. Exp. Rheumatol. 37, 400\u2013407 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1471_CR718","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s10875-011-9540-8","volume":"31","author":"L Zhang","year":"2011","unstructured":"Zhang, L. et al. Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. J. Clin. Immunol. 31, 606\u2013614 (2011).","journal-title":"J. Clin. Immunol."},{"key":"1471_CR719","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cellimm.2014.06.007","volume":"290","author":"L Luan","year":"2014","unstructured":"Luan, L. et al. An increased proportion of circulating Th22 and Tc22 cells in psoriasis. Cell Immunol. 290, 196\u2013200 (2014).","journal-title":"Cell Immunol."},{"key":"1471_CR720","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.humimm.2012.04.015","volume":"73","author":"Y Hu","year":"2012","unstructured":"Hu, Y. et al. Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia. Hum. Immunol. 73, 629\u2013635 (2012).","journal-title":"Hum. Immunol."},{"key":"1471_CR721","doi-asserted-by":"publisher","first-page":"3753081","DOI":"10.1155\/2018\/3753081","volume":"2018","author":"M Liang","year":"2018","unstructured":"Liang, M. et al. The Imbalance between Foxp3(+)Tregs and Th1\/Th17\/Th22 Cells in Patients with Newly Diagnosed Autoimmune Hepatitis. J. Immunol. Res. 2018, 3753081 (2018).","journal-title":"J. Immunol. Res."},{"key":"1471_CR722","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12020-017-1361-y","volume":"57","author":"M Vitales-Noyola","year":"2017","unstructured":"Vitales-Noyola, M. et al. Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders. Endocrine 57, 409\u2013417 (2017).","journal-title":"Endocrine"},{"key":"1471_CR723","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000490855","volume":"25","author":"B Robat-Jazi","year":"2018","unstructured":"Robat-Jazi, B. et al. High frequency of Tc22 and Th22 cells in myasthenia gravis patients and their significant reduction after thymectomy. Neuroimmunomodulation 25, 80\u201388 (2018).","journal-title":"Neuroimmunomodulation"},{"key":"1471_CR724","doi-asserted-by":"publisher","first-page":"R166","DOI":"10.1186\/ar3486","volume":"13","author":"ME Truchetet","year":"2011","unstructured":"Truchetet, M. E. et al. Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Res. Ther. 13, R166 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"1471_CR725","doi-asserted-by":"publisher","first-page":"e0173780","DOI":"10.1371\/journal.pone.0173780","volume":"12","author":"N Muls","year":"2017","unstructured":"Muls, N. et al. IL-22, GM-CSF and IL-17 in peripheral CD4+ T cell subpopulations during multiple sclerosis relapses and remission. Impact of corticosteroid therapy. PLoS ONE 12, e0173780 (2017).","journal-title":"PLoS ONE"},{"key":"1471_CR726","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1189\/jlb.5A0813-463RR","volume":"96","author":"S Rolla","year":"2014","unstructured":"Rolla, S. et al. Th22 cells are expanded in multiple sclerosis and are resistant to IFN-beta. J. Leukoc. Biol. 96, 1155\u20131164 (2014).","journal-title":"J. Leukoc. Biol."},{"key":"1471_CR727","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.molimm.2016.12.020","volume":"82","author":"J Zhen","year":"2017","unstructured":"Zhen, J. et al. IL-22 promotes Fas expression in oligodendrocytes and inhibits FOXP3 expression in T cells by activating the NF-kappaB pathway in multiple sclerosis. Mol. Immunol. 82, 84\u201393 (2017).","journal-title":"Mol. Immunol."},{"key":"1471_CR728","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10875-013-9878-1","volume":"33","author":"XY Yang","year":"2013","unstructured":"Yang, X. Y. et al. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus. J. Clin. Immunol. 33, 767\u2013774 (2013).","journal-title":"J. Clin. Immunol."},{"key":"1471_CR729","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/1535370213477597","volume":"238","author":"L Zhao","year":"2013","unstructured":"Zhao, L. et al. IL-22+CD4+ T-cells in patients with active systemic lupus erythematosus. Exp. Biol. Med. 238, 193\u2013199 (2013).","journal-title":"Exp. Biol. Med."},{"key":"1471_CR730","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13344-w","volume":"7","author":"W Zhong","year":"2017","unstructured":"Zhong, W. et al. Elevated levels of CCR6(+) T helper 22 cells correlate with skin and renal impairment in systemic lupus erythematosus. Sci. Rep. 7, 12962 (2017).","journal-title":"Sci. Rep."},{"key":"1471_CR731","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.3389\/fimmu.2018.02901","volume":"9","author":"Y Miyazaki","year":"2018","unstructured":"Miyazaki, Y. et al. Th22 cells promote osteoclast differentiation via production of IL-22 in rheumatoid arthritis. Front. Immunol. 9, 2901 (2018).","journal-title":"Front. Immunol."},{"key":"1471_CR732","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/art.20965","volume":"52","author":"H Ikeuchi","year":"2005","unstructured":"Ikeuchi, H. et al. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum. 52, 1037\u20131046 (2005).","journal-title":"Arthritis Rheum."},{"key":"1471_CR733","first-page":"798","volume":"36","author":"H Wen","year":"2018","unstructured":"Wen, H. et al. Inhibitory effect and mechanism of 1,25-dihydroxy vitamin D3 on RANKL expression in fibroblast-like synoviocytes and osteoclast-like cell formation induced by IL-22 in rheumatoid arthritis. Clin. Exp. Rheumatol. 36, 798\u2013805 (2018).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1471_CR734","doi-asserted-by":"publisher","first-page":"688066","DOI":"10.3389\/fimmu.2021.688066","volume":"12","author":"Q Jiang","year":"2021","unstructured":"Jiang, Q. et al. Role of Th22 cells in the pathogenesis of autoimmune diseases. Front. Immunol. 12, 688066 (2021).","journal-title":"Front. Immunol."},{"key":"1471_CR735","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1136\/gutjnl-2013-305947","volume":"64","author":"N Nalleweg","year":"2015","unstructured":"Nalleweg, N. et al. IL-9 and its receptor are predominantly involved in the pathogenesis of UC. Gut 64, 743\u2013755 (2015).","journal-title":"Gut"},{"key":"1471_CR736","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ni.2920","volume":"15","author":"K Gerlach","year":"2014","unstructured":"Gerlach, K. et al. TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat. Immunol. 15, 676\u2013686 (2014).","journal-title":"Nat. Immunol."},{"key":"1471_CR737","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3892\/mmr.2013.1258","volume":"7","author":"H Ouyang","year":"2013","unstructured":"Ouyang, H. et al. Increased interleukin\u20119 and CD4+IL-9+ T cells in patients with systemic lupus erythematosus. Mol. Med. Rep. 7, 1031\u20131037 (2013).","journal-title":"Mol. Med. Rep."},{"key":"1471_CR738","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1093\/rheumatology\/kev252","volume":"54","author":"F Ciccia","year":"2015","unstructured":"Ciccia, F. et al. Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis. Rheumatology 54, 2264\u20132272 (2015).","journal-title":"Rheumatology"},{"key":"1471_CR739","doi-asserted-by":"publisher","first-page":"e51752","DOI":"10.1371\/journal.pone.0051752","volume":"8","author":"TP Singh","year":"2013","unstructured":"Singh, T. P. et al. Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis. PLoS ONE 8, e51752 (2013).","journal-title":"PLoS ONE"},{"key":"1471_CR740","doi-asserted-by":"publisher","first-page":"6503539","DOI":"10.1155\/2020\/6503539","volume":"2020","author":"Q Shao","year":"2020","unstructured":"Shao, Q. et al. Th9 cells in peripheral blood increased in patients with immune-related pancytopenia. J. Immunol. Res. 2020, 6503539 (2020).","journal-title":"J. Immunol. Res."},{"key":"1471_CR741","doi-asserted-by":"publisher","first-page":"104096","DOI":"10.1016\/j.cellimm.2020.104096","volume":"351","author":"M Kostic","year":"2020","unstructured":"Kostic, M., Zivkovic, N., Cvetanovic, A. & Marjanovic, G. CD4(+) T cell phenotypes in the pathogenesis of immune thrombocytopenia. Cell Immunol. 351, 104096 (2020).","journal-title":"Cell Immunol."},{"key":"1471_CR742","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cytogfr.2013.09.001","volume":"24","author":"HF Pan","year":"2013","unstructured":"Pan, H. F. et al. Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases. Cytokine Growth Factor Rev. 24, 515\u2013522 (2013).","journal-title":"Cytokine Growth Factor Rev."},{"key":"1471_CR743","doi-asserted-by":"publisher","first-page":"7169","DOI":"10.4049\/jimmunol.0901906","volume":"183","author":"A Jager","year":"2009","unstructured":"Jager, A. et al. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183, 7169\u20137177 (2009).","journal-title":"J. Immunol."},{"key":"1471_CR744","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/eji.201041125","volume":"41","author":"H Li","year":"2011","unstructured":"Li, H. et al. IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system. Eur. J. Immunol. 41, 2197\u20132206 (2011).","journal-title":"Eur. J. Immunol."},{"key":"1471_CR745","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.4049\/jimmunol.1000986","volume":"185","author":"H Li","year":"2010","unstructured":"Li, H. et al. Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population. J. Immunol. 185, 4095\u20134100 (2010).","journal-title":"J. Immunol."},{"key":"1471_CR746","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1084\/jem.20090246","volume":"206","author":"EC Nowak","year":"2009","unstructured":"Nowak, E. C. et al. IL-9 as a mediator of Th17-driven inflammatory disease. J. Exp. Med. 206, 1653\u20131660 (2009).","journal-title":"J. Exp. Med."},{"key":"1471_CR747","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.4049\/jimmunol.1003307","volume":"186","author":"Y Zhou","year":"2011","unstructured":"Zhou, Y. et al. IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes. J. Immunol. 186, 4415\u20134421 (2011).","journal-title":"J. Immunol."},{"key":"1471_CR748","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.humimm.2016.12.010","volume":"78","author":"Y Deng","year":"2017","unstructured":"Deng, Y. et al. Th9 cells and IL-9 in autoimmune disorders: pathogenesis and therapeutic potentials. Hum. Immunol. 78, 120\u2013128 (2017).","journal-title":"Hum. Immunol."},{"key":"1471_CR749","doi-asserted-by":"publisher","first-page":"519638","DOI":"10.1155\/2015\/519638","volume":"2015","author":"AT Dantas","year":"2015","unstructured":"Dantas, A. T. et al. Increased serum interleukin-9 levels in rheumatoid arthritis and systemic lupus erythematosus: pathogenic role or just an epiphenomenon? Dis. Markers 2015, 519638 (2015).","journal-title":"Dis. Markers"},{"key":"1471_CR750","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2119\/molmed.2014.00237","volume":"21","author":"J Yang","year":"2015","unstructured":"Yang, J., Li, Q., Yang, X. & Li, M. Interleukin-9 is associated with elevated anti-double-stranded DNA antibodies in lupus-prone mice. Mol. Med. 21, 364\u2013370 (2015).","journal-title":"Mol. Med."},{"key":"1471_CR751","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/ar3045","volume":"12","author":"G Nagy","year":"2010","unstructured":"Nagy, G. et al. Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res. Ther. 12, 210 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"1471_CR752","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5575","volume":"5","author":"W Niedbala","year":"2014","unstructured":"Niedbala, W. et al. Nitric oxide enhances Th9 cell differentiation and airway inflammation. Nat. Commun. 5, 4575 (2014).","journal-title":"Nat. Commun."},{"key":"1471_CR753","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3389\/fimmu.2019.01120","volume":"10","author":"S Roy","year":"2019","unstructured":"Roy, S. & Awasthi, A. ATP triggers human Th9 cell differentiation via nitric oxide-mediated mTOR-HIF1alpha pathway. Front. Immunol. 10, 1120 (2019).","journal-title":"Front. Immunol."},{"key":"1471_CR754","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13075-017-1505-8","volume":"20","author":"K Chowdhury","year":"2018","unstructured":"Chowdhury, K. et al. Synovial IL-9 facilitates neutrophil survival, function and differentiation of Th17 cells in rheumatoid arthritis. Arthritis Res. Ther. 20, 18 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"1471_CR755","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/eji.201040879","volume":"41","author":"GL Stephens","year":"2011","unstructured":"Stephens, G. L. et al. IL-9 is a Th17-derived cytokine that limits pathogenic activity in organ-specific autoimmune disease. Eur. J. Immunol. 41, 952\u2013962 (2011).","journal-title":"Eur. J. Immunol."},{"key":"1471_CR756","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1042\/CS20140608","volume":"129","author":"G Ruocco","year":"2015","unstructured":"Ruocco, G. et al. T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis. Clin. Sci. 129, 291\u2013303 (2015).","journal-title":"Clin. Sci."},{"key":"1471_CR757","doi-asserted-by":"publisher","first-page":"12885","DOI":"10.1073\/pnas.0812530106","volume":"106","author":"W Elyaman","year":"2009","unstructured":"Elyaman, W. et al. IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc. Natl Acad. Sci. USA 106, 12885\u201312890 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR758","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature03555","volume":"435","author":"CG Vinuesa","year":"2005","unstructured":"Vinuesa, C. G. et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435, 452\u2013458 (2005).","journal-title":"Nature"},{"key":"1471_CR759","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nature07345","volume":"455","author":"H Qi","year":"2008","unstructured":"Qi, H. et al. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature 455, 764\u2013769 (2008).","journal-title":"Nature"},{"key":"1471_CR760","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1084\/jem.20081886","volume":"206","author":"MA Linterman","year":"2009","unstructured":"Linterman, M. A. et al. Follicular helper T cells are required for systemic autoimmunity. J. Exp. Med. 206, 561\u2013576 (2009).","journal-title":"J. Exp. Med."},{"key":"1471_CR761","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3389\/fimmu.2018.01637","volume":"9","author":"N Gensous","year":"2018","unstructured":"Gensous, N. et al. T follicular helper cells in autoimmune disorders. Front. Immunol. 9, 1637 (2018).","journal-title":"Front. Immunol."},{"key":"1471_CR762","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/ni.3054","volume":"16","author":"H Ueno","year":"2015","unstructured":"Ueno, H., Banchereau, J. & Vinuesa, C. G. Pathophysiology of T follicular helper cells in humans and mice. Nat. Immunol. 16, 142\u2013152 (2015).","journal-title":"Nat. Immunol."},{"key":"1471_CR763","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41577-022-00693-5","volume":"22","author":"LSK Walker","year":"2022","unstructured":"Walker, L. S. K. The link between circulating follicular helper T cells and autoimmunity. Nat. Rev. Immunol. 22, 567\u2013575 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR764","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrrheum.2015.151","volume":"12","author":"DS Pisetsky","year":"2016","unstructured":"Pisetsky, D. S. Anti-DNA antibodies\u2013quintessential biomarkers of SLE. Nat. Rev. Rheumatol. 12, 102\u2013110 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1471_CR765","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.immuni.2013.09.007","volume":"39","author":"J He","year":"2013","unstructured":"He, J. et al. Circulating precursor CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity 39, 770\u2013781 (2013).","journal-title":"Immunity"},{"key":"1471_CR766","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1177\/0961203314567750","volume":"24","author":"X Zhang","year":"2015","unstructured":"Zhang, X. et al. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production. Lupus 24, 909\u2013917 (2015).","journal-title":"Lupus"},{"key":"1471_CR767","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.4049\/jimmunol.1001983","volume":"186","author":"A Chang","year":"2011","unstructured":"Chang, A. et al. In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. J. Immunol. 186, 1849\u20131860 (2011).","journal-title":"J. Immunol."},{"key":"1471_CR768","doi-asserted-by":"publisher","first-page":"230ra246","DOI":"10.1126\/scitranslmed.3008146","volume":"6","author":"VM Liarski","year":"2014","unstructured":"Liarski, V. M. et al. Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue. Sci. Transl. Med. 6, 230ra246 (2014).","journal-title":"Sci. Transl. Med."},{"key":"1471_CR769","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.immuni.2007.01.009","volume":"26","author":"T Tiller","year":"2007","unstructured":"Tiller, T. et al. Autoreactivity in human IgG+ memory B cells. Immunity 26, 205\u2013213 (2007).","journal-title":"Immunity"},{"key":"1471_CR770","doi-asserted-by":"publisher","first-page":"5095","DOI":"10.1007\/s00018-021-03839-1","volume":"78","author":"J Lu","year":"2021","unstructured":"Lu, J. et al. Follicular helper T cells: potential therapeutic targets in rheumatoid arthritis. Cell Mol. Life Sci. 78, 5095\u20135106 (2021).","journal-title":"Cell Mol. Life Sci."},{"key":"1471_CR771","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08935-6","volume":"7","author":"GL Moschovakis","year":"2017","unstructured":"Moschovakis, G. L. et al. T cell specific Cxcr5 deficiency prevents rheumatoid arthritis. Sci. Rep. 7, 8933 (2017).","journal-title":"Sci. Rep."},{"key":"1471_CR772","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/apm.12399","volume":"123","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y. et al. Elevated circulating Th17 and follicular helper CD4(+) T cells in patients with rheumatoid arthritis. APMIS 123, 659\u2013666 (2015).","journal-title":"APMIS"},{"key":"1471_CR773","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/cei.12162","volume":"174","author":"J Wang","year":"2013","unstructured":"Wang, J. et al. High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new-onset rheumatoid arthritis. Clin. Exp. Immunol. 174, 212\u2013220 (2013).","journal-title":"Clin. Exp. Immunol."},{"key":"1471_CR774","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1002\/art.23966","volume":"58","author":"A Manzo","year":"2008","unstructured":"Manzo, A. et al. Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint. Arthritis Rheum. 58, 3377\u20133387 (2008).","journal-title":"Arthritis Rheum."},{"key":"1471_CR775","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature20810","volume":"542","author":"DA Rao","year":"2017","unstructured":"Rao, D. A. et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature 542, 110\u2013114 (2017).","journal-title":"Nature"},{"key":"1471_CR776","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/rheumatology\/kex012","volume":"57","author":"S Nakayamada","year":"2018","unstructured":"Nakayamada, S. et al. Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis. Rheumatology 57, 164\u2013174 (2018).","journal-title":"Rheumatology"},{"key":"1471_CR777","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.4049\/jimmunol.1001311","volume":"185","author":"AM Platt","year":"2010","unstructured":"Platt, A. M. et al. Abatacept limits breach of self-tolerance in a murine model of arthritis via effects on the generation of T follicular helper cells. J. Immunol. 185, 1558\u20131567 (2010).","journal-title":"J. Immunol."},{"key":"1471_CR778","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fimmu.2018.00382","volume":"9","author":"JL Quinn","year":"2018","unstructured":"Quinn, J. L. et al. Role of TFH cells in promoting T helper 17-induced neuroinflammation. Front. Immunol. 9, 382 (2018).","journal-title":"Front. Immunol."},{"key":"1471_CR779","doi-asserted-by":"publisher","first-page":"e0134523","DOI":"10.1371\/journal.pone.0134523","volume":"10","author":"X Fan","year":"2015","unstructured":"Fan, X. et al. Circulating CCR7+ICOS+ memory T follicular helper cells in patients with multiple sclerosis. PLoS ONE 10, e0134523 (2015).","journal-title":"PLoS ONE"},{"key":"1471_CR780","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41584-019-0254-2","volume":"15","author":"J Deng","year":"2019","unstructured":"Deng, J. et al. T follicular helper cells and T follicular regulatory cells in rheumatic diseases. Nat. Rev. Rheumatol. 15, 475\u2013490 (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1471_CR781","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1084\/jem.20080840","volume":"205","author":"JM Odegard","year":"2008","unstructured":"Odegard, J. M. et al. ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J. Exp. Med. 205, 2873\u20132886 (2008).","journal-title":"J. Exp. Med."},{"key":"1471_CR782","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.immuni.2020.04.015","volume":"52","author":"C Soni","year":"2020","unstructured":"Soni, C. et al. Plasmacytoid dendritic cells and type I interferon promote extrafollicular B cell responses to extracellular self-DNA. Immunity 52, 1022\u20131038 e1027 (2020).","journal-title":"Immunity"},{"key":"1471_CR783","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1172\/JCI76238","volume":"125","author":"R Kenefeck","year":"2015","unstructured":"Kenefeck, R. et al. Follicular helper T cell signature in type 1 diabetes. J. Clin. Invest. 125, 292\u2013303 (2015).","journal-title":"J. Clin. Invest."},{"key":"1471_CR784","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00125-015-3509-8","volume":"58","author":"RC Ferreira","year":"2015","unstructured":"Ferreira, R. C. et al. IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients. Diabetologia 58, 781\u2013790 (2015).","journal-title":"Diabetologia"},{"key":"1471_CR785","doi-asserted-by":"publisher","first-page":"e79858","DOI":"10.1371\/journal.pone.0079858","volume":"8","author":"X Xu","year":"2013","unstructured":"Xu, X. et al. Inhibition of increased circulating Tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes. PLoS ONE 8, e79858 (2013).","journal-title":"PLoS ONE"},{"key":"1471_CR786","first-page":"E4142","volume":"115","author":"Correction for Serr.","year":"2018","unstructured":"Correction for Serr. et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc. Natl Acad. Sci. USA 115, E4142 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR787","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2337\/db16-0714","volume":"66","author":"T Viisanen","year":"2017","unstructured":"Viisanen, T. et al. Circulating CXCR5+PD-1+ICOS+ follicular T helper cells are increased close to the diagnosis of type 1 diabetes in children with multiple autoantibodies. Diabetes 66, 437\u2013447 (2017).","journal-title":"Diabetes"},{"key":"1471_CR788","doi-asserted-by":"publisher","first-page":"102689","DOI":"10.1016\/j.jaut.2021.102689","volume":"122","author":"HM Ren","year":"2021","unstructured":"Ren, H. M., Lukacher, A. E., Rahman, Z. S. M. & Olsen, N. J. New developments implicating IL-21 in autoimmune disease. J. Autoimmun. 122, 102689 (2021).","journal-title":"J. Autoimmun."},{"key":"1471_CR789","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","volume":"34","author":"R Morita","year":"2011","unstructured":"Morita, R. et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34, 108\u2013121 (2011).","journal-title":"Immunity"},{"key":"1471_CR790","first-page":"81","volume":"77","author":"A Ali Abdulla","year":"2022","unstructured":"Ali Abdulla, A., Abdulaali Abed, T. & Razzaq Abdul-Ameer, W. Impact of IL-21 gene polymorphisms (rs2055979) and the levels of serum IL-21 on the risk of multiple sclerosis. Arch. Razi Inst. 77, 81\u201386 (2022).","journal-title":"Arch. Razi Inst."},{"key":"1471_CR791","doi-asserted-by":"publisher","first-page":"100460","DOI":"10.1016\/j.jhepr.2022.100460","volume":"4","author":"M Biewenga","year":"2022","unstructured":"Biewenga, M. et al. B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis. JHEP Rep. 4, 100460 (2022).","journal-title":"JHEP Rep."},{"key":"1471_CR792","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/08916934.2020.1736047","volume":"53","author":"E Iervasi","year":"2020","unstructured":"Iervasi, E. et al. Serum IL-21 levels from celiac disease patients correlates with anti-tTG IgA autoantibodies and mucosal damage. Autoimmunity 53, 225\u2013230 (2020).","journal-title":"Autoimmunity"},{"key":"1471_CR793","doi-asserted-by":"publisher","first-page":"7867","DOI":"10.4049\/jimmunol.175.12.7867","volume":"175","author":"R Ettinger","year":"2005","unstructured":"Ettinger, R. et al. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 175, 7867\u20137879 (2005).","journal-title":"J. Immunol."},{"key":"1471_CR794","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.4049\/jimmunol.179.9.5886","volume":"179","author":"S Kuchen","year":"2007","unstructured":"Kuchen, S. et al. Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J. Immunol. 179, 5886\u20135896 (2007).","journal-title":"J. Immunol."},{"key":"1471_CR795","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.2337\/db08-0882","volume":"58","author":"AP Sutherland","year":"2009","unstructured":"Sutherland, A. P. et al. Interleukin-21 is required for the development of type 1 diabetes in NOD mice. Diabetes 58, 1144\u20131155 (2009).","journal-title":"Diabetes"},{"key":"1471_CR796","doi-asserted-by":"publisher","first-page":"14028","DOI":"10.1073\/pnas.0804358105","volume":"105","author":"R Spolski","year":"2008","unstructured":"Spolski, R. et al. IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc. Natl Acad. Sci. USA 105, 14028\u201314033 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR797","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/art.33390","volume":"64","author":"SK Kwok","year":"2012","unstructured":"Kwok, S. K. et al. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis. Arthritis Rheum. 64, 740\u2013751 (2012).","journal-title":"Arthritis Rheum."},{"key":"1471_CR798","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/cei.12751","volume":"184","author":"R Xing","year":"2016","unstructured":"Xing, R. et al. Interleukin-21 induces migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis. Clin. Exp. Immunol. 184, 147\u2013158 (2016).","journal-title":"Clin. Exp. Immunol."},{"key":"1471_CR799","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/sji.12396","volume":"83","author":"R Xing","year":"2016","unstructured":"Xing, R. et al. Interleukin-21 induces proliferation and proinflammatory cytokine profile of fibroblast-like synoviocytes of patients with rheumatoid arthritis. Scand. J. Immunol. 83, 64\u201371 (2016).","journal-title":"Scand. J. Immunol."},{"key":"1471_CR800","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/nm.1995","volume":"15","author":"R Caruso","year":"2009","unstructured":"Caruso, R. et al. Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat. Med. 15, 1013\u20131015 (2009).","journal-title":"Nat. Med."},{"key":"1471_CR801","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/art.20218","volume":"50","author":"A Jungel","year":"2004","unstructured":"Jungel, A. et al. Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis. Arthritis Rheum. 50, 1468\u20131476 (2004).","journal-title":"Arthritis Rheum."},{"key":"1471_CR802","doi-asserted-by":"publisher","first-page":"732","DOI":"10.4049\/jimmunol.178.2.732","volume":"178","author":"I Peluso","year":"2007","unstructured":"Peluso, I. et al. IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. J. Immunol. 178, 732\u2013739 (2007).","journal-title":"J. Immunol."},{"key":"1471_CR803","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.4049\/jimmunol.180.8.5393","volume":"180","author":"LE Clough","year":"2008","unstructured":"Clough, L. E. et al. Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21. J. Immunol. 180, 5393\u20135401 (2008).","journal-title":"J. Immunol."},{"key":"1471_CR804","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s13311-022-01279-8","volume":"19","author":"A Edo","year":"2022","unstructured":"Edo, A. et al. Therapeutic effect of IL-21 blockage by gene therapy in experimental autoimmune encephalomyelitis. Neurotherapeutics 19, 1617\u20131633 (2022).","journal-title":"Neurotherapeutics"},{"key":"1471_CR805","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.4049\/jimmunol.1601687","volume":"198","author":"JY Choi","year":"2017","unstructured":"Choi, J. Y. et al. Disruption of pathogenic cellular networks by IL-21 blockade leads to disease amelioration in murine lupus. J. Immunol. 198, 2578\u20132588 (2017).","journal-title":"J. Immunol."},{"key":"1471_CR806","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1002\/art.39233","volume":"67","author":"M Zhang","year":"2015","unstructured":"Zhang, M. et al. Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB x NZW)F1 systemic lupus erythematosus model. Arthritis Rheumatol. 67, 2723\u20132731 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"1471_CR807","doi-asserted-by":"publisher","first-page":"e51982","DOI":"10.1371\/journal.pone.0051982","volume":"7","author":"X Feng","year":"2012","unstructured":"Feng, X. et al. Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus. PLoS ONE 7, e51982 (2012).","journal-title":"PLoS ONE"},{"key":"1471_CR808","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nm.4148","volume":"22","author":"J He","year":"2016","unstructured":"He, J. et al. Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus. Nat. Med. 22, 991\u2013993 (2016).","journal-title":"Nat. Med."},{"key":"1471_CR809","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","volume":"78","author":"M Rosenzwajg","year":"2019","unstructured":"Rosenzwajg, M. et al. Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial. Ann. Rheum. Dis. 78, 209\u2013217 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"1471_CR810","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.3389\/fimmu.2019.02608","volume":"10","author":"CC Qiu","year":"2019","unstructured":"Qiu, C. C., Caricchio, R. & Gallucci, S. Triggers of autoimmunity: the role of bacterial infections in the extracellular exposure of lupus nuclear autoantigens. Front. Immunol. 10, 2608 (2019).","journal-title":"Front. Immunol."},{"key":"1471_CR811","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2015.00520","volume":"6","author":"AJ Steelman","year":"2015","unstructured":"Steelman, A. J. Infection as an environmental trigger of multiple sclerosis disease exacerbation. Front. Immunol. 6, 520 (2015).","journal-title":"Front. Immunol."},{"key":"1471_CR812","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s11892-018-1077-2","volume":"18","author":"T Rodriguez-Calvo","year":"2018","unstructured":"Rodriguez-Calvo, T. Enteroviral infections as a trigger for type 1 diabetes. Curr. Diab. Rep. 18, 106 (2018).","journal-title":"Curr. Diab. Rep."},{"key":"1471_CR813","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41591-019-0667-0","volume":"25","author":"K Vehik","year":"2019","unstructured":"Vehik, K. et al. Prospective virome analyses in young children at increased genetic risk for type 1 diabetes. Nat. Med. 25, 1865\u20131872 (2019).","journal-title":"Nat. Med."},{"key":"1471_CR814","doi-asserted-by":"publisher","first-page":"369ra176","DOI":"10.1126\/scitranslmed.aaj1921","volume":"8","author":"MF Konig","year":"2016","unstructured":"Konig, M. F. et al. Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci. Transl. Med. 8, 369ra176 (2016).","journal-title":"Sci. Transl. Med."},{"key":"1471_CR815","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","volume":"603","author":"TV Lanz","year":"2022","unstructured":"Lanz, T. V. et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603, 321\u2013327 (2022).","journal-title":"Nature"},{"key":"1471_CR816","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik, K. et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375, 296\u2013301 (2022).","journal-title":"Science"},{"key":"1471_CR817","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1136\/annrheumdis-2018-214125","volume":"78","author":"Z Zhao","year":"2019","unstructured":"Zhao, Z. et al. Nature of T cell epitopes in lupus antigens and HLA-DR determines autoantibody initiation and diversification. Ann. Rheum. Dis. 78, 380\u2013390 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"1471_CR818","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","volume":"595","author":"EY Wang","year":"2021","unstructured":"Wang, E. Y. et al. Diverse functional autoantibodies in patients with COVID-19. Nature 595, 283\u2013288 (2021).","journal-title":"Nature"},{"key":"1471_CR819","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1084\/jem.20091225","volume":"206","author":"TA Schwickert","year":"2009","unstructured":"Schwickert, T. A., Alabyev, B., Manser, T. & Nussenzweig, M. C. Germinal center reutilization by newly activated B cells. J. Exp. Med. 206, 2907\u20132914 (2009).","journal-title":"J. Exp. Med."},{"key":"1471_CR820","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1073\/pnas.1614472114","volume":"114","author":"NS Sanderson","year":"2017","unstructured":"Sanderson, N. S. et al. Cocapture of cognate and bystander antigens can activate autoreactive B cells. Proc. Natl Acad. Sci. USA 114, 734\u2013739 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR821","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","volume":"19","author":"M Dominguez-Villar","year":"2018","unstructured":"Dominguez-Villar, M. & Hafler, D. A. Regulatory T cells in autoimmune disease. Nat. Immunol. 19, 665\u2013673 (2018).","journal-title":"Nat. Immunol."},{"key":"1471_CR822","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","volume":"50","author":"JB Wing","year":"2019","unstructured":"Wing, J. B., Tanaka, A. & Sakaguchi, S. Human FOXP3(+) regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity 50, 302\u2013316 (2019).","journal-title":"Immunity"},{"key":"1471_CR823","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0022-3476(82)80573-8","volume":"100","author":"BR Powell","year":"1982","unstructured":"Powell, B. R., Buist, N. R. & Stenzel, P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J. Pediatr. 100, 731\u2013737 (1982).","journal-title":"J. Pediatr."},{"key":"1471_CR824","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.13011","volume":"1417","author":"R Bacchetta","year":"2018","unstructured":"Bacchetta, R., Barzaghi, F. & Roncarolo, M. G. From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation. Ann. N. Y Acad. Sci. 1417, 5\u201322 (2018).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"1471_CR825","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jaci.2006.10.007","volume":"119","author":"AA Caudy","year":"2007","unstructured":"Caudy, A. A. et al. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J. Allergy Clin. Immunol. 119, 482\u2013487 (2007).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1471_CR826","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.3746","volume":"20","author":"D Schubert","year":"2014","unstructured":"Schubert, D. et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat. Med. 20, 1410\u20131416 (2014).","journal-title":"Nat. Med."},{"key":"1471_CR827","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1126\/science.1255904","volume":"345","author":"HS Kuehn","year":"2014","unstructured":"Kuehn, H. S. et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 345, 1623\u20131627 (2014).","journal-title":"Science"},{"key":"1471_CR828","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.aaa1663","volume":"349","author":"B Lo","year":"2015","unstructured":"Lo, B. et al. AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science 349, 436\u2013440 (2015).","journal-title":"Science"},{"key":"1471_CR829","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1126\/science.aaa7017","volume":"348","author":"S Yang","year":"2015","unstructured":"Yang, S. et al. Immune tolerance. Regulatory T cells generated early in life play a distinct role in maintaining self-tolerance. Science 348, 589\u2013594 (2015).","journal-title":"Science"},{"key":"1471_CR830","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.4049\/jimmunol.178.2.1208","volume":"178","author":"E Kekalainen","year":"2007","unstructured":"Kekalainen, E. et al. A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Immunol. 178, 1208\u20131215 (2007).","journal-title":"J. Immunol."},{"key":"1471_CR831","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","volume":"155","author":"S Sakaguchi","year":"1995","unstructured":"Sakaguchi, S. et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151\u20131164 (1995).","journal-title":"J. Immunol."},{"key":"1471_CR832","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature16169","volume":"528","author":"Z Liu","year":"2015","unstructured":"Liu, Z. et al. Immune homeostasis enforced by co-localized effector and regulatory T cells. Nature 528, 225\u2013230 (2015).","journal-title":"Nature"},{"key":"1471_CR833","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/ni1428","volume":"8","author":"JM Kim","year":"2007","unstructured":"Kim, J. M., Rasmussen, J. P. & Rudensky, A. Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191\u2013197 (2007).","journal-title":"Nat. Immunol."},{"key":"1471_CR834","doi-asserted-by":"publisher","first-page":"102461","DOI":"10.1016\/j.jaut.2020.102461","volume":"111","author":"X Zhang","year":"2020","unstructured":"Zhang, X., Olsen, N. & Zheng, S. G. The progress and prospect of regulatory T cells in autoimmune diseases. J. Autoimmun. 111, 102461 (2020).","journal-title":"J. Autoimmun."},{"key":"1471_CR835","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fimmu.2012.00178","volume":"3","author":"JB Wing","year":"2012","unstructured":"Wing, J. B. & Sakaguchi, S. Multiple treg suppressive modules and their adaptability. Front. Immunol. 3, 178 (2012).","journal-title":"Front. Immunol."},{"key":"1471_CR836","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/ni.1731","volume":"10","author":"MA Koch","year":"2009","unstructured":"Koch, M. A. et al. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10, 595\u2013602 (2009).","journal-title":"Nat. Immunol."},{"key":"1471_CR837","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature22360","volume":"546","author":"AG Levine","year":"2017","unstructured":"Levine, A. G. et al. Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature 546, 421\u2013425 (2017).","journal-title":"Nature"},{"key":"1471_CR838","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nature07674","volume":"458","author":"Y Zheng","year":"2009","unstructured":"Zheng, Y. et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458, 351\u2013356 (2009).","journal-title":"Nature"},{"key":"1471_CR839","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1172\/JCI57456","volume":"121","author":"EA Wohlfert","year":"2011","unstructured":"Wohlfert, E. A. et al. GATA3 controls Foxp3(+) regulatory T cell fate during inflammation in mice. J. Clin. Invest. 121, 4503\u20134515 (2011).","journal-title":"J. Clin. Invest."},{"key":"1471_CR840","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1126\/science.1172702","volume":"326","author":"A Chaudhry","year":"2009","unstructured":"Chaudhry, A. et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326, 986\u2013991 (2009).","journal-title":"Science"},{"key":"1471_CR841","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1126\/science.aaa9420","volume":"349","author":"E Sefik","year":"2015","unstructured":"Sefik, E. et al. MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORgamma(+) regulatory T cells. Science 349, 993\u2013997 (2015).","journal-title":"Science"},{"key":"1471_CR842","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nm.2425","volume":"17","author":"MA Linterman","year":"2011","unstructured":"Linterman, M. A. et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nat. Med. 17, 975\u2013982 (2011).","journal-title":"Nat. Med."},{"key":"1471_CR843","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.2426","volume":"17","author":"Y Chung","year":"2011","unstructured":"Chung, Y. et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat. Med. 17, 983\u2013988 (2011).","journal-title":"Nat. Med."},{"key":"1471_CR844","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00281-019-00741-8","volume":"41","author":"L Goschl","year":"2019","unstructured":"Goschl, L., Scheinecker, C. & Bonelli, M. Treg cells in autoimmunity: from identification to Treg-based therapies. Semin. Immunopathol. 41, 301\u2013314 (2019).","journal-title":"Semin. Immunopathol."},{"key":"1471_CR845","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/j.1365-2362.2007.01882.x","volume":"37","author":"SC Lin","year":"2007","unstructured":"Lin, S. C. et al. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur. J. Clin. Invest. 37, 987\u2013996 (2007).","journal-title":"Eur. J. Clin. Invest."},{"key":"1471_CR846","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1111\/cea.12594","volume":"45","author":"AJ Baatjes","year":"2015","unstructured":"Baatjes, A. J. et al. T regulatory cell phenotypes in peripheral blood and bronchoalveolar lavage from non-asthmatic and asthmatic subjects. Clin. Exp. Allergy 45, 1654\u20131662 (2015).","journal-title":"Clin. Exp. Allergy"},{"key":"1471_CR847","doi-asserted-by":"publisher","first-page":"604","DOI":"10.2337\/db06-1248","volume":"56","author":"T Brusko","year":"2007","unstructured":"Brusko, T. et al. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes 56, 604\u2013612 (2007).","journal-title":"Diabetes"},{"key":"1471_CR848","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1212\/WNL.0b013e3181d31e47","volume":"74","author":"N Matsui","year":"2010","unstructured":"Matsui, N. et al. Undiminished regulatory T cells in the thymus of patients with myasthenia gravis. Neurology 74, 816\u2013820 (2010).","journal-title":"Neurology"},{"key":"1471_CR849","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/rheumatology\/kel089","volume":"45","author":"CA Lawson","year":"2006","unstructured":"Lawson, C. A. et al. Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood. Rheumatology 45, 1210\u20131217 (2006).","journal-title":"Rheumatology"},{"key":"1471_CR850","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1136\/ard.2005.044974","volume":"65","author":"S Mellor-Pita","year":"2006","unstructured":"Mellor-Pita, S. et al. Decrease of regulatory T cells in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 65, 553\u2013554 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"1471_CR851","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cellimm.2008.05.007","volume":"253","author":"GM Han","year":"2008","unstructured":"Han, G. M., O\u2019Neil-Andersen, N. J., Zurier, R. B. & Lawrence, D. A. CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. Cell Immunol. 253, 92\u2013101 (2008).","journal-title":"Cell Immunol."},{"key":"1471_CR852","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1365-2249.2008.03665.x","volume":"153","author":"J Yates","year":"2008","unstructured":"Yates, J. et al. Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin. Exp. Immunol. 153, 44\u201355 (2008).","journal-title":"Clin. Exp. Immunol."},{"key":"1471_CR853","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.4049\/jimmunol.1003099","volume":"186","author":"SA McClymont","year":"2011","unstructured":"McClymont, S. A. et al. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J. Immunol. 186, 3918\u20133926 (2011).","journal-title":"J. Immunol."},{"key":"1471_CR854","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nm.2389","volume":"17","author":"M Dominguez-Villar","year":"2011","unstructured":"Dominguez-Villar, M., Baecher-Allan, C. M. & Hafler, D. A. Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease. Nat. Med. 17, 673\u2013675 (2011).","journal-title":"Nat. Med."},{"key":"1471_CR855","doi-asserted-by":"publisher","first-page":"e48624","DOI":"10.15252\/embr.201948624","volume":"20","author":"A Kitz","year":"2019","unstructured":"Kitz, A. et al. AKT isoforms modulate Th1-like Treg generation and function in human autoimmune disease. EMBO Rep. 20, e48624 (2019).","journal-title":"EMBO Rep."},{"key":"1471_CR856","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.4049\/jimmunol.1502276","volume":"196","author":"AS Arterbery","year":"2016","unstructured":"Arterbery, A. S. et al. Production of proinflammatory cytokines by monocytes in liver-transplanted recipients with de novo autoimmune hepatitis is enhanced and induces TH1-like regulatory T cells. J. Immunol. 196, 4040\u20134051 (2016).","journal-title":"J. Immunol."},{"key":"1471_CR857","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1016\/j.ajpath.2015.07.007","volume":"185","author":"A Yamada","year":"2015","unstructured":"Yamada, A. et al. Impaired expansion of regulatory T cells in a neonatal thymectomy-induced autoimmune mouse model. Am. J. Pathol. 185, 2886\u20132897 (2015).","journal-title":"Am. J. Pathol."},{"key":"1471_CR858","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nm1564","volume":"13","author":"T Korn","year":"2007","unstructured":"Korn, T. et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13, 423\u2013431 (2007).","journal-title":"Nat. Med."},{"key":"1471_CR859","doi-asserted-by":"publisher","first-page":"14103","DOI":"10.1073\/pnas.1616710113","volume":"113","author":"TG Tan","year":"2016","unstructured":"Tan, T. G., Mathis, D. & Benoist, C. Singular role for T-BET+CXCR3+ regulatory T cells in protection from autoimmune diabetes. Proc. Natl Acad. Sci. USA 113, 14103\u201314108 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR860","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1266-6","volume":"10","author":"S Yang","year":"2019","unstructured":"Yang, S. et al. Differential roles of TNFalpha-TNFR1 and TNFalpha-TNFR2 in the differentiation and function of CD4(+)Foxp3(+) induced Treg cells in vitro and in vivo periphery in autoimmune diseases. Cell Death Dis. 10, 27 (2019).","journal-title":"Cell Death Dis."},{"key":"1471_CR861","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3389\/fimmu.2016.00604","volume":"7","author":"Y Luo","year":"2016","unstructured":"Luo, Y. & Zheng, S. G. Hall of fame among pro-inflammatory cytokines: interleukin-6 gene and its transcriptional regulation mechanisms. Front. Immunol. 7, 604 (2016).","journal-title":"Front. Immunol."},{"key":"1471_CR862","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molimm.2017.01.008","volume":"83","author":"M Tarique","year":"2017","unstructured":"Tarique, M. et al. IL-12 and IL-23 modulate plasticity of FoxP3(+) regulatory T cells in human Leprosy. Mol. Immunol. 83, 72\u201381 (2017).","journal-title":"Mol. Immunol."},{"key":"1471_CR863","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nature11581","volume":"491","author":"W Ouyang","year":"2012","unstructured":"Ouyang, W. et al. Novel Foxo1-dependent transcriptional programs control T(reg) cell function. Nature 491, 554\u2013559 (2012).","journal-title":"Nature"},{"key":"1471_CR864","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/ni.3077","volume":"16","author":"A Huynh","year":"2015","unstructured":"Huynh, A. et al. Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability. Nat. Immunol. 16, 188\u2013196 (2015).","journal-title":"Nat. Immunol."},{"key":"1471_CR865","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jaci.2014.12.1932","volume":"135","author":"KG MacDonald","year":"2015","unstructured":"MacDonald, K. G. et al. Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis. J. Allergy Clin. Immunol. 135, 946\u2013955 e949 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1471_CR866","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.immuni.2015.02.004","volume":"42","author":"M Noval Rivas","year":"2015","unstructured":"Noval Rivas, M. et al. Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy. Immunity 42, 512\u2013523 (2015).","journal-title":"Immunity"},{"key":"1471_CR867","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1172\/JCI69355","volume":"123","author":"HS Jin","year":"2013","unstructured":"Jin, H. S., Park, Y., Elly, C. & Liu, Y. C. Itch expression by Treg cells controls Th2 inflammatory responses. J. Clin. Invest. 123, 4923\u20134934 (2013).","journal-title":"J. Clin. Invest."},{"key":"1471_CR868","doi-asserted-by":"publisher","first-page":"3096183","DOI":"10.1155\/2018\/3096183","volume":"2018","author":"T Chen","year":"2018","unstructured":"Chen, T. et al. The imbalance of FOXP3\/GATA3 in regulatory T cells from the peripheral blood of asthmatic patients. J. Immunol. Res. 2018, 3096183 (2018).","journal-title":"J. Immunol. Res."},{"key":"1471_CR869","first-page":"48","volume":"38","author":"N Gao","year":"2020","unstructured":"Gao, N. et al. Contribution of Th2-like Treg cells to the pathogenesis of Takayasu\u2019s arteritis. Clin. Exp. Rheumatol. 38, 48\u201354 (2020).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1471_CR870","doi-asserted-by":"publisher","first-page":"634847","DOI":"10.3389\/fimmu.2021.634847","volume":"12","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. Increased dysfunctional and plastic regulatory T cells in idiopathic orbital inflammation. Front. Immunol. 12, 634847 (2021).","journal-title":"Front. Immunol."},{"key":"1471_CR871","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13075-018-1521-3","volume":"20","author":"R Saigusa","year":"2018","unstructured":"Saigusa, R. et al. Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells. Arthritis Res. Ther. 20, 23 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"1471_CR872","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm.3432","volume":"20","author":"N Komatsu","year":"2014","unstructured":"Komatsu, N. et al. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat. Med. 20, 62\u201368 (2014).","journal-title":"Nat. Med."},{"key":"1471_CR873","doi-asserted-by":"publisher","first-page":"108267","DOI":"10.1016\/j.clim.2019.108267","volume":"209","author":"C Jiang","year":"2019","unstructured":"Jiang, C. et al. Reprograming of peripheral Foxp3(+) regulatory T cell towards Th17-like cell in patients with active systemic lupus erythematosus. Clin. Immunol. 209, 108267 (2019).","journal-title":"Clin. Immunol."},{"key":"1471_CR874","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1038\/jid.2011.139","volume":"131","author":"HJ Bovenschen","year":"2011","unstructured":"Bovenschen, H. J. et al. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J. Invest. Dermatol. 131, 1853\u20131860 (2011).","journal-title":"J. Invest. Dermatol."},{"key":"1471_CR875","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/mi.2015.74","volume":"9","author":"BH Yang","year":"2016","unstructured":"Yang, B. H. et al. Foxp3(+) T cells expressing RORgammat represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation. Mucosal Immunol. 9, 444\u2013457 (2016).","journal-title":"Mucosal Immunol."},{"key":"1471_CR876","doi-asserted-by":"publisher","first-page":"6725","DOI":"10.4049\/jimmunol.178.11.6725","volume":"178","author":"L Xu","year":"2007","unstructured":"Xu, L., Kitani, A., Fuss, I. & Strober, W. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J. Immunol. 178, 6725\u20136729 (2007).","journal-title":"J. Immunol."},{"key":"1471_CR877","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/nm.4147","volume":"22","author":"AH Massoud","year":"2016","unstructured":"Massoud, A. H. et al. An asthma-associated IL4R variant exacerbates airway inflammation by promoting conversion of regulatory T cells to TH17-like cells. Nat. Med. 22, 1013\u20131022 (2016).","journal-title":"Nat. Med."},{"key":"1471_CR878","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.4049\/jimmunol.1003715","volume":"187","author":"MH Nyirenda","year":"2011","unstructured":"Nyirenda, M. H. et al. TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function. J. Immunol. 187, 2278\u20132290 (2011).","journal-title":"J. Immunol."},{"key":"1471_CR879","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.2500\/ajra.2014.28.3995","volume":"28","author":"SN Cho","year":"2014","unstructured":"Cho, S. N. et al. Role of staphylococcal enterotoxin B on the differentiation of regulatory T cells in nasal polyposis. Am. J. Rhinol. Allergy 28, e17\u2013e24 (2014).","journal-title":"Am. J. Rhinol. Allergy"},{"key":"1471_CR880","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.2147\/IJGM.S330389","volume":"14","author":"W Yu","year":"2021","unstructured":"Yu, W. et al. IRF4 is correlated with the conversion to a Th17-like phenotype in regulatory T cells from the malignant pleural effusion. Int. J. Gen. Med. 14, 6009\u20136019 (2021).","journal-title":"Int. J. Gen. Med."},{"key":"1471_CR881","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4049\/jimmunol.1600441","volume":"199","author":"R Takahashi","year":"2017","unstructured":"Takahashi, R., Nakatsukasa, H., Shiozawa, S. & Yoshimura, A. SOCS1 is a key molecule that prevents regulatory T cell plasticity under inflammatory conditions. J. Immunol. 199, 149\u2013158 (2017).","journal-title":"J. Immunol."},{"key":"1471_CR882","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.4049\/jimmunol.0900986","volume":"183","author":"B Baban","year":"2009","unstructured":"Baban, B. et al. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J. Immunol. 183, 2475\u20132483 (2009).","journal-title":"J. Immunol."},{"key":"1471_CR883","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.coi.2009.05.007","volume":"21","author":"X Zhou","year":"2009","unstructured":"Zhou, X., Bailey-Bucktrout, S., Jeker, L. T. & Bluestone, J. A. Plasticity of CD4(+) FoxP3(+) T cells. Curr. Opin. Immunol. 21, 281\u2013285 (2009).","journal-title":"Curr. Opin. Immunol."},{"key":"1471_CR884","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nature05479","volume":"445","author":"YY Wan","year":"2007","unstructured":"Wan, Y. Y. & Flavell, R. A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445, 766\u2013770 (2007).","journal-title":"Nature"},{"key":"1471_CR885","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.immuni.2008.03.016","volume":"28","author":"Q Tang","year":"2008","unstructured":"Tang, Q. et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28, 687\u2013697 (2008).","journal-title":"Immunity"},{"key":"1471_CR886","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1749-6632.2012.06840.x","volume":"1274","author":"M Thiruppathi","year":"2012","unstructured":"Thiruppathi, M. et al. Functional defect in regulatory T cells in myasthenia gravis. Ann. N. Y Acad. Sci. 1274, 68\u201376 (2012).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"1471_CR887","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","volume":"105","author":"A Balandina","year":"2005","unstructured":"Balandina, A. et al. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 105, 735\u2013741 (2005).","journal-title":"Blood"},{"key":"1471_CR888","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/jnr.20522","volume":"81","author":"J Huan","year":"2005","unstructured":"Huan, J. et al. Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res. 81, 45\u201352 (2005).","journal-title":"J. Neurosci. Res."},{"key":"1471_CR889","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1365-2249.2008.03686.x","volume":"153","author":"B Zhang","year":"2008","unstructured":"Zhang, B. et al. Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus. Clin. Exp. Immunol. 153, 182\u2013187 (2008).","journal-title":"Clin. Exp. Immunol."},{"key":"1471_CR890","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/ni.1774","volume":"10","author":"X Zhou","year":"2009","unstructured":"Zhou, X. et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000\u20131007 (2009).","journal-title":"Nat. Immunol."},{"key":"1471_CR891","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1126\/science.1191996","volume":"329","author":"YP Rubtsov","year":"2010","unstructured":"Rubtsov, Y. P. et al. Stability of the regulatory T cell lineage in vivo. Science 329, 1667\u20131671 (2010).","journal-title":"Science"},{"key":"1471_CR892","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.348","volume":"7","author":"L Li","year":"2016","unstructured":"Li, L. et al. Block of both TGF-beta and IL-2 signaling impedes Neurophilin-1(+) regulatory T cell and follicular regulatory T cell development. Cell Death Dis. 7, e2439 (2016).","journal-title":"Cell Death Dis."},{"key":"1471_CR893","doi-asserted-by":"publisher","first-page":"842","DOI":"10.4049\/jimmunol.0904100","volume":"185","author":"T Takimoto","year":"2010","unstructured":"Takimoto, T. et al. Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development. J. Immunol. 185, 842\u2013855 (2010).","journal-title":"J. Immunol."},{"key":"1471_CR894","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1084\/jem.20041982","volume":"201","author":"R Setoguchi","year":"2005","unstructured":"Setoguchi, R., Hori, S., Takahashi, T. & Sakaguchi, S. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201, 723\u2013735 (2005).","journal-title":"J. Exp. Med."},{"key":"1471_CR895","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12016-018-8721-0","volume":"58","author":"R Qiu","year":"2020","unstructured":"Qiu, R. et al. Regulatory T cell plasticity and stability and autoimmune diseases. Clin. Rev. Allergy Immunol. 58, 52\u201370 (2020).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"1471_CR896","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.molimm.2013.04.015","volume":"56","author":"S Kumar","year":"2013","unstructured":"Kumar, S. et al. CD4+CD25+ T regs with acetylated FoxP3 are associated with immune suppression in human leprosy. Mol. Immunol. 56, 513\u2013520 (2013).","journal-title":"Mol. Immunol."},{"key":"1471_CR897","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41590-018-0055-9","volume":"19","author":"J Geng","year":"2018","unstructured":"Geng, J. et al. Publisher correction: the transcriptional coactivator TAZ regulates reciprocal differentiation of T(H)17 cells and T(reg) cells. Nat. Immunol. 19, 1036 (2018).","journal-title":"Nat. Immunol."},{"key":"1471_CR898","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08300-3","volume":"10","author":"B Liu","year":"2019","unstructured":"Liu, B. et al. The lineage stability and suppressive program of regulatory T cells require protein O-GlcNAcylation. Nat. Commun. 10, 354 (2019).","journal-title":"Nat. Commun."},{"key":"1471_CR899","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3389\/fimmu.2017.00219","volume":"8","author":"EK Alvarez Salazar","year":"2017","unstructured":"Alvarez Salazar, E. K. et al. Methylation of FOXP3 TSDR underlies the impaired suppressive function of Tregs from long-term belatacept-treated kidney transplant patients. Front. Immunol. 8, 219 (2017).","journal-title":"Front. Immunol."},{"key":"1471_CR900","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.immuni.2011.12.012","volume":"36","author":"T Miyao","year":"2012","unstructured":"Miyao, T. et al. Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 36, 262\u2013275 (2012).","journal-title":"Immunity"},{"key":"1471_CR901","doi-asserted-by":"publisher","first-page":"20211","DOI":"10.1074\/jbc.M115.638221","volume":"290","author":"G Deng","year":"2015","unstructured":"Deng, G. et al. Pim-2 kinase influences regulatory T cell function and stability by mediating Foxp3 protein N-terminal phosphorylation. J. Biol. Chem. 290, 20211\u201320220 (2015).","journal-title":"J. Biol. Chem."},{"key":"1471_CR902","doi-asserted-by":"publisher","first-page":"24494","DOI":"10.1074\/jbc.M113.467704","volume":"288","author":"PA Morawski","year":"2013","unstructured":"Morawski, P. A. et al. Foxp3 protein stability is regulated by cyclin-dependent kinase 2. J. Biol. Chem. 288, 24494\u201324502 (2013).","journal-title":"J. Biol. Chem."},{"key":"1471_CR903","doi-asserted-by":"crossref","unstructured":"Xu, Y. et al. The E3 ligase Hrd1 stabilizes Tregs by antagonizing inflammatory cytokine-induced ER stress response. JCI Insight 4, e121887 (2019).","DOI":"10.1172\/jci.insight.121887"},{"key":"1471_CR904","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nature08750","volume":"463","author":"Y Zheng","year":"2010","unstructured":"Zheng, Y. et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808\u2013812 (2010).","journal-title":"Nature"},{"key":"1471_CR905","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.cell.2014.07.030","volume":"158","author":"X Li","year":"2014","unstructured":"Li, X. et al. Function of a Foxp3 cis-element in protecting regulatory T cell identity. Cell 158, 734\u2013748 (2014).","journal-title":"Cell"},{"key":"1471_CR906","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.cell.2014.07.031","volume":"158","author":"Y Feng","year":"2014","unstructured":"Feng, Y. et al. Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus. Cell 158, 749\u2013763 (2014).","journal-title":"Cell"},{"key":"1471_CR907","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1128\/MCB.00144-13","volume":"33","author":"L Wang","year":"2013","unstructured":"Wang, L. et al. Mbd2 promotes foxp3 demethylation and T-regulatory-cell function. Mol. Cell Biol. 33, 4106\u20134115 (2013).","journal-title":"Mol. Cell Biol."},{"key":"1471_CR908","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1126\/science.aad0616","volume":"350","author":"HJ Kim","year":"2015","unstructured":"Kim, H. J. et al. Stable inhibitory activity of regulatory T cells requires the transcription factor Helios. Science 350, 334\u2013339 (2015).","journal-title":"Science"},{"key":"1471_CR909","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.immuni.2013.01.013","volume":"38","author":"MD Sharma","year":"2013","unstructured":"Sharma, M. D. et al. An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos. Immunity 38, 998\u20131012 (2013).","journal-title":"Immunity"},{"key":"1471_CR910","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaut.2016.03.017","volume":"70","author":"N Messina","year":"2016","unstructured":"Messina, N. et al. The NF-kappaB transcription factor RelA is required for the tolerogenic function of Foxp3(+) regulatory T cells. J. Autoimmun. 70, 52\u201362 (2016).","journal-title":"J. Autoimmun."},{"key":"1471_CR911","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1038\/sj.onc.1204448","volume":"20","author":"F Verrecchia","year":"2001","unstructured":"Verrecchia, F. et al. Smad3\/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner. Oncogene 20, 3332\u20133340 (2001).","journal-title":"Oncogene"},{"key":"1471_CR912","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1016\/j.celrep.2016.11.045","volume":"17","author":"KS Rauch","year":"2016","unstructured":"Rauch, K. S. et al. Id3 maintains Foxp3 expression in regulatory T cells by controlling a transcriptional network of E47, Spi-B, and SOCS3. Cell Rep. 17, 2827\u20132836 (2016).","journal-title":"Cell Rep."},{"key":"1471_CR913","doi-asserted-by":"publisher","first-page":"966364","DOI":"10.3389\/fimmu.2022.966364","volume":"13","author":"PR Arnold","year":"2022","unstructured":"Arnold, P. R. et al. Suppression of FOXP3 expression by the AP-1 family transcription factor BATF3 requires partnering with IRF4. Front. Immunol. 13, 966364 (2022).","journal-title":"Front. Immunol."},{"key":"1471_CR914","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41590-021-00949-7","volume":"22","author":"JL Collier","year":"2021","unstructured":"Collier, J. L. et al. Not-so-opposite ends of the spectrum: CD8(+) T cell dysfunction across chronic infection, cancer and autoimmunity. Nat. Immunol. 22, 809\u2013819 (2021).","journal-title":"Nat. Immunol."},{"key":"1471_CR915","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.coi.2005.09.014","volume":"17","author":"U Walter","year":"2005","unstructured":"Walter, U. & Santamaria, P. CD8+ T cells in autoimmunity. Curr. Opin. Immunol. 17, 624\u2013631 (2005).","journal-title":"Curr. Opin. Immunol."},{"key":"1471_CR916","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/S0140-6736(73)91360-3","volume":"1","author":"DA Brewerton","year":"1973","unstructured":"Brewerton, D. A. et al. Ankylosing spondylitis and HL-A 27. Lancet 1, 904\u2013907 (1973).","journal-title":"Lancet"},{"key":"1471_CR917","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8146","volume":"6","author":"A Cortes","year":"2015","unstructured":"Cortes, A. et al. Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1. Nat. Commun. 6, 7146 (2015).","journal-title":"Nat. Commun."},{"key":"1471_CR918","doi-asserted-by":"publisher","first-page":"916","DOI":"10.2337\/db14-0332","volume":"64","author":"A Skowera","year":"2015","unstructured":"Skowera, A. et al. beta-cell-specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposure. Diabetes 64, 916\u2013925 (2015).","journal-title":"Diabetes"},{"key":"1471_CR919","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1172\/JCI132531","volume":"130","author":"CA Wagner","year":"2020","unstructured":"Wagner, C. A. et al. Myelin-specific CD8+ T cells exacerbate brain inflammation in CNS autoimmunity. J. Clin. Invest. 130, 203\u2013213 (2020).","journal-title":"J. Clin. Invest."},{"key":"1471_CR920","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1172\/JCI59255","volume":"121","author":"JC Lee","year":"2011","unstructured":"Lee, J. C. et al. Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis. J. Clin. Invest. 121, 4170\u20134179 (2011).","journal-title":"J. Clin. Invest."},{"key":"1471_CR921","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1046\/j.0022-202x.2001.01605.x","volume":"117","author":"FA Le Gal","year":"2001","unstructured":"Le Gal, F. A. et al. Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo. J. Invest Dermatol. 117, 1464\u20131470 (2001).","journal-title":"J. Invest Dermatol"},{"key":"1471_CR922","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","volume":"46","author":"S Cheuk","year":"2017","unstructured":"Cheuk, S. et al. CD49a expression defines tissue-resident CD8(+) T cells poised for cytotoxic function in human skin. Immunity 46, 287\u2013300 (2017).","journal-title":"Immunity"},{"key":"1471_CR923","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/35021081","volume":"406","author":"A Amrani","year":"2000","unstructured":"Amrani, A. et al. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406, 739\u2013742 (2000).","journal-title":"Nature"},{"key":"1471_CR924","doi-asserted-by":"publisher","first-page":"11230","DOI":"10.1074\/jbc.M115.713362","volume":"291","author":"JW Garyu","year":"2016","unstructured":"Garyu, J. W. et al. Characterization of Diabetogenic CD8+ T Cells: IMMUNE THERAPY WITH METABOLIC BLOCKADE. J. Biol. Chem. 291, 11230\u201311240 (2016).","journal-title":"J. Biol. Chem."},{"key":"1471_CR925","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1172\/JCI24219","volume":"115","author":"B Han","year":"2005","unstructured":"Han, B. et al. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes. J. Clin. Invest. 115, 1879\u20131887 (2005).","journal-title":"J. Clin. Invest."},{"key":"1471_CR926","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1073\/pnas.0308689100","volume":"101","author":"C Skulina","year":"2004","unstructured":"Skulina, C. et al. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc. Natl Acad. Sci. USA 101, 2428\u20132433 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR927","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrrheum.2016.74","volume":"12","author":"A Petrelli","year":"2016","unstructured":"Petrelli, A. & van Wijk, F. CD8(+) T cells in human autoimmune arthritis: the unusual suspects. Nat. Rev. Rheumatol. 12, 421\u2013428 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1471_CR928","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/art.38941","volume":"67","author":"H Carvalheiro","year":"2015","unstructured":"Carvalheiro, H. et al. CD8+ T cell profiles in patients with rheumatoid arthritis and their relationship to disease activity. Arthritis Rheumatol. 67, 363\u2013371 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"1471_CR929","doi-asserted-by":"crossref","unstructured":"Bender, C. et al. The healthy exocrine pancreas contains preproinsulin-specific CD8 T cells that attack islets in type 1 diabetes. Sci. Adv. 6, eabc5586 (2020).","DOI":"10.1126\/sciadv.abc5586"},{"key":"1471_CR930","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1093\/brain\/awr268","volume":"134","author":"I Ifergan","year":"2011","unstructured":"Ifergan, I. et al. Central nervous system recruitment of effector memory CD8+ T lymphocytes during neuroinflammation is dependent on alpha4 integrin. Brain 134, 3560\u20133577 (2011).","journal-title":"Brain"},{"key":"1471_CR931","doi-asserted-by":"crossref","unstructured":"Zakharov, P. N., Hu, H., Wan, X. & Unanue, E. R. Single-cell RNA sequencing of murine islets shows high cellular complexity at all stages of autoimmune diabetes. J. Exp. Med. 217, e20192362 (2020).","DOI":"10.1084\/jem.20192362"},{"key":"1471_CR932","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nature14468","volume":"523","author":"EF McKinney","year":"2015","unstructured":"McKinney, E. F. et al. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature 523, 612\u2013616 (2015).","journal-title":"Nature"},{"key":"1471_CR933","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1172\/JCI126595","volume":"130","author":"AE Wiedeman","year":"2020","unstructured":"Wiedeman, A. E. et al. Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression. J. Clin. Invest. 130, 480\u2013490 (2020).","journal-title":"J. Clin. Invest."},{"key":"1471_CR934","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41586-021-04248-x","volume":"602","author":"SV Gearty","year":"2022","unstructured":"Gearty, S. V. et al. An autoimmune stem-like CD8 T cell population drives type 1 diabetes. Nature 602, 156\u2013161 (2022).","journal-title":"Nature"},{"key":"1471_CR935","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21109-3","volume":"12","author":"N Page","year":"2021","unstructured":"Page, N. et al. Persistence of self-reactive CD8+ T cells in the CNS requires TOX-dependent chromatin remodeling. Nat. Commun. 12, 1009 (2021).","journal-title":"Nat. Commun."},{"key":"1471_CR936","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.immuni.2009.07.010","volume":"31","author":"JP Lauritsen","year":"2009","unstructured":"Lauritsen, J. P. et al. Marked induction of the helix-loop-helix protein Id3 promotes the gammadelta T cell fate and renders their functional maturation Notch independent. Immunity 31, 565\u2013575 (2009).","journal-title":"Immunity"},{"key":"1471_CR937","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3389\/fimmu.2019.01629","volume":"10","author":"K Mengrelis","year":"2019","unstructured":"Mengrelis, K. et al. Sonic hedgehog is a determinant of gammadelta T-cell differentiation in the thymus. Front. Immunol. 10, 1629 (2019).","journal-title":"Front. Immunol."},{"key":"1471_CR938","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nri2820","volume":"10","author":"M Ciofani","year":"2010","unstructured":"Ciofani, M. & Zuniga-Pflucker, J. C. Determining gammadelta versus alphass T cell development. Nat. Rev. Immunol. 10, 657\u2013663 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR939","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1084\/jem.20121798","volume":"210","author":"I Van de Walle","year":"2013","unstructured":"Van de Walle, I. et al. Specific Notch receptor-ligand interactions control human TCR-alphabeta\/gammadelta development by inducing differential Notch signal strength. J. Exp. Med. 210, 683\u2013697 (2013).","journal-title":"J. Exp. Med."},{"key":"1471_CR940","doi-asserted-by":"publisher","first-page":"e110023","DOI":"10.15252\/embj.2021110023","volume":"41","author":"S Scaramuzzino","year":"2022","unstructured":"Scaramuzzino, S. et al. Single-cell transcriptomics uncovers an instructive T-cell receptor role in adult gammadelta T-cell lineage commitment. EMBO J. 41, e110023 (2022).","journal-title":"EMBO J."},{"key":"1471_CR941","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41590-020-0747-9","volume":"21","author":"J Roels","year":"2020","unstructured":"Roels, J. et al. Distinct and temporary-restricted epigenetic mechanisms regulate human alphabeta and gammadelta T cell development. Nat. Immunol. 21, 1280\u20131292 (2020).","journal-title":"Nat. Immunol."},{"key":"1471_CR942","doi-asserted-by":"crossref","unstructured":"Yang, K. et al. Metabolic signaling directs the reciprocal lineage decisions of alphabeta and gammadelta T cells. Sci Immunol. 3, eaas9818 (2018).","DOI":"10.1126\/sciimmunol.aas9818"},{"key":"1471_CR943","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fimmu.2020.00042","volume":"11","author":"ME Parker","year":"2020","unstructured":"Parker, M. E. & Ciofani, M. Regulation of gammadelta T cell effector diversification in the thymus. Front. Immunol. 11, 42 (2020).","journal-title":"Front. Immunol."},{"key":"1471_CR944","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.4049\/jimmunol.181.3.1710","volume":"181","author":"J Kisielow","year":"2008","unstructured":"Kisielow, J., Kopf, M. & Karjalainen, K. SCART scavenger receptors identify a novel subset of adult gammadelta T cells. J. Immunol. 181, 1710\u20131716 (2008).","journal-title":"J. Immunol."},{"key":"1471_CR945","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41577-020-00452-4","volume":"21","author":"JC Ribot","year":"2021","unstructured":"Ribot, J. C., Lopes, N. & Silva-Santos, B. gammadelta T cells in tissue physiology and surveillance. Nat. Rev. Immunol. 21, 221\u2013232 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR946","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/ni.2247","volume":"13","author":"K Narayan","year":"2012","unstructured":"Narayan, K. et al. Intrathymic programming of effector fates in three molecularly distinct gammadelta T cell subtypes. Nat. Immunol. 13, 511\u2013518 (2012).","journal-title":"Nat. Immunol."},{"key":"1471_CR947","doi-asserted-by":"publisher","first-page":"e104159","DOI":"10.15252\/embj.2019104159","volume":"39","author":"Sagar","year":"2020","unstructured":"Sagar et al. Deciphering the regulatory landscape of fetal and adult gammadelta T-cell development at single-cell resolution. EMBO J. 39, e104159 (2020).","journal-title":"EMBO J."},{"key":"1471_CR948","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.immuni.2013.01.010","volume":"38","author":"N Malhotra","year":"2013","unstructured":"Malhotra, N. et al. A network of high-mobility group box transcription factors programs innate interleukin-17 production. Immunity 38, 681\u2013693 (2013).","journal-title":"Immunity"},{"key":"1471_CR949","doi-asserted-by":"publisher","first-page":"108716","DOI":"10.1016\/j.celrep.2021.108716","volume":"34","author":"SP Fahl","year":"2021","unstructured":"Fahl, S. P. et al. The E protein-TCF1 axis controls gammadelta T cell development and effector fate. Cell Rep. 34, 108716 (2021).","journal-title":"Cell Rep."},{"key":"1471_CR950","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.immuni.2011.04.018","volume":"35","author":"G Turchinovich","year":"2011","unstructured":"Turchinovich, G. & Hayday, A. C. Skint-1 identifies a common molecular mechanism for the development of interferon-gamma-secreting versus interleukin-17-secreting gammadelta T cells. Immunity 35, 59\u201368 (2011).","journal-title":"Immunity"},{"key":"1471_CR951","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","volume":"31","author":"CE Sutton","year":"2009","unstructured":"Sutton, C. E. et al. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31, 331\u2013341 (2009).","journal-title":"Immunity"},{"key":"1471_CR952","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fimmu.2015.00037","volume":"6","author":"RS Patil","year":"2015","unstructured":"Patil, R. S., Bhat, S. A., Dar, A. A. & Chiplunkar, S. V. The Jekyll and Hyde story of IL17-producing gammadeltaT cells. Front. Immunol. 6, 37 (2015).","journal-title":"Front. Immunol."},{"key":"1471_CR953","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.scib.2021.11.013","volume":"67","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. Single-cell RNA-seq and chromatin accessibility profiling decipher the heterogeneity of mouse gammadelta T cells. Sci. Bull. 67, 408\u2013426 (2022).","journal-title":"Sci. Bull."},{"key":"1471_CR954","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-immunol-102819-023144","volume":"38","author":"AC Hayday","year":"2020","unstructured":"Hayday, A. C. & Vantourout, P. The innate biologies of adaptive antigen receptors. Annu. Rev. Immunol. 38, 487\u2013510 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"1471_CR955","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cell.2016.08.030","volume":"167","author":"R Di Marco Barros","year":"2016","unstructured":"Di Marco Barros, R. et al. Epithelia use butyrophilin-like molecules to shape organ-specific gammadelta T cell compartments. Cell 167, 203\u2013218 e217 (2016).","journal-title":"Cell"},{"key":"1471_CR956","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1084\/jem.20042057","volume":"201","author":"JM Jameson","year":"2005","unstructured":"Jameson, J. M. et al. Gammadelta T cell-induced hyaluronan production by epithelial cells regulates inflammation. J. Exp. Med. 201, 1269\u20131279 (2005).","journal-title":"J. Exp. Med."},{"key":"1471_CR957","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1126\/science.1069639","volume":"296","author":"J Jameson","year":"2002","unstructured":"Jameson, J. et al. A role for skin gammadelta T cells in wound repair. Science 296, 747\u2013749 (2002).","journal-title":"Science"},{"key":"1471_CR958","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1126\/science.7973709","volume":"266","author":"R Boismenu","year":"1994","unstructured":"Boismenu, R. & Havran, W. L. Modulation of epithelial cell growth by intraepithelial gamma delta T cells. Science 266, 1253\u20131255 (1994).","journal-title":"Science"},{"key":"1471_CR959","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.4049\/jimmunol.1401244","volume":"193","author":"H Ahlfors","year":"2014","unstructured":"Ahlfors, H. et al. IL-22 fate reporter reveals origin and control of IL-22 production in homeostasis and infection. J. Immunol. 193, 4602\u20134613 (2014).","journal-title":"J. Immunol."},{"key":"1471_CR960","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1073\/pnas.1818812116","volume":"116","author":"A Wilharm","year":"2019","unstructured":"Wilharm, A. et al. Mutual interplay between IL-17-producing gammadeltaT cells and microbiota orchestrates oral mucosal homeostasis. Proc. Natl Acad. Sci. USA 116, 2652\u20132661 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR961","doi-asserted-by":"publisher","first-page":"10738","DOI":"10.1073\/pnas.1802320115","volume":"115","author":"S Krishnan","year":"2018","unstructured":"Krishnan, S. et al. Amphiregulin-producing gammadelta T cells are vital for safeguarding oral barrier immune homeostasis. Proc. Natl Acad. Sci. USA 115, 10738\u201310743 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR962","doi-asserted-by":"crossref","unstructured":"Spidale, N. A. et al. Neonatal-derived IL-17 producing dermal gammadelta T cells are required to prevent spontaneous atopic dermatitis. Elife. 9, e51188 (2020).","DOI":"10.7554\/eLife.51188"},{"key":"1471_CR963","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/ni.3726","volume":"18","author":"PH Papotto","year":"2017","unstructured":"Papotto, P. H., Ribot, J. C. & Silva-Santos, B. IL-17(+) gammadelta T cells as kick-starters of inflammation. Nat. Immunol. 18, 604\u2013611 (2017).","journal-title":"Nat. Immunol."},{"key":"1471_CR964","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10928","volume":"7","author":"T Ono","year":"2016","unstructured":"Ono, T. et al. IL-17-producing gammadelta T cells enhance bone regeneration. Nat. Commun. 7, 10928 (2016).","journal-title":"Nat. Commun."},{"key":"1471_CR965","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41586-020-2028-z","volume":"578","author":"B Hu","year":"2020","unstructured":"Hu, B. et al. gammadelta T cells and adipocyte IL-17RC control fat innervation and thermogenesis. Nature 578, 610\u2013614 (2020).","journal-title":"Nature"},{"key":"1471_CR966","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41590-018-0094-2","volume":"19","author":"AC Kohlgruber","year":"2018","unstructured":"Kohlgruber, A. C. et al. gammadelta T cells producing interleukin-17A regulate adipose regulatory T cell homeostasis and thermogenesis. Nat. Immunol. 19, 464\u2013474 (2018).","journal-title":"Nat. Immunol."},{"key":"1471_CR967","doi-asserted-by":"crossref","unstructured":"Ribeiro, M. et al. Meningeal gammadelta T cell-derived IL-17 controls synaptic plasticity and short-term memory. Sci Immunol. 4, eaay5199 (2019).","DOI":"10.1126\/sciimmunol.aay5199"},{"key":"1471_CR968","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000086659","volume":"86","author":"W Holtmeier","year":"2005","unstructured":"Holtmeier, W. & Kabelitz, D. gammadelta T cells link innate and adaptive immune responses. Chem. Immunol. Allergy 86, 151\u2013183 (2005).","journal-title":"Chem. Immunol. Allergy"},{"key":"1471_CR969","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.semcdb.2017.10.009","volume":"84","author":"D Vermijlen","year":"2018","unstructured":"Vermijlen, D. et al. gammadelta T cell responses: How many ligands will it take till we know? Semin. Cell Dev. Biol. 84, 75\u201386 (2018).","journal-title":"Semin. Cell Dev. Biol."},{"key":"1471_CR970","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1172\/JCI96481","volume":"128","author":"CA Dillen","year":"2018","unstructured":"Dillen, C. A. et al. Clonally expanded gammadelta T cells protect against Staphylococcus aureus skin reinfection. J. Clin. Invest. 128, 1026\u20131042 (2018).","journal-title":"J. Clin. Invest."},{"key":"1471_CR971","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.4049\/jimmunol.1303420","volume":"192","author":"AG Murphy","year":"2014","unstructured":"Murphy, A. G. et al. Staphylococcus aureus infection of mice expands a population of memory gammadelta T cells that are protective against subsequent infection. J. Immunol. 192, 3697\u20133708 (2014).","journal-title":"J. Immunol."},{"key":"1471_CR972","doi-asserted-by":"publisher","first-page":"e2210490120","DOI":"10.1073\/pnas.2210490120","volume":"120","author":"T Bertram","year":"2023","unstructured":"Bertram, T. et al. Kidney-resident innate-like memory gammadelta T cells control chronic Staphylococcus aureus infection of mice. Proc. Natl Acad. Sci. USA 120, e2210490120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR973","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1074-7613(01)00192-3","volume":"15","author":"J Shires","year":"2001","unstructured":"Shires, J., Theodoridis, E. & Hayday, A. C. Biological insights into TCRgammadelta+ and TCRalphabeta+ intraepithelial lymphocytes provided by serial analysis of gene expression (SAGE). Immunity 15, 419\u2013434 (2001).","journal-title":"Immunity"},{"key":"1471_CR974","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.micinf.2006.11.015","volume":"9","author":"C Nakasone","year":"2007","unstructured":"Nakasone, C. et al. Accumulation of gamma\/delta T cells in the lungs and their roles in neutrophil-mediated host defense against pneumococcal infection. Microbes Infect. 9, 251\u2013258 (2007).","journal-title":"Microbes Infect."},{"key":"1471_CR975","doi-asserted-by":"publisher","first-page":"4662","DOI":"10.4049\/jimmunol.177.7.4662","volume":"177","author":"E Lockhart","year":"2006","unstructured":"Lockhart, E., Green, A. M. & Flynn, J. L. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177, 4662\u20134669 (2006).","journal-title":"J. Immunol."},{"key":"1471_CR976","doi-asserted-by":"crossref","unstructured":"Cimini, E. & Agrati, C. gammadelta T cells in emerging viral infection: an overview. Viruses. 14, 1166 (2022).","DOI":"10.3390\/v14061166"},{"key":"1471_CR977","doi-asserted-by":"publisher","first-page":"741218","DOI":"10.3389\/fimmu.2021.741218","volume":"12","author":"G von Massow","year":"2021","unstructured":"von Massow, G., Oh, S., Lam, A. & Gustafsson, K. Gamma delta T cells and their involvement in COVID-19\u2009virus infections. Front. Immunol. 12, 741218 (2021).","journal-title":"Front. Immunol."},{"key":"1471_CR978","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41564-021-00948-2","volume":"6","author":"PH Papotto","year":"2021","unstructured":"Papotto, P. H., Yilmaz, B. & Silva-Santos, B. Crosstalk between gammadelta T cells and the microbiota. Nat. Microbiol. 6, 1110\u20131117 (2021).","journal-title":"Nat. Microbiol."},{"key":"1471_CR979","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.immuni.2013.06.015","volume":"39","author":"BS Sheridan","year":"2013","unstructured":"Sheridan, B. S. et al. gammadelta T cells exhibit multifunctional and protective memory in intestinal tissues. Immunity 39, 184\u2013195 (2013).","journal-title":"Immunity"},{"key":"1471_CR980","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/cmi.2012.44","volume":"10","author":"S Kalyan","year":"2013","unstructured":"Kalyan, S. & Kabelitz, D. Defining the nature of human gammadelta T cells: a biographical sketch of the highly empathetic. Cell Mol. Immunol. 10, 21\u201329 (2013).","journal-title":"Cell Mol. Immunol."},{"key":"1471_CR981","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41571-022-00722-1","volume":"20","author":"S Mensurado","year":"2023","unstructured":"Mensurado, S., Blanco-Dominguez, R. & Silva-Santos, B. The emerging roles of gammadelta T cells in cancer immunotherapy. Nat. Rev. Clin. Oncol. 20, 178\u2013191 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1471_CR982","doi-asserted-by":"crossref","unstructured":"Lee, D. et al. Human gammadelta T cell subsets and their clinical applications for cancer immunotherapy. Cancers. 14, 3005 (2022).","DOI":"10.3390\/cancers14123005"},{"key":"1471_CR983","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3389\/fimmu.2018.01501","volume":"9","author":"CR Willcox","year":"2018","unstructured":"Willcox, C. R., Davey, M. S. & Willcox, B. E. Development and selection of the human Vgamma9Vdelta2(+) T-cell repertoire. Front. Immunol. 9, 1501 (2018).","journal-title":"Front. Immunol."},{"key":"1471_CR984","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1084\/jem.20021500","volume":"197","author":"HJ Gober","year":"2003","unstructured":"Gober, H. J. et al. Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J. Exp. Med. 197, 163\u2013168 (2003).","journal-title":"J. Exp. Med."},{"key":"1471_CR985","unstructured":"Rigau, M. et al. Butyrophilin 2A1 is essential for phosphoantigen reactivity by gammadelta T cells. Science. 367, eaay5516 (2020)."},{"key":"1471_CR986","doi-asserted-by":"publisher","first-page":"eabj0835","DOI":"10.1126\/scitranslmed.abj0835","volume":"13","author":"A De Gassart","year":"2021","unstructured":"De Gassart, A. et al. Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vgamma9Vdelta2 T cell-mediated antitumor immune response. Sci. Transl. Med. 13, eabj0835 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1471_CR987","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3389\/fimmu.2018.00800","volume":"9","author":"T Hoeres","year":"2018","unstructured":"Hoeres, T., Smetak, M., Pretscher, D. & Wilhelm, M. Improving the efficiency of Vgamma9Vdelta2 T-cell immunotherapy in cancer. Front. Immunol. 9, 800 (2018).","journal-title":"Front. Immunol."},{"key":"1471_CR988","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.it.2014.09.003","volume":"35","author":"AM Luoma","year":"2014","unstructured":"Luoma, A. M., Castro, C. D. & Adams, E. J. gammadelta T cell surveillance via CD1 molecules. Trends Immunol. 35, 613\u2013621 (2014).","journal-title":"Trends Immunol."},{"key":"1471_CR989","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3389\/fimmu.2014.00366","volume":"5","author":"AA Dar","year":"2014","unstructured":"Dar, A. A., Patil, R. S. & Chiplunkar, S. V. Insights into the relationship between Toll like receptors and gamma delta T cell responses. Front. Immunol. 5, 366 (2014).","journal-title":"Front. Immunol."},{"key":"1471_CR990","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2014.03.013","volume":"40","author":"P Wu","year":"2014","unstructured":"Wu, P. et al. gammadeltaT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity 40, 785\u2013800 (2014).","journal-title":"Immunity"},{"key":"1471_CR991","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/ijc.30134","volume":"139","author":"RS Patil","year":"2016","unstructured":"Patil, R. S. et al. IL17 producing gammadeltaT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients. Int. J. Cancer 139, 869\u2013881 (2016).","journal-title":"Int. J. Cancer"},{"key":"1471_CR992","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.4049\/jimmunol.1201892","volume":"189","author":"C Ma","year":"2012","unstructured":"Ma, C. et al. Tumor-infiltrating gammadelta T lymphocytes predict clinical outcome in human breast cancer. J. Immunol. 189, 5029\u20135036 (2012).","journal-title":"J. Immunol."},{"key":"1471_CR993","doi-asserted-by":"publisher","first-page":"1007565","DOI":"10.3389\/fonc.2022.1007565","volume":"12","author":"J Zheng","year":"2022","unstructured":"Zheng, J. et al. Increased PD-1(+)Foxp3(+) gammadelta T cells associate with poor overall survival for patients with acute myeloid leukemia. Front. Oncol. 12, 1007565 (2022).","journal-title":"Front. Oncol."},{"key":"1471_CR994","doi-asserted-by":"crossref","unstructured":"Mikulak, J. et al. NKp46-expressing human gut-resident intraepithelial Vdelta1 T cell subpopulation exhibits high antitumor activity against colorectal cancer. JCI Insight 4, e125884 (2019).","DOI":"10.1172\/jci.insight.125884"},{"key":"1471_CR995","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41568-019-0153-5","volume":"19","author":"B Silva-Santos","year":"2019","unstructured":"Silva-Santos, B., Mensurado, S. & Coffelt, S. B. gammadelta T cells: pleiotropic immune effectors with therapeutic potential in cancer. Nat. Rev. Cancer 19, 392\u2013404 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"1471_CR996","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1378-2","volume":"16","author":"Y Zhao","year":"2018","unstructured":"Zhao, Y., Niu, C. & Cui, J. Gamma-delta (gammadelta) T cells: friend or foe in cancer development? J. Transl. Med. 16, 3 (2018).","journal-title":"J. Transl. Med."},{"key":"1471_CR997","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1182\/blood-2011-06-363655","volume":"119","author":"L Couzi","year":"2012","unstructured":"Couzi, L. et al. Antibody-dependent anti-cytomegalovirus activity of human gammadelta T cells expressing CD16 (FcgammaRIIIa). Blood 119, 1418\u20131427 (2012).","journal-title":"Blood"},{"key":"1471_CR998","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1002\/ijc.23365","volume":"122","author":"H Tokuyama","year":"2008","unstructured":"Tokuyama, H. et al. V gamma 9 V delta 2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs-rituximab and trastuzumab. Int. J. Cancer 122, 2526\u20132534 (2008).","journal-title":"Int. J. Cancer"},{"key":"1471_CR999","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1126\/science.1110267","volume":"309","author":"M Brandes","year":"2005","unstructured":"Brandes, M., Willimann, K. & Moser, B. Professional antigen-presentation function by human gammadelta T Cells. Science 309, 264\u2013268 (2005).","journal-title":"Science"},{"key":"1471_CR1000","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1073\/pnas.0810059106","volume":"106","author":"M Brandes","year":"2009","unstructured":"Brandes, M. et al. Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses. Proc. Natl Acad. Sci. USA 106, 2307\u20132312 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR1001","doi-asserted-by":"crossref","unstructured":"Wang, S. et al. Human gammadelta T cells induce CD8(+) T cell antitumor responses via antigen-presenting effect through HSP90-MyD88-mediated activation of JNK. Cancer Immunol. Immunother. (2023).","DOI":"10.21203\/rs.3.rs-1712757\/v1"},{"key":"1471_CR1002","doi-asserted-by":"publisher","first-page":"894315","DOI":"10.3389\/fimmu.2022.894315","volume":"13","author":"KF Chan","year":"2022","unstructured":"Chan, K. F., Duarte, J. D. G., Ostrouska, S. & Behren, A. gammadelta T cells in the tumor microenvironment-interactions with other immune cells. Front. Immunol. 13, 894315 (2022).","journal-title":"Front. Immunol."},{"key":"1471_CR1003","first-page":"10","volume":"9","author":"J Riond","year":"2009","unstructured":"Riond, J. et al. In vivo major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells is regulated by gammadelta T and NK cells during the early steps of tumor growth. Cancer Immun. 9, 10 (2009).","journal-title":"Cancer Immun."},{"key":"1471_CR1004","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1615\/CritRevImmunol.2014012204","volume":"34","author":"JJ van Beek","year":"2014","unstructured":"van Beek, J. J. et al. Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination. Crit. Rev. Immunol. 34, 517\u2013536 (2014).","journal-title":"Crit. Rev. Immunol."},{"key":"1471_CR1005","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3389\/fimmu.2020.00861","volume":"11","author":"P Girard","year":"2020","unstructured":"Girard, P. et al. Potent bidirectional cross-talk between plasmacytoid dendritic cells and gammadeltaT cells through BTN3A, type I\/II IFNs and immune checkpoints. Front. Immunol. 11, 861 (2020).","journal-title":"Front. Immunol."},{"key":"1471_CR1006","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/imm.12386","volume":"144","author":"C Cairo","year":"2014","unstructured":"Cairo, C. et al. Vgamma2Vdelta2 T cell costimulation increases NK cell killing of monocyte-derived dendritic cells. Immunology 144, 422\u2013430 (2014).","journal-title":"Immunology"},{"key":"1471_CR1007","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1182\/blood-2009-07-234211","volume":"116","author":"A Maniar","year":"2010","unstructured":"Maniar, A. et al. Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement. Blood 116, 1726\u20131733 (2010).","journal-title":"Blood"},{"key":"1471_CR1008","doi-asserted-by":"crossref","unstructured":"Qiu, L., Zhang, Y. & Zeng, X. The function of gammadelta T cells in humoral immune responses. Inflamm. Res. 72, 747\u2013755 (2023).","DOI":"10.1007\/s00011-023-01704-4"},{"key":"1471_CR1009","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41586-022-05593-1","volume":"613","author":"NL de Vries","year":"2023","unstructured":"de Vries, N. L. et al. gammadelta T cells are effectors of immunotherapy in cancers with HLA class I defects. Nature 613, 743\u2013750 (2023).","journal-title":"Nature"},{"key":"1471_CR1010","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1159\/000484390","volume":"43","author":"Z Hu","year":"2017","unstructured":"Hu, Z. et al. IL-17 activates the IL-6\/STAT3 signal pathway in the proliferation of hepatitis B virus-related hepatocellular carcinoma. Cell Physiol. Biochem. 43, 2379\u20132390 (2017).","journal-title":"Cell Physiol. Biochem."},{"key":"1471_CR1011","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","volume":"176","author":"C Jin","year":"2019","unstructured":"Jin, C. et al. Commensal microbiota promote lung cancer development via gammadelta T cells. Cell 176, 998\u20131013 e1016 (2019).","journal-title":"Cell"},{"key":"1471_CR1012","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.cell.2020.10.041","volume":"183","author":"D Daley","year":"2020","unstructured":"Daley, D. et al. gammadelta T cells support pancreatic oncogenesis by restraining alphabeta T cell activation. Cell 183, 1134\u20131136 (2020).","journal-title":"Cell"},{"key":"1471_CR1013","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/JLB.3MA0420-278RR","volume":"107","author":"G Chabab","year":"2020","unstructured":"Chabab, G. et al. Identification of a regulatory Vdelta1 gamma delta T cell subpopulation expressing CD73 in human breast cancer. J. Leukoc. Biol. 107, 1057\u20131067 (2020).","journal-title":"J. Leukoc. Biol."},{"key":"1471_CR1014","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.immuni.2007.05.020","volume":"27","author":"G Peng","year":"2007","unstructured":"Peng, G. et al. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity 27, 334\u2013348 (2007).","journal-title":"Immunity"},{"key":"1471_CR1015","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/cmi.2015.07","volume":"13","author":"Y Mao","year":"2016","unstructured":"Mao, Y. et al. A new effect of IL-4 on human gammadelta T cells: promoting regulatory Vdelta1 T cells via IL-10 production and inhibiting function of Vdelta2 T cells. Cell Mol. Immunol. 13, 217\u2013228 (2016).","journal-title":"Cell Mol. Immunol."},{"key":"1471_CR1016","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1146\/annurev-immunol-032414-112049","volume":"34","author":"SH Baumeister","year":"2016","unstructured":"Baumeister, S. H., Freeman, G. J., Dranoff, G. & Sharpe, A. H. Coinhibitory pathways in immunotherapy for cancer. Annu. Rev. Immunol. 34, 539\u2013573 (2016).","journal-title":"Annu. Rev. Immunol."},{"key":"1471_CR1017","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/d41573-022-00030-4","volume":"21","author":"S Upadhaya","year":"2022","unstructured":"Upadhaya, S., Neftelinov, S. T., Hodge, J. & Campbell, J. Challenges and opportunities in the PD1\/PDL1 inhibitor clinical trial landscape. Nat. Rev. Drug Disco. 21, 482\u2013483 (2022).","journal-title":"Nat. Rev. Drug Disco."},{"key":"1471_CR1018","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nri.2017.112","volume":"18","author":"MN Wykes","year":"2018","unstructured":"Wykes, M. N. & Lewin, S. R. Immune checkpoint blockade in infectious diseases. Nat. Rev. Immunol. 18, 91\u2013104 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR1019","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","volume":"30","author":"X He","year":"2020","unstructured":"He, X. & Xu, C. Immune checkpoint signaling and cancer immunotherapy. Cell Res. 30, 660\u2013669 (2020).","journal-title":"Cell Res."},{"key":"1471_CR1020","doi-asserted-by":"crossref","unstructured":"Albrecht, L. J., Livingstone, E., Zimmer, L. & Schadendorf, D. The latest option: nivolumab and relatlimab in advanced melanoma. Curr. Oncol. Rep. 25, 647\u2013657 (2023).","DOI":"10.1007\/s11912-023-01406-4"},{"key":"1471_CR1021","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa2109970","volume":"386","author":"HA Tawbi","year":"2022","unstructured":"Tawbi, H. A. et al. Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma. N. Engl. J. Med. 386, 24\u201334 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1471_CR1022","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nri3405","volume":"13","author":"L Chen","year":"2013","unstructured":"Chen, L. & Flies, D. B. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 13, 227\u2013242 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"1471_CR1023","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrd.2018.75","volume":"17","author":"PA Mayes","year":"2018","unstructured":"Mayes, P. A., Hance, K. W. & Hoos, A. The promise and challenges of immune agonist antibody development in cancer. Nat. Rev. Drug Disco. 17, 509\u2013527 (2018).","journal-title":"Nat. Rev. Drug Disco."},{"key":"1471_CR1024","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/d41573-019-00214-5","volume":"19","author":"K Garber","year":"2020","unstructured":"Garber, K. Immune agonist antibodies face critical test. Nat. Rev. Drug Disco. 19, 3\u20135 (2020).","journal-title":"Nat. Rev. Drug Disco."},{"key":"1471_CR1025","doi-asserted-by":"crossref","unstructured":"Yao, Y., Hu, Y. & Wang, F. Trispecific antibodies for cancer immunotherapy. Immunology (2023).","DOI":"10.1111\/imm.13636"},{"key":"1471_CR1026","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41573-019-0028-1","volume":"18","author":"AF Labrijn","year":"2019","unstructured":"Labrijn, A. F., Janmaat, M. L., Reichert, J. M. & Parren, P. Bispecific antibodies: a mechanistic review of the pipeline. Nat. Rev. Drug Disco. 18, 585\u2013608 (2019).","journal-title":"Nat. Rev. Drug Disco."},{"key":"1471_CR1027","doi-asserted-by":"publisher","first-page":"181","DOI":"10.20892\/j.issn.2095-3941.2023.0002","volume":"20","author":"T Zhang","year":"2023","unstructured":"Zhang, T., Lin, Y. & Gao, Q. Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy. Cancer Biol. Med. 20, 181\u2013195 (2023).","journal-title":"Cancer Biol. Med."},{"key":"1471_CR1028","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s40265-022-01761-9","volume":"82","author":"SJ Keam","year":"2022","unstructured":"Keam, S. J. Cadonilimab: first approval. Drugs 82, 1333\u20131339 (2022).","journal-title":"Drugs"},{"key":"1471_CR1029","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1158\/2159-8290.CD-21-1345","volume":"12","author":"A Muik","year":"2022","unstructured":"Muik, A. et al. Preclinical characterization and phase I trial results of a bispecific antibody targeting PD-L1 and 4-1BB (GEN1046) in patients with advanced refractory solid tumors. Cancer Disco. 12, 1248\u20131265 (2022).","journal-title":"Cancer Disco."},{"key":"1471_CR1030","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1158\/1535-7163.MCT-20-0226","volume":"19","author":"Z Kuang","year":"2020","unstructured":"Kuang, Z. et al. A novel bispecific antibody with PD-L1-assisted OX40 activation for cancer tTreatment. Mol. Cancer Ther. 19, 2564\u20132574 (2020).","journal-title":"Mol. Cancer Ther."},{"key":"1471_CR1031","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s40425-019-0570-8","volume":"7","author":"AM Kvarnhammar","year":"2019","unstructured":"Kvarnhammar, A. M. et al. The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation. J. Immunother. Cancer 7, 103 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"1471_CR1032","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s00262-020-02610-y","volume":"69","author":"LA Vitale","year":"2020","unstructured":"Vitale, L. A. et al. Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapy. Cancer Immunol. Immunother. 69, 2125\u20132137 (2020).","journal-title":"Cancer Immunol. Immunother."},{"key":"1471_CR1033","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.tranon.2020.100916","volume":"14","author":"L Li","year":"2021","unstructured":"Li, L. et al. Tumor-targeting anti-EGFR x anti-PD1 bispecific antibody inhibits EGFR-overexpressing tumor growth by combining EGFR blockade and immune activation with direct tumor cell killing. Transl. Oncol. 14, 100916 (2021).","journal-title":"Transl. Oncol."},{"key":"1471_CR1034","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41401-021-00683-8","volume":"43","author":"CL Gu","year":"2022","unstructured":"Gu, C. L. et al. Bispecific antibody simultaneously targeting PD1 and HER2 inhibits tumor growth via direct tumor cell killing in combination with PD1\/PDL1 blockade and HER2 inhibition. Acta Pharm. Sin. 43, 672\u2013680 (2022).","journal-title":"Acta Pharm. Sin."},{"key":"1471_CR1035","doi-asserted-by":"crossref","unstructured":"Nixon, B. G., Gao, S., Wang, X. & Li, M. O. TGFbeta control of immune responses in cancer: a holistic immuno-oncology perspective. Nat. Rev. Immunol. (2022).","DOI":"10.1038\/s41577-022-00796-z"},{"key":"1471_CR1036","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s40259-022-00521-1","volume":"36","author":"NP Tschernia","year":"2022","unstructured":"Tschernia, N. P. & Gulley, J. L. Tumor in the crossfire: inhibiting TGF-beta to enhance cancer immunotherapy. BioDrugs 36, 153\u2013180 (2022).","journal-title":"BioDrugs"},{"key":"1471_CR1037","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/CCO.0000000000000869","volume":"34","author":"PA Baeuerle","year":"2022","unstructured":"Baeuerle, P. A. & Wesche, H. T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities. Curr. Opin. Oncol. 34, 552\u2013558 (2022).","journal-title":"Curr. Opin. Oncol."},{"key":"1471_CR1038","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1080\/14712598.2022.2098674","volume":"22","author":"TT Chen","year":"2022","unstructured":"Chen, T. T. Conditionally active T cell engagers for the treatment of solid tumors: rationale and clinical development. Expert Opin. Biol. Ther. 22, 955\u2013963 (2022).","journal-title":"Expert Opin. Biol. Ther."},{"key":"1471_CR1039","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/d41573-022-00040-2","volume":"21","author":"A Esfandiari","year":"2022","unstructured":"Esfandiari, A., Cassidy, S. & Webster, R. M. Bispecific antibodies in oncology. Nat. Rev. Drug Disco. 21, 411\u2013412 (2022).","journal-title":"Nat. Rev. Drug Disco."},{"key":"1471_CR1040","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ccell.2023.02.008","volume":"41","author":"MJ Friedrich","year":"2023","unstructured":"Friedrich, M. J. et al. The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients. Cancer Cell 41, 711\u2013725 e716 (2023).","journal-title":"Cancer Cell"},{"key":"1471_CR1041","doi-asserted-by":"crossref","unstructured":"Middelburg, J. et al. Overcoming challenges for CD3-bispecific antibody therapy in solid tumors. Cancers 13, 287 (2021).","DOI":"10.3390\/cancers13020287"},{"key":"1471_CR1042","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum, D. C. & June, C. H. Cytokine storm. N. Engl. J. Med. 383, 2255\u20132273 (2020).","journal-title":"N. Engl. J. Med"},{"key":"1471_CR1043","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s40265-022-01704-4","volume":"82","author":"S Dhillon","year":"2022","unstructured":"Dhillon, S. Tebentafusp: first approval. Drugs 82, 703\u2013710 (2022).","journal-title":"Drugs"},{"key":"1471_CR1044","doi-asserted-by":"publisher","first-page":"2167189","DOI":"10.1080\/19420862.2023.2167189","volume":"15","author":"C Claus","year":"2023","unstructured":"Claus, C., Ferrara-Koller, C. & Klein, C. The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy. MAbs 15, 2167189 (2023).","journal-title":"MAbs"},{"key":"1471_CR1045","unstructured":"Skokos, D. et al. A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies. Sci. Transl. Med. 12, eaaw7888 (2020)."},{"key":"1471_CR1046","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41571-021-00530-z","volume":"18","author":"KM Cappell","year":"2021","unstructured":"Cappell, K. M. & Kochenderfer, J. N. A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains. Nat. Rev. Clin. Oncol. 18, 715\u2013727 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1471_CR1047","doi-asserted-by":"publisher","first-page":"102931","DOI":"10.1016\/j.ebiom.2020.102931","volume":"58","author":"J Jayaraman","year":"2020","unstructured":"Jayaraman, J. et al. CAR-T design: elements and their synergistic function. EBioMedicine 58, 102931 (2020).","journal-title":"EBioMedicine"},{"key":"1471_CR1048","doi-asserted-by":"publisher","first-page":"112512","DOI":"10.1016\/j.biopha.2021.112512","volume":"146","author":"AZ Mehrabadi","year":"2022","unstructured":"Mehrabadi, A. Z. et al. Therapeutic potential of CAR T cell in malignancies: a scoping review. Biomed. Pharmacother. 146, 112512 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"1471_CR1049","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40164-023-00373-7","volume":"12","author":"T Yan","year":"2023","unstructured":"Yan, T., Zhu, L. & Chen, J. Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment. Exp. Hematol. Oncol. 12, 14 (2023).","journal-title":"Exp. Hematol. Oncol."},{"key":"1471_CR1050","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1158\/2159-8290.CD-21-1683","volume":"12","author":"RM Young","year":"2022","unstructured":"Young, R. M. et al. Next-generation CAR T-cell therapies. Cancer Disco. 12, 1625\u20131633 (2022).","journal-title":"Cancer Disco."},{"key":"1471_CR1051","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21078-7","volume":"12","author":"JH Cho","year":"2021","unstructured":"Cho, J. H. et al. Engineering advanced logic and distributed computing in human CAR immune cells. Nat. Commun. 12, 792 (2021).","journal-title":"Nat. Commun."},{"key":"1471_CR1052","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41586-023-05778-2","volume":"615","author":"AM Tousley","year":"2023","unstructured":"Tousley, A. M. et al. Co-opting signalling molecules enables logic-gated control of CAR T cells. Nature 615, 507\u2013516 (2023).","journal-title":"Nature"},{"key":"1471_CR1053","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coi.2021.09.003","volume":"74","author":"S Simon","year":"2022","unstructured":"Simon, S., Bugos, G., Salter, A. I. & Riddell, S. R. Synthetic receptors for logic gated T cell recognition and function. Curr. Opin. Immunol. 74, 9\u201317 (2022).","journal-title":"Curr. Opin. Immunol."},{"key":"1471_CR1054","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1158\/2159-8290.CD-23-0101","volume":"13","author":"M Hamieh","year":"2023","unstructured":"Hamieh, M., Mansilla-Soto, J., Riviere, I. & Sadelain, M. Programming CAR T cell tumor recognition: tuned antigen sensing and logic gating. Cancer Disco. 13, 829\u2013843 (2023).","journal-title":"Cancer Disco."},{"key":"1471_CR1055","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1126\/science.abc6270","volume":"370","author":"JZ Williams","year":"2020","unstructured":"Williams, J. Z. et al. Precise T cell recognition programs designed by transcriptionally linking multiple receptors. Science 370, 1099\u20131104 (2020).","journal-title":"Science"},{"key":"1471_CR1056","doi-asserted-by":"crossref","unstructured":"Salter, A. I. et al. Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function. Sci. Signal. 14, eabe2606 (2021).","DOI":"10.1126\/scisignal.abe2606"},{"key":"1471_CR1057","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/imr.12772","volume":"290","author":"SS Chandran","year":"2019","unstructured":"Chandran, S. S. & Klebanoff, C. A. T cell receptor-based cancer immunotherapy: emerging efficacy and pathways of resistance. Immunol. Rev. 290, 127\u2013147 (2019).","journal-title":"Immunol. Rev."},{"key":"1471_CR1058","doi-asserted-by":"publisher","first-page":"1056622","DOI":"10.3389\/fimmu.2022.1056622","volume":"13","author":"W Mao","year":"2022","unstructured":"Mao, W. Overcoming current challenges to T-cell receptor therapy via metabolic targeting to increase antitumor efficacy, durability, and tolerability. Front. Immunol. 13, 1056622 (2022).","journal-title":"Front. Immunol."},{"key":"1471_CR1059","doi-asserted-by":"crossref","unstructured":"Zhang, S. Q. et al. High-throughput determination of the antigen specificities of T cell receptors in single cells. Nat. Biotechnol. 36, 1156\u20131159 (2018).","DOI":"10.1038\/nbt.4282"},{"key":"1471_CR1060","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ymthe.2017.10.018","volume":"26","author":"YC Lu","year":"2018","unstructured":"Lu, Y. C. et al. An efficient single-cell RNA-seq approach to identify neoantigen-specific T cell receptors. Mol. Ther. 26, 379\u2013389 (2018).","journal-title":"Mol. Ther."},{"key":"1471_CR1061","doi-asserted-by":"crossref","unstructured":"Lu, Y. C. et al. Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing. J. Immunother. Cancer. 9, e002595 (2021).","DOI":"10.1136\/jitc-2021-002595"},{"key":"1471_CR1062","doi-asserted-by":"publisher","first-page":"110873","DOI":"10.1016\/j.biopha.2020.110873","volume":"132","author":"B Lin","year":"2020","unstructured":"Lin, B. et al. Tumor-infiltrating lymphocytes: warriors fight against tumors powerfully. Biomed. Pharmacother. 132, 110873 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"1471_CR1063","doi-asserted-by":"publisher","first-page":"8412","DOI":"10.1158\/0008-5472.CAN-09-0852","volume":"69","author":"S Attig","year":"2009","unstructured":"Attig, S. et al. Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas. Cancer Res. 69, 8412\u20138419 (2009).","journal-title":"Cancer Res."},{"key":"1471_CR1064","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1093\/annonc\/mdz398","volume":"30","author":"U Dafni","year":"2019","unstructured":"Dafni, U. et al. Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis. Ann. Oncol. 30, 1902\u20131913 (2019).","journal-title":"Ann. Oncol."},{"key":"1471_CR1065","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ncponc0666","volume":"3","author":"P Muranski","year":"2006","unstructured":"Muranski, P. et al. Increased intensity lymphodepletion and adoptive immunotherapy-how far can we go? Nat. Clin. Pr. Oncol. 3, 668\u2013681 (2006).","journal-title":"Nat. Clin. Pr. Oncol."},{"key":"1471_CR1066","doi-asserted-by":"crossref","unstructured":"Chesney, J. et al. Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study. J. Immunother. Cancer. 10, e005755 (2022).","DOI":"10.1136\/jitc-2022-005755"},{"key":"1471_CR1067","doi-asserted-by":"publisher","first-page":"690499","DOI":"10.3389\/fimmu.2021.690499","volume":"12","author":"A Kumar","year":"2021","unstructured":"Kumar, A., Watkins, R. & Vilgelm, A. E. Cell therapy with TILs: training and taming T cells to fight cancer. Front. Immunol. 12, 690499 (2021).","journal-title":"Front. Immunol."},{"key":"1471_CR1068","doi-asserted-by":"publisher","first-page":"6122","DOI":"10.1158\/1078-0432.CCR-10-1297","volume":"16","author":"ME Dudley","year":"2010","unstructured":"Dudley, M. E. et al. CD8+ enriched \u201cyoung\u201d tumor infiltrating lymphocytes can mediate regression of metastatic melanoma. Clin. Cancer Res. 16, 6122\u20136131 (2010).","journal-title":"Clin. Cancer Res"},{"key":"1471_CR1069","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s40259-014-0097-y","volume":"28","author":"GC Sim","year":"2014","unstructured":"Sim, G. C. et al. Tumor-infiltrating lymphocyte therapy for melanoma: rationale and issues for further clinical development. BioDrugs 28, 421\u2013437 (2014).","journal-title":"BioDrugs"},{"key":"1471_CR1070","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-9-131","volume":"9","author":"Q Ye","year":"2011","unstructured":"Ye, Q. et al. Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes. J. Transl. Med. 9, 131 (2011).","journal-title":"J. Transl. Med."},{"key":"1471_CR1071","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.4049\/jimmunol.163.6.2999","volume":"163","author":"MF Krummel","year":"1999","unstructured":"Krummel, M. F., Heath, W. R. & Allison, J. Differential coupling of second signals for cytotoxicity and proliferation in CD8+ T cell effectors: amplification of the lytic potential by B7. J. Immunol. 163, 2999\u20133006 (1999).","journal-title":"J. Immunol."},{"key":"1471_CR1072","doi-asserted-by":"publisher","first-page":"1018962","DOI":"10.3389\/fimmu.2022.1018962","volume":"13","author":"MH Kazemi","year":"2022","unstructured":"Kazemi, M. H. et al. Tumor-infiltrating lymphocytes for treatment of solid tumors: it takes two to tango? Front. Immunol. 13, 1018962 (2022).","journal-title":"Front. Immunol."},{"key":"1471_CR1073","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3389\/fphar.2017.00460","volume":"8","author":"P Li","year":"2017","unstructured":"Li, P., Zheng, Y. & Chen, X. Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics. Front. Pharm. 8, 460 (2017).","journal-title":"Front. Pharm."},{"key":"1471_CR1074","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.4110\/in.2022.22.e9","volume":"22","author":"SM Jung","year":"2022","unstructured":"Jung, S. M. & Kim, W. U. Targeted immunotherapy for autoimmune disease. Immune Netw. 22, e9 (2022).","journal-title":"Immune Netw."},{"key":"1471_CR1075","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/d41573-021-00079-7","volume":"20","author":"A Mullard","year":"2021","unstructured":"Mullard, A. FDA approves 100th monoclonal antibody product. Nat. Rev. Drug Disco. 20, 491\u2013495 (2021).","journal-title":"Nat. Rev. Drug Disco."},{"key":"1471_CR1076","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/intimm\/dxv063","volume":"28","author":"Y Lai","year":"2016","unstructured":"Lai, Y. & Dong, C. Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases. Int. Immunol. 28, 181\u2013188 (2016).","journal-title":"Int. Immunol."},{"key":"1471_CR1077","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0140-6736(21)00438-4","volume":"398","author":"DP McLornan","year":"2021","unstructured":"McLornan, D. P., Pope, J. E., Gotlib, J. & Harrison, C. N. Current and future status of JAK inhibitors. Lancet 398, 803\u2013816 (2021).","journal-title":"Lancet"},{"key":"1471_CR1078","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu, X. et al. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct. Target Ther. 6, 402 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"1471_CR1079","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3389\/fimmu.2018.00835","volume":"9","author":"K Hofmann","year":"2018","unstructured":"Hofmann, K., Clauder, A. K. & Manz, R. A. Targeting B cells and plasma cells in autoimmune diseases. Front. Immunol. 9, 835 (2018).","journal-title":"Front. Immunol."},{"key":"1471_CR1080","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.1016\/j.cell.2022.10.026","volume":"185","author":"DJ Baker","year":"2022","unstructured":"Baker, D. J. & June, C. H. CAR T therapy extends its reach to autoimmune diseases. Cell 185, 4471\u20134473 (2022).","journal-title":"Cell"},{"key":"1471_CR1081","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","volume":"28","author":"A Mackensen","year":"2022","unstructured":"Mackensen, A. et al. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nat. Med. 28, 2124\u20132132 (2022).","journal-title":"Nat. Med."},{"key":"1471_CR1082","doi-asserted-by":"publisher","first-page":"102931","DOI":"10.1016\/j.autrev.2021.102931","volume":"21","author":"M Su","year":"2022","unstructured":"Su, M., Zhao, C. & Luo, S. Therapeutic potential of chimeric antigen receptor based therapies in autoimmune diseases. Autoimmun. Rev. 21, 102931 (2022).","journal-title":"Autoimmun. Rev."},{"key":"1471_CR1083","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00011-021-01470-1","volume":"70","author":"Y Santamaria-Alza","year":"2021","unstructured":"Santamaria-Alza, Y. & Vasquez, G. Are chimeric antigen receptor T cells (CAR-T cells) the future in immunotherapy for autoimmune diseases? Inflamm. Res. 70, 651\u2013663 (2021).","journal-title":"Inflamm. Res."},{"key":"1471_CR1084","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41573-020-00092-2","volume":"20","author":"DSW Lee","year":"2021","unstructured":"Lee, D. S. W., Rojas, O. L. & Gommerman, J. L. B cell depletion therapies in autoimmune disease: advances and mechanistic insights. Nat. Rev. Drug Disco. 20, 179\u2013199 (2021).","journal-title":"Nat. Rev. Drug Disco."},{"key":"1471_CR1085","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/s41375-020-0951-5","volume":"35","author":"L Lin","year":"2021","unstructured":"Lin, L. et al. Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma. Leukemia 35, 752\u2013763 (2021).","journal-title":"Leukemia"},{"key":"1471_CR1086","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/s41423-020-0472-1","volume":"18","author":"X Jin","year":"2021","unstructured":"Jin, X. et al. Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus. Cell Mol. Immunol. 18, 1896\u20131903 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"1471_CR1087","doi-asserted-by":"crossref","unstructured":"Kansal, R. et al. Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus. Sci. Transl. Med. 11, eaav1648 (2019).","DOI":"10.1126\/scitranslmed.aav1648"},{"key":"1471_CR1088","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(23)00023-5","volume":"401","author":"F Muller","year":"2023","unstructured":"Muller, F. et al. CD19-targeted CAR T cells in refractory antisynthetase syndrome. Lancet 401, 815\u2013818 (2023).","journal-title":"Lancet"},{"key":"1471_CR1089","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41392-022-01278-3","volume":"8","author":"C Qin","year":"2023","unstructured":"Qin, C. et al. Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results. Signal Transduct. Target Ther. 8, 5 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"1471_CR1090","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMc2107725","volume":"385","author":"D Mougiakakos","year":"2021","unstructured":"Mougiakakos, D. et al. CD19-targeted CAR T cells in refractory systemic lupus erythematosus. N. Engl. J. Med. 385, 567\u2013569 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1471_CR1091","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.aaf6756","volume":"353","author":"CT Ellebrecht","year":"2016","unstructured":"Ellebrecht, C. T. et al. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science 353, 179\u2013184 (2016).","journal-title":"Science"},{"key":"1471_CR1092","doi-asserted-by":"publisher","first-page":"6317","DOI":"10.1172\/JCI138416","volume":"130","author":"J Lee","year":"2020","unstructured":"Lee, J. et al. Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris. J. Clin. Invest. 130, 6317\u20136324 (2020).","journal-title":"J. Clin. Invest."},{"key":"1471_CR1093","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jneuroim.2015.12.016","volume":"291","author":"MG Huijbers","year":"2016","unstructured":"Huijbers, M. G. et al. Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity. J. Neuroimmunol. 291, 82\u201388 (2016).","journal-title":"J. Neuroimmunol."},{"key":"1471_CR1094","doi-asserted-by":"publisher","first-page":"28950","DOI":"10.1073\/pnas.2012495117","volume":"117","author":"S Kobayashi","year":"2020","unstructured":"Kobayashi, S. et al. A biomimetic five-module chimeric antigen receptor ((5\u2009M)CAR) designed to target and eliminate antigen-specific T cells. Proc. Natl Acad. Sci. USA 117, 28950\u201328959 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1471_CR1095","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jaut.2018.08.004","volume":"96","author":"L Zhang","year":"2019","unstructured":"Zhang, L. et al. Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes. J. Autoimmun. 96, 50\u201358 (2019).","journal-title":"J. Autoimmun."},{"key":"1471_CR1096","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ymthe.2016.12.007","volume":"25","author":"S Fishman","year":"2017","unstructured":"Fishman, S. et al. Adoptive transfer of mRNA-transfected T cells redirected against diabetogenic CD8 T cells can prevent diabetes. Mol. Ther. 25, 456\u2013464 (2017).","journal-title":"Mol. Ther."},{"key":"1471_CR1097","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.molmed.2022.04.010","volume":"28","author":"Y Yuan","year":"2022","unstructured":"Yuan, Y. et al. Therapeutic potential of interleukin-2 in autoimmune diseases. Trends Mol. Med. 28, 596\u2013612 (2022).","journal-title":"Trends Mol. Med."},{"key":"1471_CR1098","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41584-021-00707-x","volume":"17","author":"AGA Kolios","year":"2021","unstructured":"Kolios, A. G. A., Tsokos, G. C. & Klatzmann, D. Interleukin-2 and regulatory T cells in rheumatic diseases. Nat. Rev. Rheumatol. 17, 749\u2013766 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1471_CR1099","doi-asserted-by":"publisher","first-page":"104193","DOI":"10.1016\/j.cellimm.2020.104193","volume":"356","author":"J Rana","year":"2020","unstructured":"Rana, J. & Biswas, M. Regulatory T cell therapy: current and future design perspectives. Cell Immunol. 356, 104193 (2020).","journal-title":"Cell Immunol."},{"key":"1471_CR1100","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-112","volume":"9","author":"M Fransson","year":"2012","unstructured":"Fransson, M. et al. CAR\/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery. J. Neuroinflammation 9, 112 (2012).","journal-title":"J. Neuroinflammation"},{"key":"1471_CR1101","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1053\/j.gastro.2008.02.060","volume":"134","author":"E Elinav","year":"2008","unstructured":"Elinav, E., Waks, T. & Eshhar, Z. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice. Gastroenterology 134, 2014\u20132024 (2008).","journal-title":"Gastroenterology"},{"key":"1471_CR1102","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/mt.2014.41","volume":"22","author":"D Blat","year":"2014","unstructured":"Blat, D. et al. Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells. Mol. Ther. 22, 1018\u20131028 (2014).","journal-title":"Mol. Ther."},{"key":"1471_CR1103","doi-asserted-by":"crossref","unstructured":"Raffin, C. et al. Development of citrullinated-vimentin-specific CAR for targeting Tregs to treat autoimmune rheumatoid arthritis. J. Immunol. 200, 176.117 (2018).","DOI":"10.4049\/jimmunol.200.Supp.176.17"},{"key":"1471_CR1104","doi-asserted-by":"publisher","first-page":"102289","DOI":"10.1016\/j.jaut.2019.05.017","volume":"103","author":"M Tenspolde","year":"2019","unstructured":"Tenspolde, M. et al. Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes. J. Autoimmun. 103, 102289 (2019).","journal-title":"J. Autoimmun."},{"key":"1471_CR1105","doi-asserted-by":"crossref","unstructured":"Proics, E. et al. Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation. Gene Ther. 30, 309\u2013322 (2022).","DOI":"10.1038\/s41434-022-00358-x"},{"key":"1471_CR1106","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/ajt.14175","volume":"17","author":"F Noyan","year":"2017","unstructured":"Noyan, F. et al. Prevention of allograft rejection by use of regulatory T cells with an MHC-specific chimeric antigen receptor. Am. J. Transpl. 17, 917\u2013930 (2017).","journal-title":"Am. J. Transpl."},{"key":"1471_CR1107","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41392-020-00256-x","volume":"5","author":"J Wei","year":"2020","unstructured":"Wei, J. et al. The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma. Signal Transduct. Target Ther. 5, 134 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"1471_CR1108","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41392-021-00823-w","volume":"6","author":"K Shah","year":"2021","unstructured":"Shah, K., Al-Haidari, A., Sun, J. & Kazi, J. U. T cell receptor (TCR) signaling in health and disease. Signal Transduct. Target Ther. 6, 412 (2021).","journal-title":"Signal Transduct. Target Ther."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01471-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01471-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01471-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,18]],"date-time":"2023-06-18T20:02:46Z","timestamp":1687118566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01471-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":1108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1471"],"URL":"https:\/\/doi.org\/10.1038\/s41392-023-01471-y","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"assertion":[{"value":"12 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}